| C495657 | 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | "CYP1A2 protein results in increased chemical synthesis of 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane" | 9733665 |
| C495657 | 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | "CYP1A2 protein results in increased hydroxylation of 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane" | 9047321 |
| C412791 | 1,2,3,4,6,7-hexachlorinated naphthalene | "1,2,3,4,6,7-hexachlorinated naphthalene results in increased activity of CYP1A2 protein" | 22813907 |
| C575652 | 1,2,3,5,6,7-hexachloronaphthalene | "1,2,3,5,6,7-hexachloronaphthalene results in increased activity of CYP1A2 protein" | 22813907 |
| C057584 | 1,2,3,7,8-pentachlorodibenzofuran | "1,2,3,7,8-pentachlorodibenzofuran results in increased expression of CYP1A2 mRNA" | 24713691 |
| C051452 | 1,2,3,7,8-pentachlorodibenzo-p-dioxin | "1,2,3,7,8-pentachlorodibenzo-p-dioxin results in increased expression of CYP1A2 mRNA" | 23674508 |
| C018673 | 1,2,4,5-tetrachlorobenzene | "1,2,4,5-tetrachlorobenzene results in increased expression of CYP1A2 protein" | 10696772 |
| C009947 | 1,2,4-trichlorobenzene | "CYP1A2 protein results in increased oxidation of 1,2,4-trichlorobenzene" | 7747284 |
| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in decreased activity of CYP1A2 protein" | 11162773 |
| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein" | 19362136 |
| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in increased expression of CYP1A2 mRNA" | 16269432|1725372 |
| C026486 | 1,2,5,6-dibenzanthracene | "alyssin inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]" | 19362136 |
| C026486 | 1,2,5,6-dibenzanthracene | "[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA" | 17690111 |
| C026486 | 1,2,5,6-dibenzanthracene | "[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene" | 8961944 |
| C026486 | 1,2,5,6-dibenzanthracene | "CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene" | 8638931 |
| C026486 | 1,2,5,6-dibenzanthracene | "[CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-1,2-dihydrodiol" | 8638931 |
| C026486 | 1,2,5,6-dibenzanthracene | "[CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-3,4-dihydrodiol" | 8638931 |
| C026486 | 1,2,5,6-dibenzanthracene | "EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]" | 8961944 |
| C026486 | 1,2,5,6-dibenzanthracene | "sulforafan inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]" | 19362136 |
| C026486 | 1,2,5,6-dibenzanthracene | "[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene" | 8961944 |
| C026486 | 1,2,5,6-dibenzanthracene | "EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]" | 8961944 |
| C026486 | 1,2,5,6-dibenzanthracene | "[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA" | 18711122 |
| C026486 | 1,2,5,6-dibenzanthracene | "[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA" | 18711122 |
| C026486 | 1,2,5,6-dibenzanthracene | "[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA" | 18711122 |
| C057485 | 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane | "1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane results in increased expression of and results in increased activity of CYP1A2 protein" | 26827781 |
| C057485 | 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane | "1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane results in increased expression of CYP1A2 mRNA" | 26827781 |
| C035384 | 1,2-dichloroethylene | "1,2-dichloroethylene affects the expression of CYP1A2 protein" | 9493318 |
| C035384 | 1,2-dichloroethylene | "1,2-dichloroethylene results in decreased activity of CYP1A2 protein" | 9671540 |
| C117619 | 1,2-dimethylnaphthalene | "1,2-dimethylnaphthalene results in decreased activity of CYP1A2 protein" | 15916432 |
| C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione results in decreased expression of CYP1A2 mRNA" | 19162173 |
| C439392 | 1-(2-methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline | "1-(2-methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline results in decreased activity of CYP1A2 protein" | 15585365 |
| C576882 | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone results in decreased expression of CYP1A2 mRNA | 25596134 |
| C585955 | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | Ketoconazole affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| C585955 | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | [NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 24120545 |
| C585955 | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | Quercetin inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| C585955 | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| C585955 | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | Tranylcypromine affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| C037413 | 1,3-dinitropyrene | "[CYP1A2 protein co-treated with POR protein] results in decreased metabolism of 1,3-dinitropyrene" | 11113705 |
| C037413 | 1,3-dinitropyrene | "CYP1A2 protein affects the metabolism of 1,3-dinitropyrene" | 2180560 |
| C517215 | 13-hydroxyellipticine | CYP1A2 protein results in increased chemical synthesis of 13-hydroxyellipticine | 22917556 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP1A2 mRNA" | 15764585 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "NCOA6 protein promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP1A2 mRNA]" | 15764585 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP1A2 mRNA" | 16109766|2249639 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "CTNNB1 protein affects the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP1A2 mRNA]" | 23578392 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "MED1 protein promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP1A2 mRNA]" | 16109766 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "NR1I3 protein affects the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP1A2 mRNA]" | 22496397 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "NR1I3 protein promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CYP1A2 mRNA]" | 22698814 |
| C091765 | 1,4-dihydroxy-2-nonene | "[CYP1A2 protein results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene" | 21766881 |
| C031969 | 1,4-dimethylnaphthalene | "1,4-dimethylnaphthalene results in decreased activity of CYP1A2 protein" | 15916432 |
| C090768 | 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene | "CYP1A2 protein results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene" | 29285606 |
| C090768 | 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene | "CYP1A2 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene" | 29285606 |
| C090768 | 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene | "[CYP1A2 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene] which results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene metabolite" | 29285606 |
| C090768 | 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene | "[CYP1A2 protein results in increased metabolism of N-desmethyltamoxifen] which results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene" | 29285606 |
| C090768 | 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene | "[CYP1A2 protein results in increased metabolism of Tamoxifen] which results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene" | 29285606 |
| C035342 | 1,4-naphthoquinone | "1,4-naphthoquinone results in increased expression of CYP1A2 mRNA" | 18602459 |
| C035342 | 1,4-naphthoquinone | "CYP1A2 protein results in increased abundance of 1,4-naphthoquinone" | 16243959 |
| C074153 | 1,4-phenylenebis(methylene)selenocyanate | "1,4-phenylenebis(methylene)selenocyanate binds to and results in decreased activity of CYP1A2 protein" | 21732699 |
| C401932 | 15,16-dihydrotanshinone I | "15,16-dihydrotanshinone I promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]" | 21262253 |
| C401932 | 15,16-dihydrotanshinone I | "15,16-dihydrotanshinone I promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]" | 21262253 |
| C401932 | 15,16-dihydrotanshinone I | "15,16-dihydrotanshinone I results in increased expression of CYP1A2 mRNA" | 21262253 |
| C401932 | 15,16-dihydrotanshinone I | "15,16-dihydrotanshinone I results in increased expression of CYP1A2 protein" | 21262253 |
| C401932 | 15,16-dihydrotanshinone I | "Dactinomycin inhibits the reaction [15,16-dihydrotanshinone I results in increased expression of CYP1A2 mRNA]" | 21262253 |
| C401932 | 15,16-dihydrotanshinone I | "resveratrol inhibits the reaction [15,16-dihydrotanshinone I results in increased expression of CYP1A2 mRNA]" | 21262253 |
| C466921 | 1,6-dimethylnaphthalene | "1,6-dimethylnaphthalene results in decreased activity of CYP1A2 protein" | 15916432 |
| C033309 | 1,6-dinitropyrene | "CYP1A2 protein affects the metabolism of 1,6-dinitropyrene" | 2180560 |
| C486136 | 16-O-demethylaconitine | [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased chemical synthesis of 16-O-demethylaconitine metabolite | 21277363 |
| C021183 | 1,7-dimethylxanthine | "CYP1A2 protein affects the metabolism of 1,7-dimethylxanthine" | 1302044 |
| C021183 | 1,7-dimethylxanthine | "CYP1A2 protein results in increased chemical synthesis of 1,7-dimethylxanthine" | 1302044 |
| C021183 | 1,7-dimethylxanthine | "CYP1A2 protein results in increased hydroxylation of 1,7-dimethylxanthine" | 15980104 |
| C021183 | 1,7-dimethylxanthine | "CYP1A2 protein results in increased metabolism of 1,7-dimethylxanthine" | 19215233 |
| C021183 | 1,7-dimethylxanthine | "[CYP1A2 protein results in increased metabolism of 1,7-dimethylxanthine] which results in increased chemical synthesis of 1-methylxanthine" | 19215233 |
| C021183 | 1,7-dimethylxanthine | "[CYP1A2 protein results in increased metabolism of Caffeine] which results in increased chemical synthesis of 1,7-dimethylxanthine" | 19215233 |
| C053486 | 1,7-phenanthroline | "1,7-phenanthroline inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 protein]" | 17967931 |
| C053486 | 1,7-phenanthroline | "1,7-phenanthroline results in increased expression of CYP1A2 protein" | 17967931 |
| C033310 | 1,8-dinitropyrene | "CYP1A2 protein affects the metabolism of 1,8-dinitropyrene" | 2180560 |
| C033020 | 1-aminobenzotriazole | 1-aminobenzotriazole results in decreased activity of CYP1A2 protein | 15618748 |
| C004482 | 1-aminopyrene | CYP1A2 protein results in increased activity of 1-aminopyrene | 15728263 |
| C031337 | 1-chloronaphthalene | 1-chloronaphthalene results in decreased activity of CYP1A2 protein | 15916432 |
| C040345 | 1-chloropyrene | CYP1A2 protein results in increased metabolism of 1-chloropyrene | 26252339 |
| C478004 | 1-hydroxy-2,3,5-trimethoxyxanthone | "CYP1A2 protein results in increased metabolism of 1-hydroxy-2,3,5-trimethoxyxanthone" | 24380714 |
| C025968 | 1-methylnaphthalene | 1-methylnaphthalene results in decreased activity of CYP1A2 protein | 15916432 |
| C053085 | 1-methylxanthine | 1-methylxanthine results in decreased activity of CYP1A2 protein | 11465391 |
| C053085 | 1-methylxanthine | "[CYP1A2 protein results in increased metabolism of 1,7-dimethylxanthine] which results in increased chemical synthesis of 1-methylxanthine" | 19215233 |
| C029350 | 1-naphthol | 1-naphthol results in decreased activity of CYP1A2 protein | 15916432 |
| C029350 | 1-naphthol | CYP1A2 protein results in increased abundance of 1-naphthol | 16243959 |
| C032668 | 1-nitropyrene | 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| C032668 | 1-nitropyrene | CYP1A2 affects the reaction [1-nitropyrene results in increased mutagenesis of HPRT1 gene] | 10727902 |
| C032668 | 1-nitropyrene | CYP1A2 affects the susceptibility to 1-nitropyrene | 10727902 |
| C032668 | 1-nitropyrene | 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| C081906 | 1-O-hexyl-2,3,5-trimethylhydroquinone | "1-O-hexyl-2,3,5-trimethylhydroquinone results in increased expression of CYP1A2" | 10503899 |
| C024336 | 1-phenylazo-2-naphthol | CYB5A protein promotes the reaction [CYP1A2 protein results in increased oxidation of 1-phenylazo-2-naphthol] | 17159775 |
| C024336 | 1-phenylazo-2-naphthol | CYP1A2 protein results in increased oxidation of 1-phenylazo-2-naphthol | 17159775 |
| C024336 | 1-phenylazo-2-naphthol | 1-phenylazo-2-naphthol affects the expression of and affects the activity of CYP1A2 protein | 26845733 |
| C024336 | 1-phenylazo-2-naphthol | [1-phenylazo-2-naphthol co-treated with aristolochic acid I] results in increased expression of CYP1A2 mRNA | 26845733 |
| C024336 | 1-phenylazo-2-naphthol | 1-phenylazo-2-naphthol results in increased expression of CYP1A2 mRNA | 26845733 |
| C024336 | 1-phenylazo-2-naphthol | [aristolochic acid I co-treated with 1-phenylazo-2-naphthol] results in increased expression of and results in increased activity of CYP1A2 protein | 26845733 |
| C054919 | 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene | "2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene results in increased expression of CYP1A2 mRNA" | 25542188 |
| C541131 | 2,2',3,3',4,4',5-heptachlorobiphenyl | "2,2',3,3',4,4',5-heptachlorobiphenyl results in increased activity of CYP1A2 protein" | 15743714 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "2,2',3',4,4',5-hexachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]" | 20961953 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] promotes the reaction [AHR protein results in increased expression of CYP1A2 mRNA]" | 20961953 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[AHR protein co-treated with CYP1A2 protein] affects the susceptibility to [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180]" | 20961953 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "CYP1A2 results in decreased susceptibility to 2,2',3',4,4',5-hexachlorobiphenyl" | 21571617 |
| C477694 | 2,2',4,4',5-brominated diphenyl ether | "2,2',4,4',5-brominated diphenyl ether results in increased expression of CYP1A2 mRNA" | 22331496 |
| C477694 | 2,2',4,4',5-brominated diphenyl ether | "CYP1A2 protein results in increased oxidation of 2,2',4,4',5-brominated diphenyl ether" | 21673328 |
| C477694 | 2,2',4,4',5-brominated diphenyl ether | "[CYP1A2 protein results in increased oxidation of 2,2',4,4',5-brominated diphenyl ether] which results in increased abundance of 2,2',4,4',5-brominated diphenyl ether metabolite" | 21673328 |
| C541980 | 2,2',4,6'-tetramethoxystilbene | "2,2',4,6'-tetramethoxystilbene results in decreased activity of CYP1A2 protein" | 19463925 |
| C029141 | 2,2,5,7,8-pentamethyl-1-hydroxychroman | "2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of CYP1A2 mRNA" | 19135037 |
| C520611 | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester | "2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]" | 19276279 |
| C520611 | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester | "2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]" | 19276279 |
| C520611 | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester | "2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester results in decreased activity of CYP1A2 protein" | 19276279 |
| C094210 | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine | "2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased activity of CYP1A2 protein" | 15542068 |
| C087667 | 2,3,3',4,4',5-hexachlorobiphenyl | "2,3,3',4,4',5-hexachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| C087667 | 2,3,3',4,4',5-hexachlorobiphenyl | "2,3,3',4,4',5-hexachlorobiphenyl results in decreased activity of CYP1A2 protein" | 15659567 |
| C087667 | 2,3,3',4,4',5-hexachlorobiphenyl | "2,3,3',4,4',5-hexachlorobiphenyl results in increased activity of CYP1A2 protein" | 10986007 |
| C087667 | 2,3,3',4,4',5-hexachlorobiphenyl | "2,3,3',4,4',5-hexachlorobiphenyl results in increased expression of CYP1A2 mRNA" | 23674508 |
| C087667 | 2,3,3',4,4',5-hexachlorobiphenyl | "2,3,3',4,4',5-hexachlorobiphenyl results in decreased activity of CYP1A2 protein" | 15659567 |
| C067940 | 2,3,3',4,4'-pentachlorobiphenyl | "2,3,3',4,4'-pentachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| C067940 | 2,3,3',4,4'-pentachlorobiphenyl | "2,3,3',4,4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein" | 15659567 |
| C067940 | 2,3,3',4,4'-pentachlorobiphenyl | "2,3,3',4,4'-pentachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]" | 20961953 |
| C067940 | 2,3,3',4,4'-pentachlorobiphenyl | "2,3,3',4,4'-pentachlorobiphenyl results in increased activity of CYP1A2 protein" | 10986007 |
| C067940 | 2,3,3',4,4'-pentachlorobiphenyl | "[3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] promotes the reaction [AHR protein results in increased expression of CYP1A2 mRNA]" | 20961953 |
| C067940 | 2,3,3',4,4'-pentachlorobiphenyl | "[AHR protein co-treated with CYP1A2 protein] affects the susceptibility to [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180]" | 20961953 |
| C067940 | 2,3,3',4,4'-pentachlorobiphenyl | "CYP1A2 results in decreased susceptibility to 2,3,3',4,4'-pentachlorobiphenyl" | 21571617 |
| C067940 | 2,3,3',4,4'-pentachlorobiphenyl | "2,3,3',4,4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein" | 15659567 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | "2,3',4,4',5-pentachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | "2,3',4,4',5-pentachlorobiphenyl results in decreased activity of CYP1A2 protein" | 15659567 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | "2,3',4,4',5-pentachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]" | 20961953 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | "2,3',4,4',5-pentachlorobiphenyl results in increased activity of CYP1A2 protein" | 10986007 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | "2,3',4,4',5-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA" | 23674508 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | "[3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] promotes the reaction [AHR protein results in increased expression of CYP1A2 mRNA]" | 20961953 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | "[AHR protein co-treated with CYP1A2 protein] affects the susceptibility to [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180]" | 20961953 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | "CYP1A2 results in decreased susceptibility to 2,3',4,4',5-pentachlorobiphenyl" | 21571617 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | "2,3',4,4',5-pentachlorobiphenyl results in decreased activity of CYP1A2 protein" | 15659567 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | "[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl] results in increased activity of CYP1A2 protein" | 17342196 |
| C038890 | 2,3,4,7,8-pentachlorodibenzofuran | "2,3,4,7,8-pentachlorodibenzofuran results in increased activity of CYP1A2 protein" | 20705892 |
| C038890 | 2,3,4,7,8-pentachlorodibenzofuran | "2,3,4,7,8-pentachlorodibenzofuran results in increased expression of CYP1A2 mRNA" | 20705892 |
| C038890 | 2,3,4,7,8-pentachlorodibenzofuran | "2,3,4,7,8-pentachlorodibenzofuran results in increased expression of CYP1A2 mRNA" | 23674508|2471369 |
| C038890 | 2,3,4,7,8-pentachlorodibenzofuran | "CYP1A2 protein affects the abundance of 2,3,4,7,8-pentachlorodibenzofuran" | 10448125|9240455 |
| C038890 | 2,3,4,7,8-pentachlorodibenzofuran | "2,3,4,7,8-pentachlorodibenzofuran results in increased expression of CYP1A2 mRNA" | 19041884 |
| C038890 | 2,3,4,7,8-pentachlorodibenzofuran | "2,3,4,7,8-pentachlorodibenzofuran results in increased activity of CYP1A2 protein" | 17160103|2070589 |
| C038890 | 2,3,4,7,8-pentachlorodibenzofuran | "2,3,4,7,8-pentachlorodibenzofuran results in increased expression of CYP1A2 mRNA" | 20705892|2172422 |
| C038890 | 2,3,4,7,8-pentachlorodibenzofuran | "[Tetrachlorodibenzodioxin co-treated with 2,3,4,7,8-pentachlorodibenzofuran co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein" | 17342195 |
| C010498 | 2,3,6,2',3',6'-hexachlorobiphenyl | "2,3,6,2',3',6'-hexachlorobiphenyl results in decreased expression of CYP1A2 mRNA" | 28431184 |
| C010498 | 2,3,6,2',3',6'-hexachlorobiphenyl | "2,3,6,2',3',6'-hexachlorobiphenyl results in increased expression of CYP1A2 protein" | 28431184 |
| C066841 | 2,3,7,8-tetrabromodibenzo-4-dioxin | "2,3,7,8-tetrabromodibenzo-4-dioxin results in increased expression of and results in increased activity of CYP1A2 protein" | 27604104 |
| C014211 | 2,3,7,8-tetrachlorodibenzofuran | "2,3,7,8-tetrachlorodibenzofuran results in increased activity of CYP1A2 protein" | 20705892 |
| C014211 | 2,3,7,8-tetrachlorodibenzofuran | "2,3,7,8-tetrachlorodibenzofuran results in increased expression of CYP1A2 mRNA" | 20705892 |
| C014211 | 2,3,7,8-tetrachlorodibenzofuran | "2,3,7,8-tetrachlorodibenzofuran results in increased expression of CYP1A2 mRNA" | 20702594|2471369 |
| C014211 | 2,3,7,8-tetrachlorodibenzofuran | "AHR protein promotes the reaction [2,3,7,8-tetrachlorodibenzofuran results in increased expression of CYP1A2 mRNA]" | 25768209 |
| C014211 | 2,3,7,8-tetrachlorodibenzofuran | "2,3,7,8-tetrachlorodibenzofuran results in increased expression of CYP1A2 mRNA" | 19041884 |
| C014211 | 2,3,7,8-tetrachlorodibenzofuran | "2,3,7,8-tetrachlorodibenzofuran results in increased activity of CYP1A2 protein" | 20705892 |
| C014211 | 2,3,7,8-tetrachlorodibenzofuran | "2,3,7,8-tetrachlorodibenzofuran results in increased expression of CYP1A2 mRNA" | 20705892|2172422 |
| C100420 | 2,3-diaminotoluene | "2,3-diaminotoluene results in increased expression of CYP1A2 protein" | 8685904 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of CYP1A2 protein" | 15743714 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]" | 20961953 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CYP1A2 mRNA" | 21851831 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] promotes the reaction [AHR protein results in increased expression of CYP1A2 mRNA]" | 20961953 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[AHR protein co-treated with CYP1A2 protein] affects the susceptibility to [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180]" | 20961953 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "CYP1A2 results in decreased susceptibility to 2,4,5,2',4',5'-hexachlorobiphenyl" | 21571617 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of CYP1A2 mRNA" | 28433925 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein" | 16835634 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of CYP1A2 protein" | 16835634 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CYP1A2 protein" | 3302669 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased activity of CYP1A2 protein" | 17160104 |
| C533342 | 2,4,6-triphenyl-1-hexene | "2,4,6-triphenyl-1-hexene results in decreased expression of CYP1A2 mRNA" | 18560529 |
| C010914 | 2,4-diaminotoluene | "2,4-diaminotoluene results in increased expression of CYP1A2 protein" | 8685904 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "2,5,2',5'-tetrachlorobiphenyl results in increased expression of CYP1A2 mRNA" | 21703328 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "CYP1A2 protein affects the susceptibility to 2,5,2',5'-tetrachlorobiphenyl" | 27913846 |
| C028519 | 2,6-dimethylnaphthalene | "2,6-dimethylnaphthalene results in decreased activity of CYP1A2 protein" | 15916432 |
| C085049 | 2,7-dinitrofluorene | "2,7-dinitrofluorene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| C085049 | 2,7-dinitrofluorene | "2,7-dinitrofluorene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| C519626 | 2-amino-1,7-dimethylimidazo(4,5-g)quinoxaline | "CYP1A2 protein results in increased oxidation of 2-amino-1,7-dimethylimidazo(4,5-g)quinoxaline" | 22118226 |
| C077584 | 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine | "[CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine" | 17279779 |
| C077584 | 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine | "[CYP1A2 protein results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine" | 16167840 |
| C522525 | 2-amino-1-methyl-6-phenyl-1H-imidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenyl-1H-imidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA" | 27644595 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased metabolism of and results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 9364010 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of CYP1A2 mRNA" | 20307560 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with CYP1A2 protein] results in increased mutagenesis of HPRT1 gene" | 8625468 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [CYP1A2 protein results in decreased ethylation of Phenacetin]" | 8020169 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA" | 20307560|2081688 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "AHR mutant form inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]" | 20816883 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "alpha-naphthoflavone inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]" | 20816883 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[CYP1A2 protein co-treated with CYP1A1 protein] results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 16167840 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[[CYP1A2 protein co-treated with CYP1A1 protein] results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 16167840 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[CYP1A2 protein co-treated with POR protein co-treated with OAT protein] results in increased susceptibility to 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 10503888|9581821 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein polymorphism results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 15110095 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 12949046|1511009 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 14725854|1594421 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased hydroxylation of and results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 9202738 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased hydroxylation of and results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 15310245 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 17279779 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine" | 17279779 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 17279779 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine metabolite" | 20192249 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased metabolism of and results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 1913651 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 28160022 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased oxidation of and results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 20192249 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 2334931 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 results in increased oxidation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 10503887 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "furafylline inhibits the reaction [CYP1A2 protein results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine]" | 8020169 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 2023932 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[CYP1A2 protein co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in increased mutagenesis of APRT gene" | 2023932 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 16167840 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[CYP1A2 protein results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine" | 16167840 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 17279779 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased abundance of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 1943715 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased metabolism of and results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 1943715 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased susceptibility to 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 1943715 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[1-Naphthylisothiocyanate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in decreased expression of CYP1A2 protein" | 15598703 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with 1-Naphthylisothiocyanate] results in decreased expression of CYP1A2 protein" | 15598703 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA" | 12706856|8902619 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 protein" | 15598703|8902619 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "Caffeine promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]" | 12706856 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 affects the oxidation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 10503887 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 15598703 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased metabolism of and results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 1913651 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]" | 8902619 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 protein]" | 8902619 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 17909072 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 17909072 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 17909072 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "CYP1A2 protein affects the metabolism of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline" | 2655891 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "CYP1A2 protein binds to 2-amino-3,4-dimethylimidazo(4,5-f)quinoline" | 9334905 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "[CYP1A2 protein co-treated with POR protein co-treated with OAT protein] results in increased susceptibility to 2-amino-3,4-dimethylimidazo(4,5-f)quinoline" | 10503888|9581821 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "CYP1A2 protein mutant form results in increased metabolism of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline" | 14744142 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "CYP1A2 protein results in increased hydroxylation of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline" | 14725854 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-3,4-dimethylimidazo(4,5-f)quinoline" | 28160022 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "CYP1A2 results in increased activity of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline" | 10775323|1086195 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "CYP1A2 results in increased metabolism of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline" | 14744142 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "oltipraz inhibits the reaction [CYP1A2 results in increased activity of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline]" | 10775323 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "2-amino-3,4-dimethylimidazo(4,5-f)quinoline inhibits the reaction [CYP1A2 protein results in increased oxidation of Uroporphyrinogens]" | 1567206 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "CYP1A2 protein results in increased activity of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline" | 1544149 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "2-amino-3,4-dimethylimidazo(4,5-f)quinoline affects the expression of CYP1A2 protein" | 1617633 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "2-amino-3,4-dimethylimidazo(4,5-f)quinoline results in decreased activity of CYP1A2 protein" | 1617633 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "CYP1A2 protein results in increased metabolism of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline" | 1617633 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "[Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] which results in increased activity of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline" | 11585058 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "CYP1A2 protein results in increased metabolism of and results in increased activity of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline" | 9364010 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of CYP1A2 mRNA" | 20307560 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased activity of CYP1A2 protein" | 20307560 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA" | 20307560|2081688 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "AHR mutant form inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA]" | 20816883 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "alpha-naphthoflavone inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA]" | 20816883 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "CYP1A2 protein affects the metabolism of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline" | 2655891 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "[CYP1A2 protein co-treated with POR protein co-treated with OAT protein] results in increased susceptibility to 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline" | 10503888|9581821 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "CYP1A2 protein results in decreased activity of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline" | 20192249 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "CYP1A2 protein results in increased hydroxylation of and results in increased activity of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline" | 9202738 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "[CYP1A2 protein results in increased metabolism of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] which results in increased chemical synthesis of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline metabolite" | 20192249 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "[CYP1A2 protein results in increased metabolism of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] which results in increased chemical synthesis of 2-amino-4-hydroxymethyl-3,8-dimethylimidazo(4,5-f)quinoxaline" | 20192249 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline" | 28160022 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "CYP1A2 protein results in increased oxidation of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline" | 20192249|2211822 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "CYP1A2 results in increased activity of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline" | 2334931 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "CYP1A2 results in increased oxidation of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline" | 10503887 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "xanthohumol inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA]" | 22138251 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA" | 23681119 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "[flumequine co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of CYP1A2 mRNA" | 23681119 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "[Phenobarbital co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of CYP1A2 mRNA" | 23681119 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "[2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with alpha-naphthoflavone] results in increased expression of CYP1A2 protein" | 20448087 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "[2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 protein" | 20448087 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "[2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with Carbon Tetrachloride] results in increased expression of CYP1A2 mRNA" | 20930465 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline promotes the reaction [Carbon Tetrachloride results in decreased expression of CYP1A2 protein]" | 20930465 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA" | 12079509|1496536 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 protein" | 12079509|2044808 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "CYP1A2 affects the oxidation of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline" | 10503887 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "LTF protein inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA]" | 12079509 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "LTF protein inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 protein]" | 12079509 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "CYP1A2 protein results in increased hydroxylation of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline" | 20448087 |
| C546460 | 2-amino-3-methyl-3H-imidazo(4,5-f)quinoline | "2-amino-3-methyl-3H-imidazo(4,5-f)quinoline results in increased expression of CYP1A2 mRNA" | 23810796 |
| C017821 | 2-amino-3-methyl-9H-pyrido(2,3-b)indole | "2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA" | 27644595 |
| C017821 | 2-amino-3-methyl-9H-pyrido(2,3-b)indole | "CYP1A2 protein results in increased activity of and results in increased hydroxylation of 2-amino-3-methyl-9H-pyrido(2,3-b)indole" | 14729582 |
| C017821 | 2-amino-3-methyl-9H-pyrido(2,3-b)indole | "CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-3-methyl-9H-pyrido(2,3-b)indole" | 28160022 |
| C017821 | 2-amino-3-methyl-9H-pyrido(2,3-b)indole | "2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA" | 8902619 |
| C017821 | 2-amino-3-methyl-9H-pyrido(2,3-b)indole | "2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 protein" | 8902619 |
| C017821 | 2-amino-3-methyl-9H-pyrido(2,3-b)indole | "lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA]" | 8902619 |
| C017821 | 2-amino-3-methyl-9H-pyrido(2,3-b)indole | "lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 protein]" | 8902619 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "CYP1A2 protein results in increased metabolism of and results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline" | 9364010 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "2-amino-3-methylimidazo(4,5-f)quinoline results in increased expression of CYP1A2 mRNA" | 27644595 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "CYP1A2 protein affects the metabolism of 2-amino-3-methylimidazo(4,5-f)quinoline" | 2655891 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "[CYP1A2 protein co-treated with POR protein co-treated with OAT protein] results in increased susceptibility to 2-amino-3-methylimidazo(4,5-f)quinoline" | 10503888|9581821 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "CYP1A2 protein results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline" | 15728263 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "CYP1A2 protein results in increased hydroxylation of and results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline" | 14725854 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-3-methylimidazo(4,5-f)quinoline" | 28160022 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "CYP1A2 results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline" | 2334931 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "CYP1A2 protein affects the susceptibility to 2-amino-3-methylimidazo(4,5-f)quinoline" | 2023932 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "[CYP1A2 protein co-treated with 2-amino-3-methylimidazo(4,5-f)quinoline] results in increased mutagenesis of APRT gene" | 2023932 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "CYP1A2 results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline" | 11752233 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "Quercetin inhibits the reaction [CYP1A2 results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline]" | 11752233 |
| C432523 | 2-amino-3-methylimidazo(4,5-f)quinoxaline | "CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-3-methylimidazo(4,5-f)quinoxaline" | 28160022 |
| C035208 | 2-amino-4,6-dinitrotoluene | "2-amino-4,6-dinitrotoluene affects the expression of CYP1A2 mRNA" | 21346803 |
| C085470 | 2-amino-4-hydroxymethyl-3,8-dimethylimidazo(4,5-f)quinoxaline | "[CYP1A2 protein results in increased metabolism of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] which results in increased chemical synthesis of 2-amino-4-hydroxymethyl-3,8-dimethylimidazo(4,5-f)quinoxaline" | 20192249 |
| C023785 | 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole | "CYP1A2 protein affects the metabolism of 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole" | 2655891 |
| C023785 | 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole | "CYP1A2 protein results in increased hydroxylation of 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole" | 14725854 |
| C023785 | 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole | "CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole" | 28160022 |
| C017822 | 2-amino-9H-pyrido(2,3-b)indole | "2-amino-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA" | 27644595 |
| C017822 | 2-amino-9H-pyrido(2,3-b)indole | "[CYP1A2 protein co-treated with NAT2 gene polymorphism] promotes the reaction [2-amino-9H-pyrido(2,3-b)indole binds to and results in increased mutagenesis of HPRT1 gene]" | 19243127 |
| C017822 | 2-amino-9H-pyrido(2,3-b)indole | "CYP1A2 protein results in increased metabolism of and results in increased activity of 2-amino-9H-pyrido(2,3-b)indole" | 1913651 |
| C017822 | 2-amino-9H-pyrido(2,3-b)indole | "CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-9H-pyrido(2,3-b)indole" | 28160022 |
| C017822 | 2-amino-9H-pyrido(2,3-b)indole | "[furafylline results in decreased activity of CYP1A2 protein] which results in decreased susceptibility to 2-amino-9H-pyrido(2,3-b)indole" | 23898916 |
| C017822 | 2-amino-9H-pyrido(2,3-b)indole | "CYP1A2 protein results in increased metabolism of and results in increased activity of 2-amino-9H-pyrido(2,3-b)indole" | 1913651 |
| C017822 | 2-amino-9H-pyrido(2,3-b)indole | "CYP1A2 protein results in increased activity of and results in increased oxidation of 2-amino-9H-pyrido(2,3-b)indole" | 19243127 |
| C017822 | 2-amino-9H-pyrido(2,3-b)indole | "[CYP1A2 protein results in increased activity of and results in increased oxidation of 2-amino-9H-pyrido(2,3-b)indole] which results in increased chemical synthesis of 2-amino-9H-pyrido(2,3-b)indole metabolite" | 19243127 |
| C012177 | 2-aminofluorene | 2-aminofluorene inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 28119166 |
| C012177 | 2-aminofluorene | 2-aminofluorene results in decreased activity of CYP1A2 protein | 28119166 |
| C012177 | 2-aminofluorene | CYP1A2 protein affects the metabolism of 2-aminofluorene | 2655891 |
| C012177 | 2-aminofluorene | CYP1A2 results in increased activity of 2-aminofluorene | 11166912 |
| C003898 | 2-anisidine | CYP1A2 protein results in increased oxidation of 2-anisidine | 15828049 |
| C003898 | 2-anisidine | CYP1A2 protein results in increased oxidation of 2-anisidine | 16601807 |
| C003898 | 2-anisidine | 2-anisidine results in increased expression of CYP1A2 | 11409192 |
| C006593 | 2-anthramine | CYB5A protein promotes the reaction [CYP1A2 protein results in increased activity of 2-anthramine] | 15728263 |
| C006593 | 2-anthramine | CYP1A2 protein affects the metabolism of 2-anthramine | 2655891 |
| C006593 | 2-anthramine | CYP1A2 protein results in increased activity of 2-anthramine | 15728263 |
| C055142 | 2-chlorobiphenyl | 2-chlorobiphenyl results in decreased activity of CYP1A2 protein | 15916432 |
| C004726 | 2-dichlorobenzene | CYP1A2 protein results in increased oxidation of 2-dichlorobenzene | 7747284 |
| C586542 | 2'-(glutathion-S-yl)-deschlorodiclofenac | [CYP1A2 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac | 24246759 |
| C060533 | 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[[CYP1A2 protein co-treated with CYP1A1 protein] results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 16167840 |
| C060533 | 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 17279779 |
| C060533 | 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine metabolite" | 20192249 |
| C060533 | 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased abundance of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 1943715 |
| C060533 | 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine" | 17909072 |
| C053054 | 2-hydroxyemodin | CYP1A2 protein results in increased chemical synthesis of 2-hydroxyemodin | 27989148 |
| C001390 | 2-hydroxyestradiol | Carbaryl inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | 16790556 |
| C001390 | 2-hydroxyestradiol | Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | 16790556 |
| C001390 | 2-hydroxyestradiol | CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol | 16790556 |
| C001390 | 2-hydroxyestradiol | Fonofos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | 16790556 |
| C001390 | 2-hydroxyestradiol | naphthalene inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | 16790556 |
| C053767 | 2-methoxy-4-aminoazobenzene | 2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 mRNA | 7553614|8902619 |
| C053767 | 2-methoxy-4-aminoazobenzene | 2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 protein | 7553614|8902619 |
| C053767 | 2-methoxy-4-aminoazobenzene | lead nitrate inhibits the reaction [2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 mRNA] | 8902619 |
| C053767 | 2-methoxy-4-aminoazobenzene | lead nitrate inhibits the reaction [2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 protein] | 8902619 |
| C082155 | 2-methoxynaphthalene | 2-methoxynaphthalene results in decreased activity of CYP1A2 protein | 15916432 |
| C027384 | 2-methylnaphthalene | 2-methylnaphthalene results in decreased activity of CYP1A2 protein | 15916432 |
| C037073 | 2-methylquinoline | 2-methylquinoline results in decreased activity of CYP1A2 protein | 15916432 |
| C028405 | 2-naphthol | 2-naphthol results in decreased activity of CYP1A2 protein | 15916432 |
| C028405 | 2-naphthol | CYP1A2 protein results in increased abundance of 2-naphthol | 16243959 |
| C005328 | 2-nitroanisole | 2-nitroanisole results in increased expression of CYP1A2 | 11409192 |
| C005328 | 2-nitroanisole | 2-nitroanisole results in increased expression of CYP1A2 protein | 16601807 |
| C049030 | 2-nitrofluoranthene | 2-nitrofluoranthene results in increased expression of CYP1A2 mRNA | 12107646 |
| C524315 | 2-oxohexyl isothiocyanate | 2-oxohexyl isothiocyanate inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | 19202560 |
| C109602 | 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate | "3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate results in decreased activity of CYP1A2 protein" | 16049129 |
| C549241 | 3-((2,4-dimethylpyrrol-5-yl)methylidenyl)-2-indolinone | "[3-((2,4-dimethylpyrrol-5-yl)methylidenyl)-2-indolinone binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A2 mRNA" | 20171196 |
| C549241 | 3-((2,4-dimethylpyrrol-5-yl)methylidenyl)-2-indolinone | "3-((2,4-dimethylpyrrol-5-yl)methylidenyl)-2-indolinone results in increased expression of CYP1A2 mRNA" | 20171196 |
| C549241 | 3-((2,4-dimethylpyrrol-5-yl)methylidenyl)-2-indolinone | "AHR protein affects the susceptibility to [3-((2,4-dimethylpyrrol-5-yl)methylidenyl)-2-indolinone results in increased expression of CYP1A2 mRNA]" | 20171196 |
| C472365 | 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine | "3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine results in decreased activity of CYP1A2 protein" | 15193955 |
| C041525 | 3,3',4,5'-tetrahydroxystilbene | "CYP1A2 protein affects the chemical synthesis of 3,3',4,5'-tetrahydroxystilbene" | 15276085 |
| C016392 | 3,3'-diindolylmethane | "3,3'-diindolylmethane results in decreased activity of CYP1A2 protein" | 19770484 |
| C016392 | 3,3'-diindolylmethane | "3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA" | 15672752|1977048 |
| C016392 | 3,3'-diindolylmethane | "[3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA] which results in increased abundance of aflatoxin B1-DNA adduct" | 19770484 |
| C016392 | 3,3'-diindolylmethane | "3,3'-diindolylmethane results in increased expression of CYP1A2 protein" | 15672752 |
| C016392 | 3,3'-diindolylmethane | "CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane" | 16544949 |
| C016392 | 3,3'-diindolylmethane | "Quercetin inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane]" | 16544949 |
| C016392 | 3,3'-diindolylmethane | "resveratrol inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane]" | 16544949 |
| C016392 | 3,3'-diindolylmethane | "3,3'-diindolylmethane results in increased expression of CYP1A2 protein" | 8384853 |
| C520945 | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide | "3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein]" | 17183067 |
| C520945 | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide | "3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]" | 17183067 |
| C520945 | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide | "3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 17183067 |
| C520945 | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide | "3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]" | 17183067 |
| C013279 | 3,4,3',4'-tetrachloroazobenzene | "3,4,3',4'-tetrachloroazobenzene results in increased activity of CYP1A2 protein" | 2315923 |
| C013279 | 3,4,3',4'-tetrachloroazobenzene | "3,4,3',4'-tetrachloroazobenzene results in increased expression of CYP1A2 protein" | 2315923 |
| C013280 | 3,4,3',4'-tetrachloroazoxybenzene | "3,4,3',4'-tetrachloroazoxybenzene results in increased activity of CYP1A2 protein" | 2315923 |
| C013280 | 3,4,3',4'-tetrachloroazoxybenzene | "3,4,3',4'-tetrachloroazoxybenzene results in increased expression of CYP1A2 protein" | 2315923 |
| C028451 | 3,4,3',4'-tetrachlorobiphenyl | "[3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] promotes the reaction [AHR protein results in increased expression of CYP1A2 mRNA]" | 20961953 |
| C028451 | 3,4,3',4'-tetrachlorobiphenyl | "3,4,3',4'-tetrachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]" | 20961953 |
| C028451 | 3,4,3',4'-tetrachlorobiphenyl | "3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A2 mRNA" | 12117779|1946730 |
| C028451 | 3,4,3',4'-tetrachlorobiphenyl | "[AHR protein co-treated with CYP1A2 protein] affects the susceptibility to [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180]" | 20961953 |
| C028451 | 3,4,3',4'-tetrachlorobiphenyl | "CYP1A2 results in decreased susceptibility to 3,4,3',4'-tetrachlorobiphenyl" | 21571617 |
| C028451 | 3,4,3',4'-tetrachlorobiphenyl | "3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [CYP1A2 protein results in decreased methylation of 7-methoxyresorufin]" | 12635099 |
| C104750 | 3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole | 3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole results in decreased expression of CYP1A2 mRNA | 26466350 |
| C027309 | 3,4,5,3',4',5'-hexachlorobiphenyl | "3,4,5,3',4',5'-hexachlorobiphenyl results in decreased activity of CYP1A2 protein" | 15659567 |
| C027309 | 3,4,5,3',4',5'-hexachlorobiphenyl | "[3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] promotes the reaction [AHR protein results in increased expression of CYP1A2 mRNA]" | 20961953 |
| C027309 | 3,4,5,3',4',5'-hexachlorobiphenyl | "3,4,5,3',4',5'-hexachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]" | 20961953 |
| C027309 | 3,4,5,3',4',5'-hexachlorobiphenyl | "[AHR protein co-treated with CYP1A2 protein] affects the susceptibility to [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180]" | 20961953 |
| C027309 | 3,4,5,3',4',5'-hexachlorobiphenyl | "CYP1A2 results in decreased susceptibility to 3,4,5,3',4',5'-hexachlorobiphenyl" | 21571617 |
| C027309 | 3,4,5,3',4',5'-hexachlorobiphenyl | "3,4,5,3',4',5'-hexachlorobiphenyl results in decreased activity of CYP1A2 protein" | 15659567 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl analog results in increased expression of CYP1A2 mRNA" | 25068733 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein" | 15659567 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA" | 16049271|1969266 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA" | 16049271 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "[3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] promotes the reaction [AHR protein results in increased expression of CYP1A2 mRNA]" | 20961953 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "[3,4,5,3',4'-pentachlorobiphenyl co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of CYP1A2 mRNA" | 28973532 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]" | 20961953 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased activity of CYP1A2 protein" | 10986007 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA" | 20702594|2133504 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "[AHR protein co-treated with CYP1A2 protein] affects the susceptibility to [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180]" | 20961953 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "CYP1A2 results in decreased susceptibility to 3,4,5,3',4'-pentachlorobiphenyl" | 21571617 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "[Methionine deficiency co-treated with Choline deficiency co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased expression of CYP1A2 mRNA" | 28163111 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "[MT1 protein affects the susceptibility to 3,4,5,3',4'-pentachlorobiphenyl] which affects the expression of CYP1A2 mRNA" | 26770886 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "[MT2 protein affects the susceptibility to 3,4,5,3',4'-pentachlorobiphenyl] which affects the expression of CYP1A2 mRNA" | 26770886 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein" | 16835634 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl] results in increased activity of CYP1A2 protein" | 17342196 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased activity of CYP1A2 protein" | 17160104 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [CYP1A2 protein results in decreased methylation of 7-methoxyresorufin]" | 12635099 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein" | 15659567 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased activity of CYP1A2 protein" | 16628245 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA" | 16049271|1969266 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 protein" | 25530946 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "[Tetrachlorodibenzodioxin co-treated with 2,3,4,7,8-pentachlorodibenzofuran co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein" | 17342195 |
| C482492 | 3,4,5,4'-tetramethoxystilbene | "3,4,5,4'-tetramethoxystilbene results in increased expression of CYP1A2 mRNA" | 28279696 |
| C482492 | 3,4,5,4'-tetramethoxystilbene | "3,4,5,4'-tetramethoxystilbene results in increased expression of CYP1A2 protein" | 28279696 |
| C497286 | 3,4',5-trimethoxystilbene | "3,4',5-trimethoxystilbene results in increased expression of CYP1A2 mRNA" | 28279696 |
| C497286 | 3,4',5-trimethoxystilbene | "3,4',5-trimethoxystilbene results in increased expression of CYP1A2 protein" | 28279696 |
| C497286 | 3,4',5-trimethoxystilbene | "3,4',5-trimethoxystilbene results in decreased activity of CYP1A2 protein" | 16684708 |
| C045421 | 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine | "3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of CYP1A2 mRNA" | 23810796 |
| C045421 | 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine | "CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine" | 28160022 |
| C045421 | 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine | "CYP1A2 results in increased activity of 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine" | 2334931 |
| C014464 | 3,4-dichloroaniline | "3,4-dichloroaniline results in increased expression of CYP1A2 mRNA" | 21784029 |
| C014464 | 3,4-dichloroaniline | "3,4-dichloroaniline results in increased expression of CYP1A2 protein" | 21784029 |
| C509288 | 3',4'-dimethoxyflavone | "3',4'-dimethoxyflavone affects the reaction [Tobacco Smoke Pollution analog results in increased expression of CYP1A2 mRNA]" | 28357125 |
| C509288 | 3',4'-dimethoxyflavone | "3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]" | 26204831 |
| C509288 | 3',4'-dimethoxyflavone | "3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A2 protein]" | 26204831 |
| C509288 | 3',4'-dimethoxyflavone | "3',4'-dimethoxyflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]" | 28357125 |
| C509288 | 3',4'-dimethoxyflavone | "3',4'-dimethoxyflavone results in decreased activity of CYP1A2 protein" | 21053930 |
| C016834 | 3,5-xylenol | "CYP1A2 protein results in increased oxidation of 3,5-xylenol analog" | 27665777 |
| C016834 | 3,5-xylenol | "[CYP1A2 protein results in increased oxidation of 3,5-xylenol analog] which results in increased abundance of 4-(methylsulfinyl)phenol analog" | 27665777 |
| C068923 | 3,6-dinitrobenzopyrene | "CYP1A2 protein results in increased metabolism of 3,6-dinitrobenzopyrene" | 19393727 |
| C019132 | 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole | "3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in increased expression of CYP1A2 mRNA" | 27644595 |
| C019132 | 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole | "CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole" | 28160022 |
| C019132 | 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole | "[[Methylcholanthrene results in increased expression of CYP1A1 protein] co-treated with [Methylcholanthrene results in increased expression of CYP1A2 protein]] results in decreased susceptibility to 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole" | 11999409 |
| C019133 | 3-amino-1-methyl-5H-pyrido(4,3-b)indole | "3-amino-1-methyl-5H-pyrido(4,3-b)indole results in increased expression of CYP1A2 mRNA" | 27644595 |
| C019133 | 3-amino-1-methyl-5H-pyrido(4,3-b)indole | "CYP1A2 protein affects the metabolism of 3-amino-1-methyl-5H-pyrido(4,3-b)indole" | 2655891 |
| C019133 | 3-amino-1-methyl-5H-pyrido(4,3-b)indole | "CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 3-amino-1-methyl-5H-pyrido(4,3-b)indole" | 28160022 |
| C019133 | 3-amino-1-methyl-5H-pyrido(4,3-b)indole | "3-amino-1-methyl-5H-pyrido(4,3-b)indole results in increased activity of CYP1A2 protein" | 12744663 |
| C019133 | 3-amino-1-methyl-5H-pyrido(4,3-b)indole | "CYP1A2 protein affects the susceptibility to 3-amino-1-methyl-5H-pyrido(4,3-b)indole" | 19140158 |
| C475568 | 3-aminobenzanthrone | CYP1A2 protein results in increased oxidation of and results in increased activity of 3-aminobenzanthrone | 15885895 |
| C571631 | 3-bromomethcathinone | CYP1A2 protein results in increased metabolism of 3-bromomethcathinone | 27320963 |
| C057714 | 3-cyano-7-ethoxycoumarin | Clotrimazole inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] | 19858067 |
| C057714 | 3-cyano-7-ethoxycoumarin | CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin | 19858067 |
| C057714 | 3-cyano-7-ethoxycoumarin | Ketoconazole inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] | 19858067 |
| C057714 | 3-cyano-7-ethoxycoumarin | Nifedipine inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] | 19858067 |
| C041477 | 3-hydroxyflavone | 3-hydroxyflavone results in decreased activity of CYP1A2 protein | 21053930 |
| C482258 | 3'-hydroxy-genistein | CYP1A2 protein results in increased chemical synthesis of 3'-hydroxy-genistein | 12814970 |
| C081194 | 3-methylquinoline | 3-methylquinoline results in decreased activity of CYP1A2 protein | 15916432 |
| C033643 | 3-nitrofluoranthene | 3-nitrofluoranthene results in increased expression of CYP1A2 mRNA | 12107646 |
| C031285 | 3-xylene | CYP1A2 protein results in increased metabolism of 3-xylene | 8558417 |
| C031285 | 3-xylene | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-xylene] | 8558417 |
| C031285 | 3-xylene | 3-xylene results in decreased activity of CYP1A2 protein | 8598570 |
| C008745 | 4,4'-bisphenol F | "CYP1A2 protein results in increased glutathionylation of 4,4'-bisphenol F" | 23470418 |
| C008745 | 4,4'-bisphenol F | "CYP1A2 protein results in increased hydroxylation of 4,4'-bisphenol F" | 23470418 |
| C570106 | 4,4'-cyclohexylidenebisphenol | "CYP1A2 protein results in increased glutathionylation of 4,4'-cyclohexylidenebisphenol" | 23470418 |
| C570106 | 4,4'-cyclohexylidenebisphenol | "CYP1A2 protein results in increased glutathionylation of 4,4'-cyclohexylidenebisphenol metabolite" | 23470418 |
| C570106 | 4,4'-cyclohexylidenebisphenol | "CYP1A2 protein results in increased hydroxylation of 4,4'-cyclohexylidenebisphenol" | 23470418 |
| C583074 | 4,4'-hexafluorisopropylidene diphenol | "CYP1A2 protein results in increased hydroxylation of 4,4'-hexafluorisopropylidene diphenol" | 23470418 |
| C545880 | 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide | "CYP1A2 protein results in increased metabolism of 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide" | 19697924 |
| C108971 | 4-amino-2-phenoxymethanesulfonanilide | 4-amino-2-phenoxymethanesulfonanilide promotes the reaction [CYP1A2 protein results in increased oxidation of Phenacetin] | 19053182 |
| C108971 | 4-amino-2-phenoxymethanesulfonanilide | CYP1A2 protein results in increased oxidation of 4-amino-2-phenoxymethanesulfonanilide | 19053182 |
| C108971 | 4-amino-2-phenoxymethanesulfonanilide | furafylline inhibits the reaction [CYP1A2 protein results in increased oxidation of 4-amino-2-phenoxymethanesulfonanilide] | 19053182 |
| C108971 | 4-amino-2-phenoxymethanesulfonanilide | Quinidine affects the reaction [CYP1A2 protein results in increased oxidation of 4-amino-2-phenoxymethanesulfonanilide] | 19053182 |
| C108971 | 4-amino-2-phenoxymethanesulfonanilide | Ticlopidine inhibits the reaction [CYP1A2 protein results in increased oxidation of 4-amino-2-phenoxymethanesulfonanilide] | 19053182 |
| C006757 | 4-biphenylamine | CYP1A2 protein affects the metabolism of 4-biphenylamine | 2655891 |
| C006757 | 4-biphenylamine | CYP1A2 protein results in increased activity of 4-biphenylamine | 15450435 |
| C006757 | 4-biphenylamine | CYP1A2 protein results in increased hydroxylation of and results in increased activity of 4-biphenylamine | 16988941 |
| C006757 | 4-biphenylamine | [furafylline results in decreased activity of CYP1A2 protein] which results in decreased susceptibility to 4-biphenylamine | 23898916 |
| C006757 | 4-biphenylamine | CYP1A2 protein results in increased metabolism of 4-biphenylamine | 11376689 |
| C006757 | 4-biphenylamine | CYP1A2 protein results in increased oxidation of 4-biphenylamine | 2908851 |
| C006757 | 4-biphenylamine | CYP1A2 protein results in increased oxidation of 4-biphenylamine | 24857880 |
| C006983 | 4-chlorobiphenyl | 4-chlorobiphenyl results in decreased activity of CYP1A2 protein | 15916432 |
| C032538 | 4-cresol | CYP1A2 protein results in increased metabolism of 4-cresol | 16174805 |
| C018511 | 4-dichlorobenzene | CYP1A2 protein results in increased oxidation of 4-dichlorobenzene | 7747284 |
| C082137 | 4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide | 4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide results in increased expression of CYP1A2 mRNA | 15681896 |
| C027576 | 4-hydroxy-2-nonenal | "[CYP1A2 protein results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene" | 21766881 |
| C027576 | 4-hydroxy-2-nonenal | CYP1A2 protein results in increased reduction of and results in increased oxidation of 4-hydroxy-2-nonenal | 21766881 |
| C031364 | 4-hydroxybenzyl isothiocyanate | 4-hydroxybenzyl isothiocyanate results in increased activity of [CYP1A1 protein co-treated with CYP1A2 protein] | 22664424 |
| C031364 | 4-hydroxybenzyl isothiocyanate | 4-hydroxybenzyl isothiocyanate results in increased expression of CYP1A2 mRNA | 22664424 |
| C451019 | 4-hydroxychalcone | CYP1A2 protein affects the chemical synthesis of 4-hydroxychalcone | 15863696 |
| C055492 | 4-hydroxy-N-desmethyltamoxifen | CYP1A2 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen | 29285606 |
| C055492 | 4-hydroxy-N-desmethyltamoxifen | [CYP1A2 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen] which results in increased abundance of 4-hydroxy-N-desmethyltamoxifen metabolite | 29285606 |
| C001470 | 4-ipomeanol | CYP1A2 protein results in increased activity of 4-ipomeanol | 15892579 |
| C487850 | 4'-methoxyflavone | 4'-methoxyflavone results in decreased activity of CYP1A2 protein | 21053930 |
| C487850 | 4'-methoxyflavone | 4'-methoxyflavone results in decreased activity of CYP1A2 protein | 19563207 |
| C044390 | 4-(methylsulfinyl)phenol | CYP1A2 protein results in increased abundance of 4-(methylsulfinyl)phenol analog | 27665777 |
| C044390 | 4-(methylsulfinyl)phenol | "[CYP1A2 protein results in increased oxidation of 3,5-xylenol analog] which results in increased abundance of 4-(methylsulfinyl)phenol analog" | 27665777 |
| C019498 | 4-nitroaniline | 4-nitroaniline analog results in increased activity of CYP1A2 protein | 9545601 |
| C019498 | 4-nitroaniline | 4-nitroaniline analog results in increased expression of CYP1A2 mRNA | 7553614|9545601 |
| C019498 | 4-nitroaniline | 4-nitroaniline analog results in increased expression of CYP1A2 protein | 7553614|9545601 |
| C024836 | 4-nitrophenol | CYP1A2 protein results in increased hydroxylation of 4-nitrophenol | 11911841 |
| C120195 | 4-nitroquinolone-1-oxide | 4-nitroquinolone-1-oxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | CYP1A2 protein affects the metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 11774366 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | CYP1A2 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 15728263 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | CYP1A2 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 25221795 |
| C468646 | 5,12-naphthacenequinone | "5,12-naphthacenequinone results in increased expression of CYP1A2 mRNA" | 17253728 |
| C483032 | 5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine | "CYP1A2 protein mutant form results in decreased metabolism of 5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine" | 15564884 |
| C483032 | 5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine | "CYP1A2 protein results in increased hydroxylation of 5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine" | 15564884 |
| C521334 | 5-(4-dimethylaminobenzoyl)-aminovaleric acid hydroxamate | 5-(4-dimethylaminobenzoyl)-aminovaleric acid hydroxamate affects the expression of CYP1A2 mRNA | 20932894 |
| C040997 | 5-bromotryptamine | 5-bromotryptamine analog results in decreased activity of CYP1A2 protein | 26599973 |
| C040997 | 5-bromotryptamine | [5-bromotryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| C529169 | 5-chlorotryptamine | 5-chlorotryptamine analog results in decreased activity of CYP1A2 protein | 26599973 |
| C529169 | 5-chlorotryptamine | [5-chlorotryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| C051101 | 5-fluoro-alpha-methyltryptamine | 5-fluoro-alpha-methyltryptamine analog results in decreased activity of CYP1A2 protein | 26599973 |
| C051101 | 5-fluoro-alpha-methyltryptamine | [5-fluoro-alpha-methyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| C051101 | 5-fluoro-alpha-methyltryptamine | 5-fluoro-alpha-methyltryptamine results in decreased activity of CYP1A2 protein | 26599973 |
| C051101 | 5-fluoro-alpha-methyltryptamine | [5-fluoro-alpha-methyltryptamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| C034536 | 5-fluorotryptamine | 5-fluorotryptamine analog results in decreased activity of CYP1A2 protein | 26599973 |
| C034536 | 5-fluorotryptamine | [5-fluorotryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| C062711 | 5-hydroxyflavone | 5-hydroxyflavone results in decreased activity of CYP1A2 protein | 21053930 |
| C487413 | 5-methoxyindole | 5-methoxyindole results in decreased activity of CYP1A2 protein | 18420780 |
| C027552 | 5-methyltryptamine | 5-methyltryptamine analog results in decreased activity of CYP1A2 protein | 26599973 |
| C027552 | 5-methyltryptamine | [5-methyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| C547858 | 5-n-butyl-pyrazolo(1,5-a)pyrimidine | "5-n-butyl-pyrazolo(1,5-a)pyrimidine metabolite binds to CYP1A2 protein" | 19928966 |
| C547858 | 5-n-butyl-pyrazolo(1,5-a)pyrimidine | "CYP1A2 protein results in increased glutathionylation of 5-n-butyl-pyrazolo(1,5-a)pyrimidine" | 19928966 |
| C547858 | 5-n-butyl-pyrazolo(1,5-a)pyrimidine | "CYP1A2 protein results in increased glutathionylation of and results in increased activity of 5-n-butyl-pyrazolo(1,5-a)pyrimidine" | 19928966 |
| C547858 | 5-n-butyl-pyrazolo(1,5-a)pyrimidine | "CYP1A2 protein results in increased metabolism of 5-n-butyl-pyrazolo(1,5-a)pyrimidine" | 19138062 |
| C547858 | 5-n-butyl-pyrazolo(1,5-a)pyrimidine | "CYP1A2 protein results in increased glutathionylation of 5-n-butyl-pyrazolo(1,5-a)pyrimidine" | 19928966 |
| C547858 | 5-n-butyl-pyrazolo(1,5-a)pyrimidine | "CYP1A2 protein results in increased metabolism of 5-n-butyl-pyrazolo(1,5-a)pyrimidine" | 19138062 |
| C485383 | 6,7-dihydroxyflavone | "6,7-dihydroxyflavone results in decreased activity of CYP1A2 protein" | 21053930 |
| C483321 | 6-bromoindirubin-3'-oxime | 6-bromoindirubin-3'-oxime results in increased expression of and results in increased activity of CYP1A2 protein | 26259606 |
| C483321 | 6-bromoindirubin-3'-oxime | 6-bromoindirubin-3'-oxime results in increased expression of CYP1A2 mRNA | 26259606 |
| C100101 | 6-chrysenamine | 6-chrysenamine results in increased expression of CYP1A2 mRNA | 12107646 |
| C100101 | 6-chrysenamine | CYP1A2 protein results in increased activity of 6-chrysenamine | 15728263 |
| C111855 | 6-formylindolo(3,2-b)carbazole | "6-formylindolo(3,2-b)carbazole results in increased expression of CYP1A2 mRNA" | 22491429 |
| C111855 | 6-formylindolo(3,2-b)carbazole | "[furafylline results in decreased activity of CYP1A2 protein] promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased activity of AHR protein]" | 22491429 |
| C054923 | 6-methyl-1,3,8-trichlorodibenzofuran | "6-methyl-1,3,8-trichlorodibenzofuran results in increased expression of CYP1A2 mRNA" | 19828881 |
| C054923 | 6-methyl-1,3,8-trichlorodibenzofuran | "[furafylline results in decreased activity of CYP1A2 protein] promotes the reaction [6-methyl-1,3,8-trichlorodibenzofuran results in increased activity of AHR protein]" | 22491429 |
| C121465 | 6-methyl-2-(phenylethynyl)pyridine | 6-methyl-2-(phenylethynyl)pyridine results in decreased activity of CYP1A2 protein | 15193955 |
| C034699 | 6-nitrobenzo(a)pyrene | 6-nitrobenzo(a)pyrene results in increased expression of CYP1A2 mRNA | 12107646 |
| C035986 | 6-nitrochrysene | 6-nitrochrysene results in increased expression of CYP1A2 mRNA | 12107646 |
| C077646 | 7,12-benz(a)anthraquinone | "7,12-benz(a)anthraquinone results in increased expression of CYP1A2 mRNA" | 17253728 |
| C046094 | 7-chlorobenz(a)anthracene | 7-chlorobenz(a)anthracene results in increased expression of CYP1A2 mRNA | 21384493|2335814 |
| C046094 | 7-chlorobenz(a)anthracene | CYP1A2 protein affects the susceptibility to 7-chlorobenz(a)anthracene | 21384493 |
| C077580 | 7-(deoxyadenosin-N(6)-yl)aristolactam I | CYP1A2 protein results in increased activity of 7-(deoxyadenosin-N(6)-yl)aristolactam I | 15386410 |
| C077580 | 7-(deoxyadenosin-N(6)-yl)aristolactam I | [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C077580 | 7-(deoxyadenosin-N(6)-yl)aristolactam I | [CYP1A1 protein co-treated with CYP1A2 protein] affects the reaction [[Thioctic Acid results in decreased activity of POR protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]] | 21932800 |
| C077580 | 7-(deoxyadenosin-N(6)-yl)aristolactam I | CYP1A2 protein promotes the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C077580 | 7-(deoxyadenosin-N(6)-yl)aristolactam I | [furafylline results in decreased activity of CYP1A2 protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C405699 | 7-(deoxyadenosin-N(6)--yl)aristolactam II | [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C405699 | 7-(deoxyadenosin-N(6)--yl)aristolactam II | [CYP1A1 protein co-treated with CYP1A2 protein] affects the reaction [[Thioctic Acid results in decreased activity of POR protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]] | 21932800 |
| C405699 | 7-(deoxyadenosin-N(6)--yl)aristolactam II | CYP1A2 protein promotes the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C405699 | 7-(deoxyadenosin-N(6)--yl)aristolactam II | [furafylline results in decreased activity of CYP1A2 protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C077579 | 7-(deoxyguanosin-N(2)-yl)aristolactam I | [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C077579 | 7-(deoxyguanosin-N(2)-yl)aristolactam I | [CYP1A1 protein co-treated with CYP1A2 protein] affects the reaction [[Thioctic Acid results in decreased activity of POR protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]] | 21932800 |
| C077579 | 7-(deoxyguanosin-N(2)-yl)aristolactam I | CYP1A2 protein promotes the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C077579 | 7-(deoxyguanosin-N(2)-yl)aristolactam I | [furafylline results in decreased activity of CYP1A2 protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C056033 | 7-ethoxy-4-trifluoromethylcoumarin | CYP1A2 protein results in decreased ethylation of 7-ethoxy-4-trifluoromethylcoumarin | 9241656 |
| C056033 | 7-ethoxy-4-trifluoromethylcoumarin | Orphenadrine inhibits the reaction [CYP1A2 protein results in decreased ethylation of 7-ethoxy-4-trifluoromethylcoumarin] | 9241656 |
| C013478 | 7H-dibenzo(c,g)carbazole | "CYP1A2 protein affects the metabolism of and results in increased activity of 7H-dibenzo(c,g)carbazole" | 15534862 |
| C084236 | 7-hydroxy-4-trifluoromethylcoumarin | CYP1A2 protein results in increased chemical synthesis of 7-hydroxy-4-trifluoromethylcoumarin | 9241656 |
| C084236 | 7-hydroxy-4-trifluoromethylcoumarin | Orphenadrine inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 7-hydroxy-4-trifluoromethylcoumarin] | 9241656 |
| C429845 | 7-hydroxyflavone | 7-hydroxyflavone results in decreased activity of CYP1A2 protein | 21053930 |
| C556297 | 7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methyl)-1,5-naphthyridin-4-amine | "[CYP1A2 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results in increased activity of 7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methyl)-1,5-naphthyridin-4-amine" | 20825217 |
| C076580 | 7-methoxyresorufin | CYB5A protein inhibits the reaction [CYP1A2 protein results in decreased methylation of 7-methoxyresorufin] | 15728263 |
| C076580 | 7-methoxyresorufin | CYP1A2 protein binds to and affects the metabolism of 7-methoxyresorufin | 15659567 |
| C076580 | 7-methoxyresorufin | CYP1A2 protein results in decreased methylation of 7-methoxyresorufin | 15728263 |
| C076580 | 7-methoxyresorufin | "3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [CYP1A2 protein results in decreased methylation of 7-methoxyresorufin]" | 12635099 |
| C076580 | 7-methoxyresorufin | "3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [CYP1A2 protein results in decreased methylation of 7-methoxyresorufin]" | 12635099 |
| C076580 | 7-methoxyresorufin | CYP1A2 protein binds to and affects the metabolism of 7-methoxyresorufin | 15659567 |
| C076580 | 7-methoxyresorufin | CYP1A2 protein results in decreased methylation of 7-methoxyresorufin | 12635099 |
| C076580 | 7-methoxyresorufin | CYP1A2 protein results in increased metabolism of 7-methoxyresorufin | 22785257 |
| C076580 | 7-methoxyresorufin | Tetrachlorodibenzodioxin inhibits the reaction [CYP1A2 protein results in decreased methylation of 7-methoxyresorufin] | 12635099 |
| C036696 | 7-methyltryptamine | 7-methyltryptamine analog results in decreased activity of CYP1A2 protein | 26599973 |
| C036696 | 7-methyltryptamine | [7-methyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| C038954 | 7-nitrobenzanthracene | 7-nitrobenzanthracene results in increased expression of CYP1A2 mRNA | 12107646 |
| C035233 | 8-hydroxyloxapine | CYP1A2 results in increased chemical synthesis of 8-hydroxyloxapine | 21826677 |
| C028322 | 8-phenyltheophylline | 8-phenyltheophylline inhibits the reaction [CYP1A2 protein results in decreased ethylation of Phenacetin] | 11465391 |
| C028322 | 8-phenyltheophylline | 8-phenyltheophylline results in decreased activity of CYP1A2 protein | 11465391 |
| C119737 | 8-prenylnaringenin | 8-prenylnaringenin results in decreased activity of CYP1A2 protein | 19770484 |
| C119737 | 8-prenylnaringenin | 8-prenylnaringenin results in increased expression of CYP1A2 mRNA | 15672752 |
| C421010 | 9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole | "CYP1A2 protein affects the metabolism of 9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole" | 17067997 |
| C421010 | 9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole | "CYP1A2 protein results in increased chemical synthesis of 9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole" | 15279827 |
| C421010 | 9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole | "CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole" | 28160022 |
| C073050 | 9-anthraldehyde | [alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased reduction of and results in decreased oxidation of 9-anthraldehyde | 21766881 |
| C091375 | 9-phenanthrol | CYP1A2 protein results in increased abundance of 9-phenanthrol | 27137136 |
| C091375 | 9-phenanthrol | [CYP1A2 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol | 27137136 |
| C023717 | acacetin | acacetin results in decreased activity of CYP1A2 protein | 21053930 |
| C042552 | acenaphthene | acenaphthene results in increased activity of CYP1A2 protein | 8001243 |
| C042552 | acenaphthene | [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA | 7750161 |
| C042553 | acenaphthylene | CYP1A2 protein results in increased oxidation of acenaphthylene | 25642975 |
| C042553 | acenaphthylene | [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA | 7750161 |
| C042553 | acenaphthylene | acenaphthylene results in increased activity of CYP1A2 protein | 10977129|8001243 |
| C042553 | acenaphthylene | acenaphthylene results in increased expression of CYP1A2 mRNA | 8001243 |
| C042553 | acenaphthylene | acenaphthylene results in increased expression of CYP1A2 protein | 8001243 |
| D000074 | Acenocoumarol | CYP1A2 protein affects the metabolism of Acenocoumarol | 11918509 |
| C001969 | acephate | [fenarimol co-treated with acephate] affects the expression of CYP1A2 protein | 17686559 |
| C001969 | acephate | [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP1A2 protein | 17686559 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased chemical synthesis of Acetaminophen | 17097115 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased chemical synthesis of Acetaminophen | 12401345|1515555 |
| D000082 | Acetaminophen | [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen | 19135037 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased oxidation of Acetaminophen | 10811468 |
| D000082 | Acetaminophen | CYP1A2 results in increased metabolism of Acetaminophen | 20566340 |
| D000082 | Acetaminophen | [CYP2E1 protein co-treated with CYP1A2 protein] results in increased susceptibility to Acetaminophen | 28762043 |
| D000082 | Acetaminophen | GSTM1 protein inhibits the reaction [[CYP2E1 protein co-treated with CYP1A2 protein] results in increased susceptibility to Acetaminophen] | 28762043 |
| D000082 | Acetaminophen | obeticholic acid inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of Acetaminophen] | 27939613 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CYP1A2 mRNA | 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CYP1A2 mRNA | 15576447|1661162 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CYP1A2 protein | 15576447|2132937 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CYP1A2 mRNA | 12958197|1497823 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CYP1A2 protein | 19002106 |
| D000082 | Acetaminophen | [Clofibrate co-treated with Acetaminophen] affects the expression of CYP1A2 mRNA | 17585979 |
| D000082 | Acetaminophen | CYP1A2 protein affects the metabolism of and results in decreased abundance of Acetaminophen | 19679878 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased abundance of Acetaminophen | 10445756 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased metabolism of Acetaminophen | 10977129|1900210 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased metabolism of and affects the susceptibility to Acetaminophen | 11376689 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased susceptibility to Acetaminophen | 16141365|1655755 |
| D000082 | Acetaminophen | IL1A protein inhibits the reaction [Acetaminophen results in increased expression of CYP1A2 protein] | 19002106 |
| D000082 | Acetaminophen | NR1I2 protein affects the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA] | 16141365 |
| D000082 | Acetaminophen | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYP1A2 mRNA] | 17585979 |
| D000082 | Acetaminophen | PPARA protein affects the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA] | 12958197 |
| D000082 | Acetaminophen | RXRA protein promotes the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA] | 14978233 |
| D000082 | Acetaminophen | SLC13A1 protein affects the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA] | 16729303 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CYP1A2 mRNA | 11245408|1736632 |
| D000082 | Acetaminophen | Acetaminophen inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CYP1A2 mRNA | 12969438|2180707 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CYP1A2 protein | 18798224 |
| D000082 | Acetaminophen | Choline deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP1A2 protein] | 18798224 |
| D000082 | Acetaminophen | CYP1A2 protein results in increased chemical synthesis of Acetaminophen | 28438436 |
| D000082 | Acetaminophen | [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen | 28438436 |
| D000082 | Acetaminophen | [Dextran Sulfate results in decreased activity of CYP1A2 protein] which results in decreased chemical synthesis of Acetaminophen | 28438436 |
| D000082 | Acetaminophen | [EGF protein co-treated with HGF protein] promotes the reaction [Acetaminophen results in decreased expression of CYP1A2 mRNA] | 12969438 |
| D000082 | Acetaminophen | CYP1A2 results in increased oxidation of Acetaminophen | 8861779 |
| D000082 | Acetaminophen | [CYP1A2 results in increased oxidation of Acetaminophen] which results in increased chemical synthesis of N-acetyl-4-benzoquinoneimine | 8861779 |
| D000096 | Acetone | Acetone promotes the reaction [Toluene results in increased expression of CYP1A2 protein] | 8996725 |
| D000111 | Acetylcysteine | [CYP1A2 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite | 27989148 |
| D000111 | Acetylcysteine | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] | 21424224 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] | 22129741 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of CYP1A2 protein] | 23159886 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP1A2 mRNA] | 23159886 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Paraquat results in increased expression of and results in increased activity of CYP1A2 protein] | 23159886 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Paraquat results in increased expression of CYP1A2 mRNA] | 23159886 |
| D000157 | Aconitine | [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in increased chemical synthesis of Aconitine metabolite | 21277363 |
| D000166 | Acridines | Acridines analog inhibits the reaction [CYP1A2 protein results in increased oxidation of vadimezan] | 16120190 |
| D000166 | Acridines | Acridines analog results in decreased activity of CYP1A2 protein | 16120190 |
| C560978 | aegeline | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CYP1A2 mRNA | 28843594 |
| C016601 | afimoxifene | CYP1A2 protein results in increased metabolism of afimoxifene | 29285606 |
| C016601 | afimoxifene | [CYP1A2 protein results in increased metabolism of afimoxifene] which results in increased abundance of afimoxifene metabolite | 29285606 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of CYP1A2 mRNA | 27153756 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CYP1A2 mRNA | 21994236 |
| D016604 | Aflatoxin B1 | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Aflatoxin B1 | 23397584 |
| D016604 | Aflatoxin B1 | CYP1A2 protein promotes the reaction [Aflatoxin B1 binds to Deoxyguanosine] | 21907773 |
| D016604 | Aflatoxin B1 | CYP1A2 protein results in increased activity of Aflatoxin B1 | 15988000 |
| D016604 | Aflatoxin B1 | CYP1A2 protein results in increased metabolism of Aflatoxin B1 | 22743290 |
| D016604 | Aflatoxin B1 | "[CYP1A2 protein results in increased metabolism of Aflatoxin B1] which results in increased chemical synthesis of aflatoxin B1-2,3-oxide" | 20707407 |
| D016604 | Aflatoxin B1 | [CYP1A2 protein results in increased metabolism of Aflatoxin B1] which results in increased chemical synthesis of Aflatoxin M1 | 20707407 |
| D016604 | Aflatoxin B1 | CYP1A2 protein results in increased metabolism of and results in increased activity of Aflatoxin B1 | 20707407 |
| D016604 | Aflatoxin B1 | CYP1A2 protein results in increased susceptibility to Aflatoxin B1 | 11189750|2791384 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of CYP1A2 mRNA | 19770486 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CYP1A2 mRNA | 26260870 |
| D016604 | Aflatoxin B1 | CYP1A2 protein results in increased susceptibility to Aflatoxin B1 | 22743290 |
| C006426 | aflatoxin B1-2,3-oxide | "[CYP1A2 protein results in increased metabolism of Aflatoxin B1] which results in increased chemical synthesis of aflatoxin B1-2,3-oxide" | 20707407 |
| C006426 | aflatoxin B1-2,3-oxide | "CYP1A2 protein results in increased chemical synthesis of aflatoxin B1-2,3-oxide" | 19146867 |
| C072611 | aflatoxin B1-DNA adduct | "[3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA] which results in increased abundance of aflatoxin B1-DNA adduct" | 19770484 |
| C072611 | aflatoxin B1-DNA adduct | CYP1A2 protein results in increased chemical synthesis of aflatoxin B1-DNA adduct | 22743290 |
| C027955 | aflatoxin G1 | CYP1A2 protein results in increased susceptibility to aflatoxin G1 | 11189750 |
| D016607 | Aflatoxin M1 | [CYP1A2 protein results in increased metabolism of Aflatoxin B1] which results in increased chemical synthesis of Aflatoxin M1 | 20707407 |
| D016607 | Aflatoxin M1 | CYP1A2 protein results in increased chemical synthesis of Aflatoxin M1 | 19146867 |
| C000188 | alachlor | alachlor results in increased expression of CYP1A2 protein | 11850968 |
| D015766 | Albendazole | Albendazole results in increased expression of CYP1A2 mRNA | 12451431 |
| D015766 | Albendazole | CYP1A2 protein affects the metabolism of Albendazole | 12920490 |
| D015766 | Albendazole | Albendazole results in increased expression of and results in increased activity of CYP1A2 protein | 15766946 |
| D015766 | Albendazole | CYP1A2 protein affects the metabolism of and results in decreased activity of Albendazole | 15766946 |
| C010078 | alizarin | alizarin results in decreased activity of CYP1A2 protein | 12379470 |
| C109505 | allocryptopine | allocryptopine results in increased expression of CYP1A2 mRNA | 21419197 |
| C006463 | allyl alcohol | allyl alcohol results in decreased expression of CYP1A2 protein | 10547960 |
| C077207 | allyl methyl sulfide | allyl methyl sulfide results in increased expression of CYP1A2 protein | 16000231 |
| C038491 | allyl sulfide | allyl sulfide inhibits the reaction [Diethylnitrosamine results in decreased expression of and results in decreased activity of CYP1A2 protein] | 23494807 |
| C038491 | allyl sulfide | allyl sulfide inhibits the reaction [Diethylnitrosamine results in decreased expression of CYP1A2 mRNA] | 23494807 |
| C038491 | allyl sulfide | allyl sulfide results in increased expression of CYP1A2 mRNA | 19695238|8849338 |
| C409045 | almotriptan | CYP1A2 protein results in decreased methylation of almotriptan | 12642466 |
| C518327 | aloe emodin | aloe emodin results in decreased activity of CYP1A2 protein | 27633141 |
| C010177 | alpha-hederin | alpha-hederin results in decreased activity of CYP1A2 protein | 9861456 |
| C010177 | alpha-hederin | alpha-hederin results in decreased expression of CYP1A2 mRNA | 9861456 |
| D017962 | alpha-Linolenic Acid | alpha-Linolenic Acid results in decreased activity of CYP1A2 protein | 16978661 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone binds to and results in decreased activity of CYP1A2 protein | 28887089 |
| C011512 | alpha-naphthoflavone | "alpha-naphthoflavone inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]" | 20816883 |
| C011512 | alpha-naphthoflavone | "alpha-naphthoflavone inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA]" | 20816883 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | 9305587 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in decreased activity of CYP1A2 protein | 15306208|1576691 |
| C011512 | alpha-naphthoflavone | [alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in increased expression of CYP1A2 mRNA | 19828881 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in increased expression of CYP1A2 protein | 28887089 |
| C011512 | alpha-naphthoflavone | CYP1A2 protein affects the metabolism of alpha-naphthoflavone | 2180560 |
| C011512 | alpha-naphthoflavone | CYP1A2 protein binds to alpha-naphthoflavone | 27966929 |
| C011512 | alpha-naphthoflavone | CYP1A2 protein results in increased metabolism of alpha-naphthoflavone | 17702393 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in decreased activity of CYP1A2 protein | 15766918 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in decreased activity of CYP1A2 protein | 15766918 |
| C011512 | alpha-naphthoflavone | [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C011512 | alpha-naphthoflavone | [alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased reduction of and results in decreased oxidation of 9-anthraldehyde | 21766881 |
| C011512 | alpha-naphthoflavone | "[2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with alpha-naphthoflavone] results in increased expression of CYP1A2 protein" | 20448087 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in increased expression of CYP1A2 protein | 20448087 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in decreased activity of CYP1A2 protein | 10828259|1550751 |
| D024502 | alpha-Tocopherol | alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA] | 26102010 |
| D024502 | alpha-Tocopherol | alpha-Tocopherol results in increased activity of CYP1A2 protein | 15665910 |
| C524316 | alyssin | "alyssin inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]" | 19362136 |
| C524316 | alyssin | alyssin inhibits the reaction [anthracene results in increased activity of CYP1A2 protein] | 19362136 |
| C524316 | alyssin | alyssin inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | 19202560 |
| C100057 | ametryne | CYP1A2 protein results in increased metabolism of ametryne | 8971136 |
| C100057 | ametryne | POR protein promotes the reaction [CYP1A2 protein results in increased metabolism of ametryne] | 8971136 |
| D000588 | Amines | CYP1A2 protein affects the metabolism of and results in increased activity of Amines | 12505289 |
| D000588 | Amines | CYP1A2 protein results in increased hydroxylation of and affects the metabolism of Amines | 15613766 |
| D009762 | o-Aminoazotoluene | o-Aminoazotoluene results in increased activity of CYP1A2 protein | 15863256 |
| D009762 | o-Aminoazotoluene | o-Aminoazotoluene results in increased expression of CYP1A2 mRNA | 10887293|1456268 |
| D015081 | 2-Naphthylamine | CYP1A2 protein results in increased activity of 2-Naphthylamine | 15450435 |
| D000634 | Aminoquinolines | Aminoquinolines inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D000634 | Aminoquinolines | Aminoquinolines results in decreased activity of CYP1A2 protein | 18563832 |
| D000634 | Aminoquinolines | Aminoquinolines inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D000638 | Amiodarone | Amiodarone results in decreased activity of CYP1A2 protein | 16449812|2659997 |
| D000638 | Amiodarone | [Amiodarone results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D000638 | Amiodarone | CYP1A2 protein results in decreased susceptibility to Amiodarone | 26477383 |
| C014983 | amitraz | amitraz results in increased expression of CYP1A2 protein | 15350676 |
| D000639 | Amitriptyline | Amitriptyline results in increased metabolism of CYP1A2 protein | 18359012 |
| D000639 | Amitriptyline | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Amitriptyline | 23397584 |
| D000639 | Amitriptyline | CYP1A2 protein results in increased metabolism of Amitriptyline | 27320963 |
| C006566 | amitriptyline N-oxide | CYP1A2 protein results in increased abundance of amitriptyline N-oxide | 27320963 |
| D000655 | Amodiaquine | Amodiaquine results in decreased activity of CYP1A2 protein | 11124226 |
| D000655 | Amodiaquine | [Gemfibrozil results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Amodiaquine | 26599973 |
| D000655 | Amodiaquine | [Trimethoprim results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Amodiaquine | 26599973 |
| D000661 | Amphetamine | CYP1A2 protein affects the chemical synthesis of Amphetamine | 15294457 |
| C030419 | andrographolide | andrographolide results in decreased expression of CYP1A2 mRNA | 19041297 |
| C030419 | andrographolide | [andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA | 17825862 |
| C030419 | andrographolide | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA | 19737545 |
| C030419 | andrographolide | andrographolide results in increased expression of CYP1A2 mRNA | 17825862 |
| C030419 | andrographolide | andrographolide affects the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | 20096675 |
| C030419 | andrographolide | andrographolide results in increased expression of CYP1A2 mRNA | 19041297 |
| D000737 | Androstenols | Androstenols results in decreased expression of CYP1A2 mRNA | 17962186 |
| C011659 | angelicin | angelicin results in increased expression of CYP1A2 protein | 18692084 |
| C023650 | aniline | CYP1A2 protein affects the metabolism of [norharman co-treated with aniline] | 15279827 |
| C023650 | aniline | aniline analog results in increased activity of CYP1A2 protein | 16639589 |
| C023650 | aniline | aniline analog results in increased expression of CYP1A2 mRNA | 16639589 |
| C023650 | aniline | aniline analog results in increased expression of CYP1A2 protein | 16639589 |
| C034020 | anthracene | alyssin inhibits the reaction [anthracene results in increased activity of CYP1A2 protein] | 19362136 |
| C034020 | anthracene | anthracene results in increased activity of CYP1A2 protein | 19362136 |
| C034020 | anthracene | sulforafan inhibits the reaction [anthracene results in increased activity of CYP1A2 protein] | 19362136 |
| C034020 | anthracene | [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA | 7750161 |
| C034020 | anthracene | anthracene results in increased activity of CYP1A2 protein | 8001243 |
| D018943 | Anthracyclines | Anthracyclines results in decreased activity of CYP1A2 protein | 15588138 |
| D047310 | Apigenin | Apigenin results in decreased activity of CYP1A2 protein | 20806393|2105393 |
| D016718 | Arachidonic Acid | Arachidonic Acid results in decreased activity of CYP1A2 protein | 16978661 |
| D016718 | Arachidonic Acid | CYP1A2 protein results in increased metabolism of Arachidonic Acid | 12675279 |
| D016718 | Arachidonic Acid | CYP1A2 protein results in increased metabolism of Arachidonic Acid | 22230337 |
| D001095 | Arachidonic Acids | CYP1A2 protein results in increased chemical synthesis of Arachidonic Acids metabolite | 12675279 |
| C059427 | aranidipine | aranidipine results in decreased activity of CYP1A2 protein | 10805063 |
| D001115 | Arecoline | Arecoline analog results in increased activity of CYP1A2 protein | 25056785 |
| C000228 | aristolochic acid I | CYP1A2 protein results in increased chemical synthesis of aristolochic acid I metabolite | 22086975 |
| C000228 | aristolochic acid I | CYP1A2 protein results in increased metabolism of aristolochic acid I | 26845733 |
| C000228 | aristolochic acid I | CYP1A2 protein results in increased oxidation of aristolochic acid I | 22086975 |
| C000228 | aristolochic acid I | [CYP1A2 protein results in increased oxidation of aristolochic acid I] which results in increased chemical synthesis of aristolochic acid I metabolite | 22086975 |
| C000228 | aristolochic acid I | CYP1A2 protein results in increased reduction of and results in increased activity of aristolochic acid I | 22086975 |
| C000228 | aristolochic acid I | Oxygen deficiency affects the reaction [CYP1A2 protein results in increased metabolism of aristolochic acid I] | 26845733 |
| C000228 | aristolochic acid I | [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C000228 | aristolochic acid I | [CYP1A1 protein co-treated with CYP1A2 protein] affects the reaction [[Thioctic Acid results in decreased activity of POR protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]] | 21932800 |
| C000228 | aristolochic acid I | CYP1A2 protein promotes the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C000228 | aristolochic acid I | [CYP1A2 protein results in increased oxidation of aristolochic acid I] which results in increased abundance of aristolochic acid I metabolite | 21932800 |
| C000228 | aristolochic acid I | CYP1A2 protein results in increased reduction of and results in increased oxidation of and affects the activity of aristolochic acid I | 21932800 |
| C000228 | aristolochic acid I | [furafylline results in decreased activity of CYP1A2 protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C000228 | aristolochic acid I | [1-phenylazo-2-naphthol co-treated with aristolochic acid I] results in increased expression of CYP1A2 mRNA | 26845733 |
| C000228 | aristolochic acid I | [aristolochic acid I co-treated with 1-phenylazo-2-naphthol] results in increased expression of and results in increased activity of CYP1A2 protein | 26845733 |
| C000228 | aristolochic acid I | aristolochic acid I results in increased expression of CYP1A2 mRNA | 26845733 |
| C000228 | aristolochic acid I | CYP1A2 protein results in increased abundance of aristolochic acid I metabolite | 21362632 |
| C000228 | aristolochic acid I | CYP1A2 protein results in increased metabolism of aristolochic acid I | 21362632|2684573 |
| C000228 | aristolochic acid I | Oxygen deficiency affects the reaction [CYP1A2 protein results in increased metabolism of aristolochic acid I] | 26845733 |
| C026987 | aroclor 1260 | aroclor 1260 results in increased expression of CYP1A2 mRNA | 24998970 |
| D001140 | Aroclors | Aroclors results in increased expression of CYP1A2 protein | 29162470 |
| C015001 | arsenite | arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] | 22159698 |
| C015001 | arsenite | arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 22159698 |
| C015001 | arsenite | Hemin inhibits the reaction [arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]] | 22159698 |
| C015001 | arsenite | tin mesoporphyrin inhibits the reaction [arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]] | 22159698 |
| C075875 | artemisin | artemisin results in decreased activity of CYP1A2 protein | 16261361 |
| C031327 | artemisinine | artemisinine results in decreased activity of CYP1A2 protein | 11124226 |
| C031327 | artemisinine | artemisinine results in increased expression of CYP1A2 mRNA | 17962186 |
| C031327 | artemisinine | artemisinine results in increased expression of CYP1A2 mRNA | 16919048 |
| D001205 | Ascorbic Acid | Ascorbic Acid deficiency results in increased expression of CYP1A2 mRNA | 8269614 |
| D001205 | Ascorbic Acid | Ascorbic Acid deficiency results in increased expression of CYP1A2 protein | 8269614 |
| D001218 | Aspartame | Aspartame results in increased activity of CYP1A2 protein | 16937917 |
| C050701 | atipamezole | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]] | 16510159 |
| C050701 | atipamezole | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | 16510159 |
| C050701 | atipamezole | atipamezole promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 16510159 |
| C050701 | atipamezole | atipamezole promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 16510159 |
| D053626 | Atovaquone | Atovaquone results in increased activity of CYP1A2 protein | 11124226 |
| D001280 | Atrazine | Atrazine results in increased activity of CYP1A2 protein | 22310298 |
| D001280 | Atrazine | Atrazine results in increased expression of CYP1A2 mRNA | 22310298 |
| D001280 | Atrazine | Atrazine results in increased expression of CYP1A2 mRNA | 26775023 |
| D001280 | Atrazine | lycopene inhibits the reaction [Atrazine results in increased expression of CYP1A2 mRNA] | 26775023 |
| D001280 | Atrazine | Atrazine results in increased activity of CYP1A2 protein | 9711812 |
| C423185 | avasimibe | avasimibe results in decreased activity of CYP1A2 protein | 15333513 |
| D001374 | Azacitidine | Azacitidine promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 12927368 |
| D001374 | Azacitidine | Azacitidine results in increased expression of CYP1A2 mRNA | 12927368 |
| D001397 | Azoxymethane | Azoxymethane results in decreased expression of CYP1A2 mRNA | 18038451 |
| C087670 | azoxystrobin | azoxystrobin results in increased expression of CYP1A2 mRNA | 21784029 |
| C087670 | azoxystrobin | azoxystrobin results in increased expression of CYP1A2 protein | 21784029 |
| C006680 | baicalein | baicalein results in decreased activity of CYP1A2 protein | 21053930 |
| C006680 | baicalein | CYP1A2 protein results in increased chemical synthesis of baicalein | 19666078 |
| C006680 | baicalein | [CYP1A2 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein | 19666078 |
| C038044 | baicalin | "3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]" | 26204831 |
| C038044 | baicalin | "3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A2 protein]" | 26204831 |
| C038044 | baicalin | baicalin results in increased expression of CYP1A2 mRNA | 26204831 |
| C038044 | baicalin | baicalin results in increased expression of CYP1A2 protein | 26204831 |
| C038044 | baicalin | baicalin results in increased expression of CYP1A2 mRNA | 26204831 |
| C038044 | baicalin | baicalin results in increased expression of CYP1A2 protein | 26204831 |
| C038044 | baicalin | resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA] | 26204831 |
| C038044 | baicalin | resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 protein] | 26204831 |
| C012765 | bakuchiol | CYP1A2 protein results in increased metabolism of bakuchiol | 26712081 |
| C061004 | benidipine | benidipine results in increased expression of CYP1A2 mRNA | 27732883 |
| C011677 | benoxaprofen | benoxaprofen results in increased expression of CYP1A2 protein | 2069584 |
| C030935 | benz(a)anthracene | benz(a)anthracene results in decreased activity of CYP1A2 protein | 11162773 |
| C030935 | benz(a)anthracene | benz(a)anthracene results in increased expression of CYP1A2 mRNA | 17253728|9783729 |
| C030935 | benz(a)anthracene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene | 8961944 |
| C030935 | benz(a)anthracene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benz(a)anthracene] | 8961944 |
| C030935 | benz(a)anthracene | [andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA | 17825862 |
| C030935 | benz(a)anthracene | benz(a)anthracene results in increased expression of CYP1A2 mRNA | 17825862 |
| C030935 | benz(a)anthracene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene | 8961944 |
| C030935 | benz(a)anthracene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benz(a)anthracene] | 8961944 |
| C030935 | benz(a)anthracene | [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA | 7750161 |
| C030935 | benz(a)anthracene | benz(a)anthracene results in increased expression of CYP1A2 mRNA | 21384493|2335814 |
| C030935 | benz(a)anthracene | CYP1A2 protein affects the susceptibility to benz(a)anthracene | 21384493 |
| D001551 | Benz(a)Anthracenes | Benz(a)Anthracenes results in increased expression of CYP1A2 mRNA | 12107646 |
| D001554 | Benzene | Benzene results in decreased expression of CYP1A2 | 9010585 |
| D001554 | Benzene | Benzene results in decreased expression of CYP1A2 protein | 8517779 |
| C006703 | benzo(b)fluoranthene | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA | 17690111 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in decreased activity of CYP1A2 protein | 11162773 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in increased expression of CYP1A2 mRNA | 16269432|1725372 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in increased expression of CYP1A2 mRNA | 12117779 |
| C006703 | benzo(b)fluoranthene | [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA | 7750161 |
| C006703 | benzo(b)fluoranthene | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA | 18711122 |
| C041512 | benzo(b)fluorene | benzo(b)fluorene results in increased expression of CYP1A2 mRNA | 17253728 |
| C002615 | benzo(c)phenanthrene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene | 8961944 |
| C002615 | benzo(c)phenanthrene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benzo(c)phenanthrene] | 8961944 |
| C002615 | benzo(c)phenanthrene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene | 8961944 |
| C002615 | benzo(c)phenanthrene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benzo(c)phenanthrene] | 8961944 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole] | 10936227 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in decreased activity of CYP1A2 protein | 21053930 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased activity of CYP1A2 protein | 10923861|1472232 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CYP1A2 mRNA | 12623754|1472232 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CYP1A2 protein | 12584154|1562918 |
| D019324 | beta-Naphthoflavone | CYP1A2 gene mutant form inhibits the reaction [beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A1 mRNA]] | 29180065 |
| D019324 | beta-Naphthoflavone | CYP1A2 gene mutant form inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA] | 29180065 |
| D019324 | beta-Naphthoflavone | CYP1A2 gene mutant form inhibits the reaction [Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]] | 29180065 |
| D019324 | beta-Naphthoflavone | CYP1A2 gene mutant form inhibits the reaction [Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of NQO1 protein]] | 29180065 |
| D019324 | beta-Naphthoflavone | CYP1A2 gene mutant form promotes the reaction [beta-Naphthoflavone results in increased expression of NQO1 mRNA] | 29180065 |
| D019324 | beta-Naphthoflavone | CYP1A2 gene mutant form results in increased susceptibility to beta-Naphthoflavone | 29180065 |
| D019324 | beta-Naphthoflavone | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA | 19737545 |
| D019324 | beta-Naphthoflavone | Berberine inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] | 22342832 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone promotes the reaction [Oxygen results in increased activity of CYP1A2 protein] | 21745492 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A2 mRNA] | 21745492 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased activity of CYP1A2 protein | 21745492 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CYP1A2 mRNA | 19737545|2174549 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CYP1A2 protein | 2208584|28201809 |
| D019324 | beta-Naphthoflavone | [beta-Naphthoflavone results in increased expression of CYP1A2 protein] inhibits the reaction [CYP1A1 gene mutant form results in increased susceptibility to Oxygen] | 28201809 |
| D019324 | beta-Naphthoflavone | [beta-Naphthoflavone results in increased expression of CYP1A2 protein] which results in decreased susceptibility to Oxygen | 28201809 |
| D019324 | beta-Naphthoflavone | CTNNB1 gene mutant form inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] | 25174530 |
| D019324 | beta-Naphthoflavone | [furafylline results in decreased activity of CYP1A2 protein] promotes the reaction [beta-Naphthoflavone results in increased activity of AHR protein] | 22491429 |
| D019324 | beta-Naphthoflavone | Oxygen inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 protein] | 29180065 |
| D019324 | beta-Naphthoflavone | Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] | 21745492 |
| D019324 | beta-Naphthoflavone | Pregnenolone Carbonitrile inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] | 28428138 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole] | 10936227 |
| D019324 | beta-Naphthoflavone | "[2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 protein" | 20448087 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased activity of CYP1A2 protein | 10463385|1546616 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of and results in increased activity of CYP1A2 protein | 26827781 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CYP1A2 mRNA | 10463385|1546616 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CYP1A2 protein | 10463385|1904129 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA | 18164116|2004503 |
| D019324 | beta-Naphthoflavone | diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A2 protein] | 26880746 |
| D019324 | beta-Naphthoflavone | lead nitrate inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 protein] | 8902619 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CYP1A2 mRNA | 19464568 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in decreased activity of CYP1A2 protein | 19563207 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CYP1A2 | 15507517|3377821 |
| C105430 | benzofuran | benzofuran analog results in decreased activity of CYP1A2 protein | 15916432 |
| D001572 | Benzofurans | Benzofurans analog results in decreased activity of CYP1A2 protein | 15659567 |
| D001572 | Benzofurans | Benzofurans analog results in decreased activity of CYP1A2 protein | 15659567 |
| C022921 | benzo(k)fluoranthene | benzo(k)fluoranthene results in decreased activity of CYP1A2 protein | 11162773 |
| C022921 | benzo(k)fluoranthene | benzo(k)fluoranthene results in increased expression of CYP1A2 mRNA | 11162773|1725372 |
| C022921 | benzo(k)fluoranthene | benzo(k)fluoranthene results in increased expression of CYP1A2 protein | 11162773|1137066 |
| C022921 | benzo(k)fluoranthene | sodium arsenite inhibits the reaction [benzo(k)fluoranthene results in increased expression of CYP1A2 mRNA] | 11162773 |
| C022921 | benzo(k)fluoranthene | sodium arsenite inhibits the reaction [benzo(k)fluoranthene results in increased expression of CYP1A2 protein] | 11162773 |
| C022921 | benzo(k)fluoranthene | [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA | 7750161 |
| D001564 | Benzo(a)pyrene | "15,16-dihydrotanshinone I promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]" | 21262253 |
| D001564 | Benzo(a)pyrene | "15,16-dihydrotanshinone I promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]" | 21262253 |
| D001564 | Benzo(a)pyrene | 2-oxohexyl isothiocyanate inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | 19202560 |
| D001564 | Benzo(a)pyrene | alyssin inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | 19202560 |
| D001564 | Benzo(a)pyrene | "[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA" | 17690111 |
| D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA | 17690111 |
| D001564 | Benzo(a)pyrene | "[Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA" | 17690111 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased activity of CYP1A2 protein | 11162773 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of CYP1A2 protein | 19202560 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | 10496959|1210764 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CYP1A2 protein | 11849738|1697093 |
| D001564 | Benzo(a)pyrene | beta-apo-8'-carotenal promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 16970932 |
| D001564 | Benzo(a)pyrene | beta Carotene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 16970932 |
| D001564 | Benzo(a)pyrene | chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 20553787 |
| D001564 | Benzo(a)pyrene | cryptotanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 21262253 |
| D001564 | Benzo(a)pyrene | cryptotanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 21262253 |
| D001564 | Benzo(a)pyrene | CYP1A2 protein affects the metabolism of Benzo(a)pyrene | 20542099 |
| D001564 | Benzo(a)pyrene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of Benzo(a)pyrene | 8961944 |
| D001564 | Benzo(a)pyrene | CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene | 19919601 |
| D001564 | Benzo(a)pyrene | CYP1A2 protein results in increased metabolism of Benzo(a)pyrene | 2791199 |
| D001564 | Benzo(a)pyrene | [CYP1A2 protein results in increased susceptibility to Benzo(a)pyrene] which results in increased mutagenesis of HPRT1 gene | 27913846 |
| D001564 | Benzo(a)pyrene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of Benzo(a)pyrene] | 8961944 |
| D001564 | Benzo(a)pyrene | kaempferol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 21256954 |
| D001564 | Benzo(a)pyrene | Melatonin inhibits the reaction [CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene] | 19919601 |
| D001564 | Benzo(a)pyrene | Quercetin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 21256954 |
| D001564 | Benzo(a)pyrene | Quercetin inhibits the reaction [beta-apo-8'-carotenal promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]] | 16970932 |
| D001564 | Benzo(a)pyrene | Quercetin inhibits the reaction [beta Carotene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]] | 16970932 |
| D001564 | Benzo(a)pyrene | resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 10496959 |
| D001564 | Benzo(a)pyrene | sulforafan inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | 19202560 |
| D001564 | Benzo(a)pyrene | tanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 21262253 |
| D001564 | Benzo(a)pyrene | tanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 21262253 |
| D001564 | Benzo(a)pyrene | AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of CYP1A2 mRNA] | 15034205 |
| D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with sodium bichromate] results in decreased expression of CYP1A2 mRNA | 22613061 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of CYP1A2 mRNA | 15034205 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of CYP1A2 protein | 15863256|1832186 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | 11171528|1135690 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CYP1A2 protein | 17997381|1832186 |
| D001564 | Benzo(a)pyrene | Bucladesine affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 1849469 |
| D001564 | Benzo(a)pyrene | Colforsin affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 1849469 |
| D001564 | Benzo(a)pyrene | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | 18321868 |
| D001564 | Benzo(a)pyrene | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 18321868 |
| D001564 | Benzo(a)pyrene | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 18321868 |
| D001564 | Benzo(a)pyrene | Cycloheximide affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 1849469 |
| D001564 | Benzo(a)pyrene | CYP1A2 protein affects the metabolism of Benzo(a)pyrene | 16256281 |
| D001564 | Benzo(a)pyrene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of Benzo(a)pyrene | 8961944 |
| D001564 | Benzo(a)pyrene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of Benzo(a)pyrene] | 8961944 |
| D001564 | Benzo(a)pyrene | [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA | 7750161 |
| D001564 | Benzo(a)pyrene | Lipopolysaccharides inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 22466549 |
| D001564 | Benzo(a)pyrene | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]] | 16510159 |
| D001564 | Benzo(a)pyrene | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | 16510159 |
| D001564 | Benzo(a)pyrene | atipamezole promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 16510159 |
| D001564 | Benzo(a)pyrene | atipamezole promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 16510159 |
| D001564 | Benzo(a)pyrene | "[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA" | 18711122 |
| D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA | 18711122 |
| D001564 | Benzo(a)pyrene | "[Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA" | 18711122 |
| D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA | 18711122 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of CYP1A2 mRNA | 21505853 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of CYP1A2 protein | 21505853 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein | 16510159|2278525 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | 16510159|1797389 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CYP1A2 protein | 8902619 |
| D001564 | Benzo(a)pyrene | Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | 16510159 |
| D001564 | Benzo(a)pyrene | Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 16510159 |
| D001564 | Benzo(a)pyrene | Guanethidine inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | 16510159 |
| D001564 | Benzo(a)pyrene | INS1 protein inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 26466350 |
| D001564 | Benzo(a)pyrene | lead nitrate inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 8902619 |
| D001564 | Benzo(a)pyrene | Oxygen inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 24657529 |
| D001564 | Benzo(a)pyrene | Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 16510159 |
| D001564 | Benzo(a)pyrene | Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 16510159 |
| D001564 | Benzo(a)pyrene | Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | 16510159 |
| D001564 | Benzo(a)pyrene | Prazosin promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 16510159 |
| D001564 | Benzo(a)pyrene | Prazosin promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 16510159 |
| D001564 | Benzo(a)pyrene | Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | 16510159 |
| D001564 | Benzo(a)pyrene | Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 16510159 |
| D001564 | Benzo(a)pyrene | [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | 16510159 |
| D001564 | Benzo(a)pyrene | [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 16510159 |
| D001564 | Benzo(a)pyrene | Sulpiride inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 26466350 |
| D001564 | Benzo(a)pyrene | wortmannin inhibits the reaction [INS1 protein inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | 26466350 |
| C006710 | benzotriphenylene | benzotriphenylene results in increased expression of CYP1A2 mRNA | 17253728 |
| C017057 | benzoxazolone | benzoxazolone results in decreased activity of CYP1A2 protein | 15916432 |
| C025383 | benzylideneacetone | CYP1A2 protein results in increased oxidation of benzylideneacetone | 15863696 |
| C031403 | benzyl isothiocyanate | benzyl isothiocyanate results in increased activity of [CYP1A1 protein co-treated with CYP1A2 protein] | 22664424 |
| C031403 | benzyl isothiocyanate | benzyl isothiocyanate results in increased expression of CYP1A2 mRNA | 22664424 |
| C057754 | benzyloxyresorufin | CYP1A2 protein results in decreased alkylation of benzyloxyresorufin | 11911841 |
| C054108 | benzyl selenocyanate | benzyl selenocyanate binds to and results in decreased activity of CYP1A2 protein | 21732699 |
| C054108 | benzyl selenocyanate | benzyl selenocyanate binds to CYP1A2 protein | 21732699 |
| C054108 | benzyl selenocyanate | benzyl selenocyanate binds to CYP1A2 protein | 21732699 |
| D001599 | Berberine | Berberine inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] | 22342832 |
| C068337 | bergamottin | bergamottin results in increased expression of CYP1A2 protein | 18692084 |
| C110652 | beta-apo-8'-carotenal | beta-apo-8'-carotenal promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 16970932 |
| C110652 | beta-apo-8'-carotenal | beta-apo-8'-carotenal results in increased expression of CYP1A2 protein | 16970932 |
| C110652 | beta-apo-8'-carotenal | Quercetin inhibits the reaction [beta-apo-8'-carotenal promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]] | 16970932 |
| C110652 | beta-apo-8'-carotenal | Quercetin inhibits the reaction [beta-apo-8'-carotenal results in increased expression of CYP1A2 protein] | 16970932 |
| C110652 | beta-apo-8'-carotenal | beta-apo-8'-carotenal results in increased expression of CYP1A2 mRNA | 9271336 |
| C110652 | beta-apo-8'-carotenal | beta-apo-8'-carotenal results in increased expression of CYP1A2 mRNA | 9271336 |
| D019207 | beta Carotene | beta Carotene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 16970932 |
| D019207 | beta Carotene | Quercetin inhibits the reaction [beta Carotene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]] | 16970932 |
| D004958 | Estradiol | Carbaryl inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | 16790556 |
| D004958 | Estradiol | Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | 16790556 |
| D004958 | Estradiol | CYP1A2 protein results in increased hydroxylation of Estradiol | 15961252 |
| D004958 | Estradiol | CYP1A2 protein results in increased metabolism of Estradiol | 16790556 |
| D004958 | Estradiol | [Estradiol binds to ESR2 protein] which results in increased expression of CYP1A2 mRNA | 20404318 |
| D004958 | Estradiol | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP1A2 mRNA | 19619570 |
| D004958 | Estradiol | Estradiol results in decreased expression of CYP1A2 mRNA | 28357125 |
| D004958 | Estradiol | Estradiol results in increased expression of CYP1A2 mRNA | 19619570 |
| D004958 | Estradiol | Fonofos inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | 16790556 |
| D004958 | Estradiol | naphthalene inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | 16790556 |
| D004958 | Estradiol | CYP1A2 protein results in increased hydroxylation of Estradiol | 10910964 |
| C095105 | bexarotene | bexarotene results in decreased expression of CYP1A2 mRNA | 16648578 |
| C053541 | bicalutamide | [bicalutamide binds to and results in decreased activity of AR protein] inhibits the reaction [Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA] | 23603339 |
| C053541 | bicalutamide | bicalutamide inhibits the reaction [Dehydroepiandrosterone results in increased degradation of CYP1A2 mRNA] | 23603339 |
| D001663 | Bilirubin | Bilirubin results in decreased activity of CYP1A2 protein | 16183037 |
| C073710 | bilobalide | bilobalide results in increased expression of and results in increased activity of CYP1A2 protein | 18421621 |
| C073710 | bilobalide | bilobalide results in increased expression of CYP1A2 mRNA | 18421621 |
| C004541 | biochanin A | biochanin A results in decreased activity of CYP1A2 protein | 26278343 |
| C004541 | biochanin A | CYP1A2 protein results in increased metabolism of biochanin A | 12814970 |
| C004541 | biochanin A | biochanin A results in decreased activity of CYP1A2 protein | 26278343 |
| C006780 | bisphenol A | CYP1A2 protein results in increased glutathionylation of bisphenol A | 23470418 |
| C006780 | bisphenol A | CYP1A2 protein results in increased glutathionylation of bisphenol A metabolite | 23470418 |
| C006780 | bisphenol A | CYP1A2 protein results in increased hydroxylation of bisphenol A | 23470418 |
| C006780 | bisphenol A | CYP1A2 protein results in increased hydroxylation of bisphenol A metabolite | 23470418 |
| C006780 | bisphenol A | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of CYP1A2 mRNA" | 28433925 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of CYP1A2 mRNA | 25181051 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in increased expression of CYP1A2 mRNA | 21784029 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in increased expression of CYP1A2 protein | 21784029 |
| D001786 | Blood Glucose | Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP1A2 protein] | 26747958 |
| D001786 | Blood Glucose | Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP1A2 protein] | 26747958 |
| D001786 | Blood Glucose | [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP1A2 protein | 26747958 |
| D001786 | Blood Glucose | [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP1A2 protein | 26747958 |
| D001786 | Blood Glucose | [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP1A2 protein | 26747958 |
| D001786 | Blood Glucose | [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP1A2 protein | 26747958 |
| C584056 | BMS-764459 | BMS-764459 results in increased expression of CYP1A2 mRNA | 23831372 |
| D000069286 | Bortezomib | CYP1A2 protein affects the metabolism of Bortezomib | 15764713 |
| C032036 | bromobenzene | bromobenzene results in decreased expression of CYP1A2 protein | 10547960 |
| C025191 | bromodichloromethane | CYP1A2 protein results in increased metabolism of bromodichloromethane | 12076521 |
| C025191 | bromodichloromethane | bromodichloromethane results in decreased expression of CYP1A2 protein | 11295256 |
| C025191 | bromodichloromethane | bromodichloromethane results in increased expression of CYP1A2 protein | 11295256 |
| C025191 | bromodichloromethane | CYP1A2 protein affects the metabolism of bromodichloromethane | 12062927 |
| C025191 | bromodichloromethane | CYP1A2 protein results in increased metabolism of bromodichloromethane | 11295256|1207652 |
| C025191 | bromodichloromethane | isosafrole inhibits the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] | 12062927 |
| C025191 | bromodichloromethane | Tetrachlorodibenzodioxin promotes the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] | 12062927 |
| C083806 | brucine | [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP1A2 protein | 21800547 |
| C010831 | bufuralol | CYP1A2 protein results in increased hydroxylation of bufuralol | 9429232 |
| D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole results in increased expression of CYP1A2 mRNA | 25174530 |
| D002083 | Butylated Hydroxyanisole | CTNNB1 gene mutant form inhibits the reaction [Butylated Hydroxyanisole results in increased expression of CYP1A2 mRNA] | 25174530 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene results in decreased activity of CYP1A2 protein | 18177683 |
| C027561 | butylbenzyl phthalate | butylbenzyl phthalate results in decreased activity of CYP1A2 protein | 27432241 |
| C474480 | butylcyclohexane | butylcyclohexane results in decreased activity of CYP1A2 protein | 15916432 |
| C038091 | butylparaben | butylparaben results in decreased activity of CYP1A2 protein | 27432241 |
| D002087 | Butyrates | Butyrates results in increased expression of CYP1A2 mRNA | 15252868 |
| D002087 | Butyrates | Tetrachlorodibenzodioxin inhibits the reaction [Butyrates results in increased expression of CYP1A2 mRNA] | 15252868 |
| D002101 | Cacodylic Acid | Cacodylic Acid results in increased expression of CYP1A2 mRNA | 17481689 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased activity of CYP1A2 protein | 11162773 |
| C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester results in decreased expression of CYP1A2 protein | 22291063 |
| C055494 | caffeic acid phenethyl ester | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP1A2 mRNA | 20360939 |
| D002110 | Caffeine | Caffeine results in decreased activity of CYP1A2 protein | 11465391|2421153 |
| D002110 | Caffeine | Ciprofloxacin inhibits the reaction [CYP1A2 protein results in decreased methylation of Caffeine] | 11145498 |
| D002110 | Caffeine | CYP1A2 protein affects the metabolism of Caffeine | 1302044|14586384 |
| D002110 | Caffeine | CYP1A2 protein affects the metabolism of Caffeine metabolite | 1302044 |
| D002110 | Caffeine | CYP1A2 protein binds to and affects the metabolism of Caffeine | 15659567|1585640 |
| D002110 | Caffeine | CYP1A2 protein binds to Caffeine | 9334905 |
| D002110 | Caffeine | CYP1A2 protein results in decreased methylation of Caffeine | 11145498|1243379 |
| D002110 | Caffeine | CYP1A2 protein results in increased metabolism of Caffeine | 11907490|1921523 |
| D002110 | Caffeine | "[CYP1A2 protein results in increased metabolism of Caffeine] which results in increased chemical synthesis of 1,7-dimethylxanthine" | 19215233 |
| D002110 | Caffeine | GH1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of Caffeine] | 11907490 |
| D002110 | Caffeine | resveratrol promotes the reaction [CYP1A2 protein results in increased metabolism of Caffeine] | 20716633 |
| D002110 | Caffeine | rofecoxib inhibits the reaction [CYP1A2 protein results in increased metabolism of Caffeine] | 16934051 |
| D002110 | Caffeine | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CYP1A2 mRNA | 28843594 |
| D002110 | Caffeine | Caffeine results in decreased activity of CYP1A2 protein | 18420780 |
| D002110 | Caffeine | CYP1A2 protein results in decreased methylation of Caffeine | 11376689 |
| D002110 | Caffeine | "Caffeine promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]" | 12706856 |
| D002110 | Caffeine | Caffeine results in increased activity of CYP1A2 protein | 15822860 |
| D002110 | Caffeine | CYP1A2 protein affects the metabolism of Caffeine | 15619608 |
| D002110 | Caffeine | CYP1A2 protein binds to and affects the metabolism of Caffeine | 15659567 |
| D002110 | Caffeine | [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Caffeine | 26599973 |
| D002110 | Caffeine | "[N,N-diallyl-5-methoxytryptamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Caffeine" | 26599973 |
| D002110 | Caffeine | CYP1A2 protein results in decreased methylation of Caffeine | 20532872 |
| C004645 | canadine | canadine results in increased expression of CYP1A2 mRNA | 28257954 |
| C004645 | canadine | canadine results in increased expression of CYP1A2 protein | 28257954 |
| D002185 | Cannabidiol | Cannabidiol results in decreased activity of CYP1A2 protein | 24667653 |
| D016644 | Canthaxanthin | Canthaxanthin results in increased expression of CYP1A2 mRNA | 9271336 |
| D016644 | Canthaxanthin | Canthaxanthin results in increased expression of CYP1A2 mRNA | 9271336 |
| D002211 | Capsaicin | Capsaicin results in decreased activity of CYP1A2 protein | 22375877 |
| D002220 | Carbamazepine | Carbamazepine results in increased expression of CYP1A2 mRNA | 17112801 |
| D002220 | Carbamazepine | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Carbamazepine | 23397584 |
| D002220 | Carbamazepine | Carbamazepine results in decreased expression of CYP1A2 mRNA | 17381134 |
| D002220 | Carbamazepine | CYP1A2 protein results in increased metabolism of Carbamazepine | 10907977 |
| D012721 | Carbaryl | Carbaryl inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | 16790556 |
| D012721 | Carbaryl | Carbaryl inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | 16790556 |
| D012721 | Carbaryl | Carbaryl results in decreased activity of CYP1A2 protein | 16790556 |
| D012721 | Carbaryl | Carbaryl results in increased expression of CYP1A2 protein | 9858662 |
| C006698 | carbendazim | carbendazim results in increased expression of CYP1A2 mRNA | 21784029 |
| C006698 | carbendazim | carbendazim results in increased expression of CYP1A2 protein | 21784029 |
| D002235 | Carbofuran | CYP1A2 protein results in increased hydroxylation of Carbofuran | 15560889 |
| D002251 | Carbon Tetrachloride | ADAM8 protein affects the reaction [Carbon Tetrachloride results in increased expression of CYP1A2 mRNA] | 24646716 |
| D002251 | Carbon Tetrachloride | ADAM8 protein affects the reaction [Carbon Tetrachloride results in increased expression of CYP1A2 protein] | 24646716 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA | 17084009|1803845 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of CYP1A2 protein | 16445600 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CYP1A2 mRNA | 24646716 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CYP1A2 protein | 24646716 |
| D002251 | Carbon Tetrachloride | CYP2E1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA] | 17084009 |
| D002251 | Carbon Tetrachloride | "[2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with Carbon Tetrachloride] results in increased expression of CYP1A2 mRNA" | 20930465 |
| D002251 | Carbon Tetrachloride | "2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline promotes the reaction [Carbon Tetrachloride results in decreased expression of CYP1A2 protein]" | 20930465 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of CYP1A2 mRNA | 15963342 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased activity of CYP1A2 protein | 14706259|1628878 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA | 14706259|1623916 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of CYP1A2 protein | 17606319|2093046 |
| D002251 | Carbon Tetrachloride | Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased activity of CYP1A2 protein] | 16288784 |
| D002251 | Carbon Tetrachloride | CYP1A2 protein results in increased metabolism of Carbon Tetrachloride | 15988118 |
| D002338 | Carotenoids | CYP1A2 protein polymorphism affects the susceptibility to Carotenoids | 15095308 |
| C024714 | caryophyllene | caryophyllene results in decreased activity of CYP1A2 protein | 29074051 |
| C024714 | caryophyllene | caryophyllene results in decreased activity of CYP1A2 protein | 29074051 |
| C515179 | caryophyllene oxide | caryophyllene oxide results in decreased activity of CYP1A2 protein | 29074051 |
| C515179 | caryophyllene oxide | caryophyllene oxide results in decreased activity of CYP1A2 protein | 29074051 |
| D002395 | Catecholamines | [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | 16510159 |
| D002395 | Catecholamines | [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 16510159 |
| D000068579 | Celecoxib | Celecoxib results in decreased activity of CYP1A2 protein | 18816299 |
| C088453 | Celsior | [Celsior co-treated with Methylcholanthrene] results in increased expression of CYP1A2 mRNA | 15448115 |
| C088453 | Celsior | Celsior results in decreased activity of CYP1A2 protein | 15448115 |
| C088453 | Celsior | Celsior results in decreased expression of CYP1A2 mRNA | 15448115 |
| D002599 | Chalcone | CYP1A2 protein results in increased hydroxylation of Chalcone | 15863696 |
| D002635 | Chenodeoxycholic Acid | Chenodeoxycholic Acid results in decreased expression of CYP1A2 mRNA | 27174168 |
| C473711 | Chir 99021 | Chir 99021 results in increased expression of CYP1A2 mRNA | 26259606 |
| D002719 | Chlormethiazole | Chlormethiazole results in decreased expression of CYP1A2 mRNA | 10751552 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | 16049271|1693415 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 protein | 17851650 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | 16049271 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | 25270620 |
| D020111 | Chlorodiphenyl (54% Chlorine) | CYP1A2 affects the susceptibility to Chlorodiphenyl (54% Chlorine) | 19772856 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased activity of CYP1A2 protein | 11713002|8471063 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | 11163329|1604927 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 protein | 8471063 |
| C543063 | chloroxoquinoline | chloroxoquinoline results in increased expression of CYP1A2 mRNA | 26397835 |
| D002746 | Chlorpromazine | [Chlorpromazine co-treated with Cholic Acids] affects the expression of CYP1A2 mRNA | 27344345 |
| D002746 | Chlorpromazine | Chlorpromazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D002746 | Chlorpromazine | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Chlorpromazine | 23397584 |
| D002746 | Chlorpromazine | CYP1A2 protein results in decreased methylation of Chlorpromazine | 20615392 |
| D002746 | Chlorpromazine | CYP1A2 protein results in decreased susceptibility to Chlorpromazine | 26477383 |
| D002746 | Chlorpromazine | CYP1A2 protein results in increased metabolism of and results in increased activity of Chlorpromazine | 19482014 |
| D002746 | Chlorpromazine | CYP1A2 protein results in increased oxidation of Chlorpromazine | 20615392 |
| D002746 | Chlorpromazine | Chlorpromazine affects the expression of CYP1A2 mRNA | 18246545 |
| D002746 | Chlorpromazine | Chlorpromazine results in increased expression of CYP1A2 mRNA | 25596134 |
| D004390 | Chlorpyrifos | Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | 16790556 |
| D004390 | Chlorpyrifos | Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | 16790556 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in decreased activity of CYP1A2 protein | 16790556|2018306 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in decreased expression of CYP1A2 protein | 21784029 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of CYP1A2 mRNA | 16190164|1932676 |
| D004390 | Chlorpyrifos | CYP1A2 protein affects the metabolism of Chlorpyrifos | 15557345|1707935 |
| C007033 | chlortoluron | CYP1A2 protein results in decreased susceptibility to chlortoluron | 24920432 |
| D002753 | Chlorzoxazone | CYP1A2 protein affects the metabolism of Chlorzoxazone | 14586387 |
| D002753 | Chlorzoxazone | CYP1A2 protein affects the metabolism of Chlorzoxazone | 15879494 |
| D002753 | Chlorzoxazone | CYP1A2 protein results in increased hydroxylation of Chlorzoxazone | 11911841 |
| D002793 | Cholic Acids | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CYP1A2 mRNA | 27344345 |
| D002793 | Cholic Acids | [Chlorpromazine co-treated with Cholic Acids] affects the expression of CYP1A2 mRNA | 27344345 |
| D002794 | Choline | "[3,4,5,3',4'-pentachlorobiphenyl co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of CYP1A2 mRNA" | 28973532 |
| D002794 | Choline | [LEP gene mutant form results in increased susceptibility to [Methionine co-treated with Choline]] which results in decreased expression of CYP1A2 mRNA | 27712037 |
| D002794 | Choline | [LEP gene mutant form results in increased susceptibility to [Methionine co-treated with Choline]] which results in decreased expression of CYP1A2 protein | 27712037 |
| D002794 | Choline | "[Methionine deficiency co-treated with Choline deficiency co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased expression of CYP1A2 mRNA" | 28163111 |
| D002794 | Choline | Choline deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP1A2 protein] | 18798224 |
| D002794 | Choline | Choline deficiency promotes the reaction [Phenobarbital results in increased expression of CYP1A2 protein] | 18798224 |
| C031180 | chrysene | chrysene results in increased expression of CYP1A2 mRNA | 12107646|1725372 |
| C031180 | chrysene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene | 8961944 |
| C031180 | chrysene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of chrysene] | 8961944 |
| C031180 | chrysene | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene | 8961944 |
| C031180 | chrysene | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of chrysene] | 8961944 |
| C031180 | chrysene | [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA | 7750161 |
| C043561 | chrysin | chrysin results in decreased activity of CYP1A2 protein | 20806393|2105393 |
| C043561 | chrysin | CYP1A2 protein results in increased metabolism of chrysin | 19666078 |
| C043561 | chrysin | [CYP1A2 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein | 19666078 |
| C007054 | chrysoeriol | chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 20553787 |
| C027113 | chrysophanic acid | chrysophanic acid results in decreased activity of CYP1A2 protein | 27633141 |
| C039671 | ciglitazone | [ciglitazone binds to PPARG protein alternative form] which results in increased expression of CYP1A2 mRNA | 16197558 |
| C039671 | ciglitazone | [ciglitazone binds to PPARG protein] which results in increased expression of CYP1A2 mRNA | 16197558 |
| D002927 | Cimetidine | Cimetidine results in decreased activity of CYP1A2 protein | 19909766 |
| D002927 | Cimetidine | styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP1A2 protein] | 19909766 |
| C019304 | ciprofibrate | ciprofibrate inhibits the reaction [Phenobarbital results in increased expression of CYP1A2 mRNA] | 17962186 |
| C019304 | ciprofibrate | ciprofibrate results in decreased expression of CYP1A2 mRNA | 17962186 |
| C019304 | ciprofibrate | ciprofibrate results in decreased expression of CYP1A2 mRNA | 7676460 |
| D002939 | Ciprofloxacin | Ciprofloxacin inhibits the reaction [CYP1A2 protein affects the metabolism of tizanidine] | 15592331 |
| D002939 | Ciprofloxacin | Ciprofloxacin inhibits the reaction [CYP1A2 protein results in decreased methylation of Caffeine] | 11145498 |
| D002939 | Ciprofloxacin | Ciprofloxacin results in decreased activity of CYP1A2 protein | 11145498|1559233 |
| D002939 | Ciprofloxacin | [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of Clozapine | 11151749 |
| D002939 | Ciprofloxacin | [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of norclozapine | 11151749 |
| D002939 | Ciprofloxacin | Ciprofloxacin results in decreased activity of CYP1A2 protein | 16556082 |
| D002939 | Ciprofloxacin | [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Theophylline | 16556082 |
| D017291 | Clarithromycin | [Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | 11408986 |
| D002976 | Clenbuterol | Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | 15710352 |
| D002976 | Clenbuterol | Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] | 15710352 |
| D004002 | Clodronic Acid | Clodronic Acid results in increased expression of CYP1A2 mRNA | 25596134 |
| D002994 | Clofibrate | Clofibrate results in decreased expression of CYP1A2 mRNA | 19952500 |
| D002994 | Clofibrate | [Clofibrate co-treated with Acetaminophen] affects the expression of CYP1A2 mRNA | 17585979 |
| D002994 | Clofibrate | Clofibrate results in decreased expression of CYP1A2 mRNA | 17585979 |
| D002994 | Clofibrate | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYP1A2 mRNA] | 17585979 |
| D002994 | Clofibrate | Clofibrate results in decreased expression of CYP1A2 mRNA | 11328961|1285110 |
| D002994 | Clofibrate | Clofibrate results in decreased expression of CYP1A2 protein | 17967931|1867016 |
| D002995 | Clofibric Acid | Clofibric Acid affects the expression of CYP1A2 mRNA | 17602206 |
| C005055 | cloflucarban | cloflucarban results in increased expression of CYP1A2 mRNA | 21784029 |
| C005055 | cloflucarban | cloflucarban results in increased expression of CYP1A2 protein | 21784029 |
| C055162 | clopidogrel | CYP1A2 protein results in increased oxidation of and results in increased cleavage of clopidogrel metabolite | 19170597 |
| C055162 | clopidogrel | CYP1A2 protein results in increased oxidation of clopidogrel | 19812348 |
| C055162 | clopidogrel | furafylline inhibits the reaction [CYP1A2 protein results in increased oxidation of clopidogrel] | 19812348 |
| D003022 | Clotrimazole | Clotrimazole inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] | 19858067 |
| D003022 | Clotrimazole | Clotrimazole results in increased expression of CYP1A2 protein | 7986207 |
| D003024 | Clozapine | [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of Clozapine | 11151749 |
| D003024 | Clozapine | Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D003024 | Clozapine | CYP1A2 gene polymorphism affects the metabolism of Clozapine | 16044115 |
| D003024 | Clozapine | CYP1A2 gene SNP affects the susceptibility to Clozapine | 15206669 |
| D003024 | Clozapine | CYP1A2 gene SNP results in decreased metabolism of Clozapine | 12919186 |
| D003024 | Clozapine | CYP1A2 gene SNP results in decreased susceptibility to Clozapine | 11763009 |
| D003024 | Clozapine | CYP1A2 gene SNP results in increased metabolism of Clozapine | 11763009|1520666 |
| D003024 | Clozapine | CYP1A2 protein affects the metabolism of Clozapine | 15286053|1588314 |
| D003024 | Clozapine | CYP1A2 protein affects the susceptibility to Clozapine | 12919186 |
| D003024 | Clozapine | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Clozapine | 23397584 |
| D003024 | Clozapine | CYP1A2 protein polymorphism affects the metabolism of Clozapine | 15949157 |
| D003024 | Clozapine | CYP1A2 protein results in increased metabolism of Clozapine | 16044115|1880973 |
| D003024 | Clozapine | Smoke affects the reaction [CYP1A2 gene polymorphism affects the metabolism of Clozapine] | 16044115 |
| D003024 | Clozapine | Smoke promotes the reaction [CYP1A2 protein results in increased metabolism of Clozapine] | 16044115 |
| D003024 | Clozapine | Clozapine results in increased expression of CYP1A2 mRNA | 12969762 |
| D003024 | Clozapine | CYP1A2 protein results in increased metabolism of Clozapine | 12969762 |
| D003024 | Clozapine | Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D003024 | Clozapine | CYP1A2 protein affects the metabolism of Clozapine | 10519459|1083015 |
| C079149 | clozapine N-oxide | CYP1A2 protein results in increased abundance of clozapine N-oxide | 27320963 |
| C079149 | clozapine N-oxide | CYP1A2 protein results in increased chemical synthesis of clozapine N-oxide | 18809730 |
| C079149 | clozapine N-oxide | Fluvoxamine inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of clozapine N-oxide] | 18809730 |
| D003033 | Coal Tar | Coal Tar results in increased expression of CYP1A2 mRNA | 16882163 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of CYP1A2 mRNA | 24386269 |
| C004690 | coclaurine | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CYP1A2 mRNA | 28843594 |
| D009249 | NADP | "[CYP1A2 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results in increased activity of 7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methyl)-1,5-naphthyridin-4-amine" | 20825217 |
| D009249 | NADP | Ketoconazole affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D009249 | NADP | [NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 24120545 |
| D009249 | NADP | NADP promotes the reaction [resveratrol results in decreased activity of CYP1A2 protein] | 11714871 |
| D009249 | NADP | Quercetin inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D009249 | NADP | Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D009249 | NADP | Tranylcypromine affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D003069 | Coffee | Coffee results in increased expression of CYP1A2 mRNA | 18028974 |
| D003069 | Coffee | NFE2L2 protein promotes the reaction [Coffee results in increased expression of CYP1A2 mRNA] | 18028974 |
| D005576 | Colforsin | Colforsin affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 1849469 |
| D005576 | Colforsin | Colforsin inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | 15710352 |
| D003276 | Contraceptives, Oral | "Contraceptives, Oral results in decreased activity of CYP1A2 protein" | 17089110 |
| D003300 | Copper | [CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol | 15576237 |
| D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of CYP1A2 mRNA | 19549813 |
| C007133 | cortisol succinate | [cortisol succinate co-treated with Dimethyl Sulfoxide] results in increased expression of CYP1A2 | 18347083 |
| D003367 | Cotinine | Cotinine results in decreased activity of CYP1A2 protein | 15916432 |
| D003367 | Cotinine | Cotinine results in increased activity of CYP1A2 protein | 16203240 |
| C043168 | coumaran | coumaran results in decreased activity of CYP1A2 protein | 15916432 |
| C030123 | coumarin | coumarin affects the expression of CYP1A2 mRNA | 16963487 |
| C030123 | coumarin | coumarin results in decreased expression of CYP1A2 mRNA | 18480146 |
| D003407 | Creosote | Creosote results in increased expression of CYP1A2 mRNA | 19389177 |
| C037886 | cryptotanshinone | cryptotanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 21262253 |
| C037886 | cryptotanshinone | cryptotanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 21262253 |
| C037886 | cryptotanshinone | cryptotanshinone results in increased expression of CYP1A2 mRNA | 21262253 |
| C037886 | cryptotanshinone | cryptotanshinone results in increased expression of CYP1A2 protein | 21262253 |
| C037886 | cryptotanshinone | Dactinomycin inhibits the reaction [cryptotanshinone results in increased expression of CYP1A2 mRNA] | 21262253 |
| C037886 | cryptotanshinone | resveratrol inhibits the reaction [cryptotanshinone results in increased expression of CYP1A2 mRNA] | 21262253 |
| D003474 | Curcumin | Curcumin results in decreased activity of CYP1A2 protein | 15841493 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | 18321868 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 18321868 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 18321868 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased activity of CYP1A2 protein] | 16288784 |
| C057862 | cyanoginosin LR | cyanoginosin LR results in increased expression of CYP1A2 mRNA | 17383702 |
| C084639 | cyclobarbital | cyclobarbital results in increased expression of CYP1A2 mRNA | 10064569 |
| D003505 | Cyclodextrins | Cyclodextrins analog results in decreased activity of CYP1A2 protein | 15665498 |
| D003513 | Cycloheximide | Cycloheximide affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 1849469 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in decreased activity of CYP1A2 protein | 18420780 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of CYP1A2 mRNA | 25596134 |
| C037304 | cyhalothrin | cyhalothrin results in increased activity of CYP1A2 protein | 22310298 |
| C089595 | cylindrospermopsin | cylindrospermopsin results in increased expression of CYP1A2 mRNA | 21607682 |
| C017160 | cypermethrin | cypermethrin results in decreased activity of CYP1A2 protein | 18420780 |
| C017160 | cypermethrin | cypermethrin results in increased expression of CYP1A2 mRNA | 23447098 |
| C093628 | cyproconazole | cyproconazole results in increased expression of CYP1A2 mRNA | 22334560|2565664 |
| C093628 | cyproconazole | NR1I3 promotes the reaction [cyproconazole results in increased expression of CYP1A2 mRNA] | 25656644 |
| D015084 | 2,4-Dichlorophenoxyacetic Acid | "2,4-Dichlorophenoxyacetic Acid results in increased expression of CYP1A2 mRNA" | 10910964 |
| D003606 | Dacarbazine | CYP1A2 protein results in increased metabolism of Dacarbazine metabolite | 11751525 |
| D003606 | Dacarbazine | O(6)-benzylguanine inhibits the reaction [CYP1A2 protein results in increased metabolism of Dacarbazine metabolite] | 11751525 |
| D003609 | Dactinomycin | "Dactinomycin inhibits the reaction [15,16-dihydrotanshinone I results in increased expression of CYP1A2 mRNA]" | 21262253 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [cryptotanshinone results in increased expression of CYP1A2 mRNA] | 21262253 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [tanshinone results in increased expression of CYP1A2 mRNA] | 21262253 |
| C004742 | daidzein | daidzein results in decreased activity of CYP1A2 protein | 18420780 |
| D003620 | Dantrolene | Dantrolene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D003630 | Daunorubicin | [pyridoxal isonicotinoyl hydrazone co-treated with Daunorubicin] results in increased activity of CYP1A2 protein | 15588138 |
| D003630 | Daunorubicin | [salicylaldehyde isonicotinoyl hydrazone co-treated with Daunorubicin] results in increased activity of CYP1A2 protein | 15588138 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether analog results in increased expression of CYP1A2 mRNA | 26854739 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of CYP1A2 mRNA | 19270788 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased activity of CYP1A2 protein | 18495385 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of CYP1A2 mRNA | 18495385 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of CYP1A2 protein | 20686340 |
| C017180 | decamethrin | decamethrin results in increased expression of CYP1A2 mRNA | 16494911|1685967 |
| C017180 | decamethrin | decamethrin results in increased expression of CYP1A2 protein | 16859670 |
| C109757 | decan-4-olide | decan-4-olide results in decreased activity of CYP1A2 protein | 15916432 |
| C014347 | decitabine | decitabine results in increased expression of CYP1A2 mRNA | 19274061|2835712 |
| D003671 | DEET | CYP1A2 protein results in increased metabolism of DEET | 11854147 |
| D003671 | DEET | DEET results in increased expression of CYP1A2 mRNA | 19326769|2709163 |
| D003671 | DEET | [fipronil co-treated with DEET] results in increased expression of CYP1A2 mRNA | 27091632 |
| D003687 | Dehydroepiandrosterone | [bicalutamide binds to and results in decreased activity of AR protein] inhibits the reaction [Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA] | 23603339 |
| D003687 | Dehydroepiandrosterone | bicalutamide inhibits the reaction [Dehydroepiandrosterone results in increased degradation of CYP1A2 mRNA] | 23603339 |
| D003687 | Dehydroepiandrosterone | Dehydroepiandrosterone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | 23603339 |
| D003687 | Dehydroepiandrosterone | Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA | 23603339 |
| D003687 | Dehydroepiandrosterone | Dehydroepiandrosterone results in increased degradation of CYP1A2 mRNA | 23603339 |
| D003849 | Deoxyguanosine | CYP1A2 protein promotes the reaction [Aflatoxin B1 binds to Deoxyguanosine] | 21907773 |
| D003849 | Deoxyguanosine | CYP1A2 protein promotes the reaction [Estrone binds to Deoxyguanosine] | 21907773 |
| C047386 | desethylamodiaquine | desethylamodiaquine results in decreased activity of CYP1A2 protein | 11124226 |
| D017135 | Desogestrel | Desogestrel results in decreased activity of CYP1A2 protein | 18816299 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | 19022236 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with Mifepristone] results in increased activity of CYP1A2 protein | 19022236 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | 19022236 |
| D003907 | Dexamethasone | Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | 19022236 |
| D003907 | Dexamethasone | Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 19022236 |
| D003907 | Dexamethasone | Dexamethasone results in decreased activity of CYP1A2 protein | 19022236 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of CYP1A2 protein | 19022236 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]] | 19022236 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] | 19022236 |
| D003907 | Dexamethasone | Dexamethasone affects the expression of CYP1A2 mRNA | 15102944 |
| D003907 | Dexamethasone | Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 17690134 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of CYP1A2 mRNA | 11328961|2060781 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of CYP1A2 mRNA | 15607757 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] | 17690134 |
| D020927 | Dexmedetomidine | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]] | 16510159 |
| D020927 | Dexmedetomidine | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | 16510159 |
| D020927 | Dexmedetomidine | Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | 16510159 |
| D020927 | Dexmedetomidine | Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 16510159 |
| D016264 | Dextran Sulfate | Dextran Sulfate results in decreased activity of CYP1A2 protein | 28438436 |
| D016264 | Dextran Sulfate | [Dextran Sulfate results in decreased activity of CYP1A2 protein] which results in decreased chemical synthesis of Acetaminophen | 28438436 |
| C028009 | diallyl disulfide | diallyl disulfide results in increased expression of CYP1A2 protein | 16000231 |
| C042577 | diallyl trisulfide | diallyl trisulfide inhibits the reaction [n-hexane results in increased expression of CYP1A2 protein] | 28115069 |
| D036381 | Diarylheptanoids | Diarylheptanoids results in decreased activity of CYP1A2 protein | 23850985 |
| D003976 | Diazinon | CYP1A2 protein affects the metabolism of Diazinon | 15557345|1576440 |
| D003976 | Diazinon | CYP1A2 protein results in decreased sulfation of and results in increased activity of Diazinon | 15764407 |
| D003976 | Diazinon | CYP1A2 protein results in increased metabolism of and results in increased activity of Diazinon | 11708902 |
| D003976 | Diazinon | Diazinon results in increased expression of CYP1A2 mRNA | 21784029 |
| D003976 | Diazinon | Diazinon results in increased expression of CYP1A2 protein | 21784029 |
| D003976 | Diazinon | [Streptozocin results in increased expression of CYP1A2 protein] which results in increased metabolism of Diazinon | 17442507 |
| C041517 | dibenzo(a,l)pyrene | "[Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA" | 17690111 |
| C041517 | dibenzo(a,l)pyrene | "dibenzo(a,l)pyrene results in increased expression of CYP1A2 mRNA" | 16269432 |
| C041517 | dibenzo(a,l)pyrene | "CYP1A2 protein results in increased activity of dibenzo(a,l)pyrene" | 15606143 |
| C041517 | dibenzo(a,l)pyrene | "[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA" | 18711122 |
| C041517 | dibenzo(a,l)pyrene | "[Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA" | 18711122 |
| C018911 | dibenzoanthracene-1,2-dihydrodiol | "[CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-1,2-dihydrodiol" | 8638931 |
| C018912 | dibenzoanthracene-3,4-dihydrodiol | "[CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-3,4-dihydrodiol" | 8638931 |
| C023614 | dibenzofuran | dibenzofuran metabolite results in increased activity of CYP1A2 protein | 26032510 |
| C023614 | dibenzofuran | [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA | 7750161 |
| C023614 | dibenzofuran | dibenzofuran results in increased activity of CYP1A2 protein | 8001243 |
| D000072338 | Dibenzofurans, Polychlorinated | "[Polychlorinated Biphenyls co-treated with Dibenzofurans, Polychlorinated] results in increased activity of CYP1A2 protein" | 17051818 |
| D000072338 | Dibenzofurans, Polychlorinated | "[Polychlorinated Dibenzodioxins co-treated with Dibenzofurans, Polychlorinated] results in increased expression of CYP1A2 mRNA" | 17850846 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased activity of CYP1A2 protein | 27432241 |
| D003994 | Bucladesine | Bucladesine affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 1849469 |
| D003999 | Dichloroacetic Acid | Dichloroacetic Acid results in decreased expression of CYP1A2 mRNA | 28962523 |
| D002945 | Cisplatin | Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D002945 | Cisplatin | Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D004008 | Diclofenac | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Diclofenac | 23397584 |
| D004008 | Diclofenac | Diclofenac metabolite results in decreased activity of CYP1A2 protein | 28960974 |
| D004008 | Diclofenac | Diclofenac results in increased expression of CYP1A2 mRNA | 21784029 |
| D004008 | Diclofenac | Diclofenac results in increased expression of CYP1A2 protein | 21784029 |
| C004354 | dicloran | CYP1A2 protein results in decreased nitrosation of dicloran | 3137698 |
| D004010 | Dicofol | Dicofol results in increased expression of CYP1A2 mRNA | 19595748 |
| C000944 | dicrotophos | dicrotophos results in increased expression of CYP1A2 mRNA | 28302478 |
| C121718 | dicyclanil | [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | 20118626 |
| C121718 | dicyclanil | [[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] which results in increased abundance of Reactive Oxygen Species | 20118626 |
| C121718 | dicyclanil | dicyclanil results in increased expression of CYP1A2 mRNA | 15664270 |
| C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate results in decreased activity of CYP1A2 protein | 27432241 |
| D004026 | Dieldrin | Dieldrin results in increased expression of CYP1A2 mRNA | 10910964 |
| D004041 | Dietary Fats | alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA] | 26102010 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 mRNA | 28433925 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA | 26102010 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of CYP1A2 mRNA | 22609946|2501614 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of CYP1A2 protein | 23358370 |
| D004041 | Dietary Fats | tetrahydrocurcumin inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA] | 26102010 |
| D004041 | Dietary Fats | "1,7-phenanthroline inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 protein]" | 17967931 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 mRNA | 17967931 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 protein | 17967931 |
| D019422 | Dietary Sucrose | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 mRNA | 28433925 |
| D019422 | Dietary Sucrose | "1,7-phenanthroline inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 protein]" | 17967931 |
| D019422 | Dietary Sucrose | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 mRNA | 17967931 |
| D019422 | Dietary Sucrose | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 protein | 17967931 |
| D004051 | Diethylhexyl Phthalate | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of CYP1A2 mRNA" | 28433925 |
| D004052 | Diethylnitrosamine | [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | 20118626 |
| D004052 | Diethylnitrosamine | [[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] which results in increased abundance of Reactive Oxygen Species | 20118626 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of CYP1A2 mRNA | 24535843 |
| D004052 | Diethylnitrosamine | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] | 22129741 |
| D004052 | Diethylnitrosamine | allyl sulfide inhibits the reaction [Diethylnitrosamine results in decreased expression of and results in decreased activity of CYP1A2 protein] | 23494807 |
| D004052 | Diethylnitrosamine | allyl sulfide inhibits the reaction [Diethylnitrosamine results in decreased expression of CYP1A2 mRNA] | 23494807 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA | 18164116|2004503 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP1A2 mRNA | 20360939 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA | 20033131 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of CYP1A2 mRNA | 20033131 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with oxfendazole] results in increased expression of CYP1A2 mRNA | 20033131 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP1A2 mRNA | 28943392 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of and results in decreased activity of CYP1A2 protein | 23494807|2756556 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of CYP1A2 mRNA | 19638242|2036093 |
| D004052 | Diethylnitrosamine | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP1A2 mRNA | 18253720 |
| D004052 | Diethylnitrosamine | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | 22129741 |
| D004052 | Diethylnitrosamine | [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | 22687989 |
| D004052 | Diethylnitrosamine | [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | 18754104 |
| C007379 | diethyl phthalate | diethyl phthalate results in decreased activity of CYP1A2 protein | 27432241 |
| D004054 | Diethylstilbestrol | CYP1A2 protein affects the susceptibility to Diethylstilbestrol | 8242868 |
| D004075 | Diglycerides | Diglycerides results in increased stability of and results in increased activity of CYP1A2 protein | 15966743 |
| C039060 | dihydroartemisinin | dihydroartemisinin results in decreased activity of CYP1A2 protein | 11124226 |
| C012906 | dihydrocapsaicin | dihydrocapsaicin results in decreased activity of CYP1A2 protein | 22375877 |
| D002396 | Catechols | [CYP1A2 protein results in increased hydroxylation of zearalenol] which results in increased chemical synthesis of Catechols | 19931366 |
| D002396 | Catechols | [CYP1A2 protein results in increased hydroxylation of Zearalenone] which results in increased chemical synthesis of Catechols | 19931366 |
| C066888 | dimethocaine | CYP1A2 protein results in increased hydroxylation of dimethocaine | 24309420 |
| C015835 | dimethyl-4-toluidine | dimethyl-4-toluidine results in decreased expression of CYP1A2 mRNA | 27638505 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]" | 19276279 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein]" | 17183067 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]" | 17183067 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein" | 17183067 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA" | 17183067|1927627 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene" | 8961944 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]" | 8961944 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]" | 25110319 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]" | 19276279 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein" | 22044346 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein]" | 22044346 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene" | 8961944 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "CYP1A2 protein results in increased activity of 9,10-Dimethyl-1,2-benzanthracene" | 15606143 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]" | 8961944 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein" | 16054776 |
| D004126 | Dimethylformamide | Dimethylformamide results in decreased expression of CYP1A2 protein | 10547960 |
| C073972 | dimethyl mercury | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] | 21424224 |
| C073972 | dimethyl mercury | dimethyl mercury results in decreased expression of CYP1A2 protein | 21424224 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of CYP1A2 mRNA | 17072980 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of CYP1A2 protein | 16997515 |
| C024629 | dimethyl phthalate | dimethyl phthalate results in decreased activity of CYP1A2 protein | 27432241 |
| D004121 | Dimethyl Sulfoxide | [cortisol succinate co-treated with Dimethyl Sulfoxide] results in increased expression of CYP1A2 | 18347083 |
| D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide affects the expression of CYP1A2 mRNA | 12843640 |
| D004130 | N,N-Dimethyltryptamine | "CYP1A2 protein results in increased metabolism of N,N-Dimethyltryptamine" | 27320963 |
| C106479 | di-n-propylphthalate | di-n-propylphthalate results in decreased activity of CYP1A2 protein | 27432241 |
| C039602 | diosmetin | diosmetin results in decreased activity of CYP1A2 protein | 28867436 |
| D004147 | Dioxins | Dioxins results in increased expression of CYP1A2 mRNA | 15977188|2341963 |
| D004147 | Dioxins | Dioxins results in increased expression of CYP1A2 protein | 15977188 |
| C010574 | diphenyl | CYP1A2 protein results in increased oxidation of diphenyl | 27137136 |
| C010574 | diphenyl | diphenyl results in decreased activity of CYP1A2 protein | 15916432 |
| C493087 | diphenylarsinic acid | diphenylarsinic acid results in decreased expression of CYP1A2 mRNA | 23999541 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A2 protein] | 26880746 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium results in decreased activity of CYP1A2 protein | 26880746 |
| D004050 | Ditiocarb | Ditiocarb inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D004050 | Ditiocarb | Ditiocarb inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D004237 | Diuron | Diuron results in increased expression of CYP1A2 mRNA | 21784029|2231029 |
| D004237 | Diuron | Diuron results in increased expression of CYP1A2 protein | 21784029 |
| D019297 | 2,4-Dinitrophenol | "2,4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| D019297 | 2,4-Dinitrophenol | "2,4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| C067311 | docetaxel | CYP1A2 gene SNP affects the susceptibility to docetaxel | 23758476 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in decreased activity of CYP1A2 protein | 16978661 |
| D004294 | Domperidone | CYP1A2 protein results in increased hydroxylation of Domperidone | 15327587 |
| D007980 | Levodopa | Levodopa inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D004298 | Dopamine | Dopamine results in decreased activity of CYP1A2 protein | 18420780 |
| D004317 | Doxorubicin | Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D004317 | Doxorubicin | [pyridoxal isonicotinoyl hydrazone co-treated with Doxorubicin] results in increased activity of CYP1A2 protein | 15588138 |
| D004317 | Doxorubicin | [salicylaldehyde isonicotinoyl hydrazone co-treated with Doxorubicin] results in increased activity of CYP1A2 protein | 15588138 |
| D004317 | Doxorubicin | Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of CYP1A2 mRNA" | 23262642 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]" | 16901605 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in decreased expression of CYP1A2 mRNA" | 26590097 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased activity of CYP1A2 protein" | 24494561 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of CYP1A2 mRNA" | 16901605 |
| D000068736 | Duloxetine Hydrochloride | CYP1A2 protein results in increased activity of and results in increased glutathionylation of Duloxetine Hydrochloride | 20669986 |
| D000068736 | Duloxetine Hydrochloride | [furafylline results in decreased activity of CYP1A2 protein] which results in decreased glutathionylation of Duloxetine Hydrochloride | 20669986 |
| D004391 | Dust | Dust results in increased expression of CYP1A2 mRNA | 21056094 |
| D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid results in decreased activity of CYP1A2 protein | 16978661 |
| C034192 | ellipticine | CYP1A2 protein results in increased metabolism of ellipticine | 22917556 |
| C034192 | ellipticine | ellipticine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| C034192 | ellipticine | ellipticine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D004642 | Emodin | [CYP1A2 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite | 27989148 |
| D004642 | Emodin | CYP1A2 protein results in increased oxidation of Emodin | 27989148 |
| D004642 | Emodin | Emodin results in decreased activity of CYP1A2 protein | 27633141 |
| D004642 | Emodin | Emodin analog results in decreased activity of CYP1A2 protein | 22185593 |
| D004642 | Emodin | Emodin results in decreased activity of CYP1A2 protein | 22185593 |
| C105196 | enfuvirtide | enfuvirtide affects the activity of CYP1A2 protein | 15656696 |
| D015365 | Enoxacin | Enoxacin inhibits the reaction [CYP1A2 protein affects the metabolism of Fluvoxamine] | 15905806 |
| D015365 | Enoxacin | Enoxacin results in decreased activity of CYP1A2 protein | 15905806 |
| D015365 | Enoxacin | Enoxacin binds to CYP1A2 protein | 8905919 |
| D015365 | Enoxacin | Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 8905919 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate binds to CYP1A2 protein | 23010222 |
| C109476 | epoxiconazole | epoxiconazole results in increased expression of CYP1A2 mRNA | 22334560 |
| C091891 | epsilon-viniferin | epsilon-viniferin results in decreased activity of CYP1A2 protein | 12818727 |
| C073539 | erucin | erucin results in increased expression of CYP1A2 protein | 20833222 |
| C007633 | estragole | CYP1A2 protein results in increased hydroxylation of estragole | 19920071 |
| D004967 | Estrogens | CYP1A2 protein results in increased hydroxylation of Estrogens | 15734958 |
| D004970 | Estrone | CYP1A2 protein binds to Estrone | 27966929 |
| D004970 | Estrone | CYP1A2 protein promotes the reaction [Estrone binds to Deoxyguanosine] | 21907773 |
| D004977 | Ethambutol | Ethambutol results in decreased activity of CYP1A2 protein | 24910189 |
| D000431 | Ethanol | Ethanol results in increased expression of CYP1A2 mRNA | 23273579 |
| D000431 | Ethanol | Ethanol results in increased expression of CYP1A2 protein | 26747958 |
| D000431 | Ethanol | Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP1A2 protein] | 26747958 |
| D000431 | Ethanol | [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP1A2 protein | 26747958 |
| D000431 | Ethanol | [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP1A2 protein | 26747958 |
| D000431 | Ethanol | [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP1A2 protein | 26747958 |
| D004997 | Ethinyl Estradiol | CYP1A2 protein results in increased hydroxylation of Ethinyl Estradiol | 15304426 |
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein | 16198659 |
| D004997 | Ethinyl Estradiol | [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in decreased metabolism of tizanidine | 16198659 |
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP1A2 protein | 16291717 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased activity of CYP1A2 protein | 18816299 |
| D005015 | Ethoxyquin | Ethoxyquin results in increased expression of CYP1A2 mRNA | 19695238 |
| C024565 | ethylene dichloride | ethylene dichloride results in decreased expression of CYP1A2 mRNA | 28189721 |
| C039614 | ethylisopropylamiloride | ethylisopropylamiloride results in decreased activity of CYP1A2 protein | 15081870 |
| C012313 | ethyl-p-hydroxybenzoate | ethyl-p-hydroxybenzoate results in decreased activity of CYP1A2 protein | 27432241 |
| D017308 | Etodolac | Etodolac results in decreased activity of CYP1A2 protein | 18816299 |
| C422649 | etoricoxib | etoricoxib results in decreased activity of CYP1A2 protein | 18816299 |
| D005054 | Eugenol | [CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol | 15576237 |
| D015025 | Zearalenone | CYP1A2 protein results in increased hydroxylation of Zearalenone | 19931366 |
| D015025 | Zearalenone | [CYP1A2 protein results in increased hydroxylation of Zearalenone] which results in increased chemical synthesis of Catechols | 19931366 |
| D005204 | Farnesol | Farnesol results in increased activity of CYP1A2 protein | 15840382 |
| C047360 | felbamate | felbamate results in decreased expression of CYP1A2 mRNA | 17381134 |
| D015736 | Felodipine | Felodipine results in increased expression of CYP1A2 mRNA | 27732883 |
| C033789 | fenarimol | [fenarimol co-treated with acephate] affects the expression of CYP1A2 protein | 17686559 |
| C033789 | fenarimol | [fenarimol co-treated with vinclozolin] affects the expression of CYP1A2 protein | 17686559 |
| C033789 | fenarimol | [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP1A2 protein | 17686559 |
| D005273 | Fenbendazole | Fenbendazole results in decreased activity of CYP1A2 protein | 22048645 |
| D005273 | Fenbendazole | Fenbendazole affects the expression of CYP1A2 mRNA | 26366864 |
| D005278 | Fenitrothion | Fenitrothion results in decreased activity of CYP1A2 protein | 20183062|2263405 |
| D005278 | Fenitrothion | Fenitrothion results in increased expression of CYP1A2 mRNA | 22310298 |
| D011345 | Fenofibrate | Fenofibrate affects the expression of CYP1A2 mRNA | 20801182|2559613 |
| D011345 | Fenofibrate | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP1A2 mRNA | 18253720 |
| C026013 | fenproporex | CYP1A2 protein results in decreased alkylation of fenproporex | 15294457 |
| C017690 | fenvalerate | fenvalerate results in increased activity of CYP1A2 protein | 22310298 |
| C004999 | ferulic acid | ferulic acid results in decreased activity of CYP1A2 protein | 15841493 |
| D018120 | Finasteride | Finasteride results in decreased expression of CYP1A2 mRNA | 24136188 |
| C082360 | fipronil | [fipronil co-treated with DEET] results in increased expression of CYP1A2 mRNA | 27091632 |
| D005411 | Flame Retardants | Flame Retardants results in increased expression of CYP1A2 | 18774282 |
| C028610 | flavanone | flavanone results in decreased activity of CYP1A2 protein | 21053930 |
| C043562 | flavone | flavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 17090139 |
| C043562 | flavone | flavone results in decreased activity of CYP1A2 protein | 21053930 |
| C043562 | flavone | flavone results in decreased activity of CYP1A2 protein | 19563207 |
| D005421 | Flavoring Agents | Flavoring Agents results in decreased activity of CYP1A2 protein | 15529323 |
| D015725 | Fluconazole | Fluconazole results in increased expression of CYP1A2 mRNA | 16730040 |
| C012976 | flumequine | "[flumequine co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of CYP1A2 mRNA" | 23681119 |
| C014558 | flunixin meglumine | flunixin meglumine affects the expression of CYP1A2 mRNA | 26366864 |
| C007738 | fluoranthene | fluoranthene results in increased expression of CYP1A2 mRNA | 12107646|2178402 |
| C007738 | fluoranthene | [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA | 7750161 |
| C007738 | fluoranthene | "[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA" | 18711122 |
| C007738 | fluoranthene | [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA | 18711122 |
| C041509 | fluorene | [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA | 7750161 |
| C041509 | fluorene | fluorene results in increased activity of CYP1A2 protein | 8001243 |
| D015073 | 2-Acetylaminofluorene | CYP1A2 protein affects the metabolism of 2-Acetylaminofluorene | 2655891 |
| D015073 | 2-Acetylaminofluorene | CYP1A2 protein results in increased activity of 2-Acetylaminofluorene | 15450435 |
| D015073 | 2-Acetylaminofluorene | CYP1A2 results in increased hydrolysis of 2-Acetylaminofluorene | 2334931 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA | 16381673 |
| D015073 | 2-Acetylaminofluorene | NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA] | 16381673 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene analog results in decreased expression of CYP1A2 protein | 15916741 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in decreased expression of CYP1A2 protein | 15916741 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of CYP1A2 protein | 28245158 |
| D024841 | Fluoroquinolones | Fluoroquinolones results in decreased activity of CYP1A2 protein | 19281725 |
| D005485 | Flutamide | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Flutamide | 23397584 |
| D005485 | Flutamide | CYP1A2 protein results in increased susceptibility to Flutamide | 28762043 |
| D005485 | Flutamide | Flutamide results in increased expression of CYP1A2 mRNA | 24136188|2648540 |
| D016666 | Fluvoxamine | CYP1A2 protein binds to and affects the metabolism of Fluvoxamine | 15905806 |
| D016666 | Fluvoxamine | CYP1A2 protein results in increased susceptibility to Fluvoxamine | 18809730 |
| D016666 | Fluvoxamine | Enoxacin inhibits the reaction [CYP1A2 protein affects the metabolism of Fluvoxamine] | 15905806 |
| D016666 | Fluvoxamine | Fluvoxamine inhibits the reaction [CYP1A2 protein affects the metabolism of olanzapine] | 15545309 |
| D016666 | Fluvoxamine | Fluvoxamine inhibits the reaction [CYP1A2 protein affects the metabolism of Theophylline] | 9029748 |
| D016666 | Fluvoxamine | Fluvoxamine inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of clozapine N-oxide] | 18809730 |
| D016666 | Fluvoxamine | Fluvoxamine inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of norclozapine] | 18809730 |
| D016666 | Fluvoxamine | Fluvoxamine results in decreased activity of CYP1A2 protein | 11763009|1554530 |
| D016666 | Fluvoxamine | [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased chemical synthesis of 16-O-demethylaconitine metabolite | 21277363 |
| D016666 | Fluvoxamine | [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D016666 | Fluvoxamine | [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in increased chemical synthesis of Aconitine metabolite | 21277363 |
| D016666 | Fluvoxamine | Fluvoxamine results in decreased activity of CYP1A2 protein | 26599973 |
| D016666 | Fluvoxamine | [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Caffeine | 26599973 |
| D016666 | Fluvoxamine | Fluvoxamine results in decreased activity of CYP1A2 protein | 11145498|9812137 |
| D004397 | Fonofos | Fonofos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | 16790556 |
| D004397 | Fonofos | Fonofos inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | 16790556 |
| D004397 | Fonofos | Fonofos results in decreased activity of CYP1A2 protein | 16790556 |
| C007768 | formononetin | formononetin results in decreased activity of CYP1A2 protein | 26278343 |
| C007768 | formononetin | formononetin results in decreased activity of CYP1A2 protein | 26278343 |
| D005632 | Fructose | alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA] | 26102010 |
| D005632 | Fructose | [Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA | 26102010 |
| D005632 | Fructose | tetrahydrocurcumin inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA] | 26102010 |
| C069837 | fullerene C60 | fullerene C60 results in decreased expression of CYP1A2 mRNA | 19167457 |
| C050131 | furafylline | furafylline affects the reaction [CYP1A2 protein results in increased metabolism of Theobromine] | 10215755 |
| C050131 | furafylline | "furafylline inhibits the reaction [CYP1A2 protein results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine]" | 8020169 |
| C050131 | furafylline | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-xylene] | 8558417 |
| C050131 | furafylline | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of Oxazines] | 12569440 |
| C050131 | furafylline | furafylline inhibits the reaction [[CYP1A2 protein results in increased metabolism of Oxazines] which results in increased chemical synthesis of Oxazines] | 23850985 |
| C050131 | furafylline | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 16049126|2385098 |
| C050131 | furafylline | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | 9305587 |
| C050131 | furafylline | furafylline inhibits the reaction [CYP1A2 protein results in increased oxidation of 4-amino-2-phenoxymethanesulfonanilide] | 19053182 |
| C050131 | furafylline | furafylline inhibits the reaction [CYP1A2 protein results in increased oxidation of clopidogrel] | 19812348 |
| C050131 | furafylline | furafylline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| C050131 | furafylline | furafylline results in decreased activity of CYP1A2 protein | 12467917|1281495 |
| C050131 | furafylline | "[furafylline results in decreased activity of CYP1A2 protein] which results in decreased susceptibility to 2-amino-9H-pyrido(2,3-b)indole" | 23898916 |
| C050131 | furafylline | [furafylline results in decreased activity of CYP1A2 protein] which results in decreased susceptibility to 4-biphenylamine | 23898916 |
| C050131 | furafylline | furafylline results in decreased hydroxylation of and results in decreased activity of CYP1A2 protein | 9202738 |
| C050131 | furafylline | furafylline results in decreased activity of CYP1A2 protein | 15766918 |
| C050131 | furafylline | furafylline results in decreased activity of CYP1A2 protein | 15766918 |
| C050131 | furafylline | [furafylline results in decreased activity of CYP1A2 protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] | 21932800 |
| C050131 | furafylline | "[furafylline results in decreased activity of CYP1A2 protein] promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased activity of AHR protein]" | 22491429 |
| C050131 | furafylline | "[furafylline results in decreased activity of CYP1A2 protein] promotes the reaction [6-methyl-1,3,8-trichlorodibenzofuran results in increased activity of AHR protein]" | 22491429 |
| C050131 | furafylline | [furafylline results in decreased activity of CYP1A2 protein] promotes the reaction [beta-Naphthoflavone results in increased activity of AHR protein] | 22491429 |
| C050131 | furafylline | furafylline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| C050131 | furafylline | furafylline results in decreased activity of CYP1A2 protein | 12814958|1587949 |
| C050131 | furafylline | [furafylline results in decreased activity of CYP1A2 protein] which results in decreased glutathionylation of Duloxetine Hydrochloride | 20669986 |
| C050131 | furafylline | furafylline results in decreased activity of CYP1A2 | 19053182 |
| C050131 | furafylline | furafylline results in decreased activity of CYP1A2 protein | 15507517|1579945 |
| C039281 | furan | furan results in decreased expression of CYP1A2 mRNA | 25539665 |
| C038958 | gadolinium chloride | gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP1A2 protein] | 18202523 |
| C037032 | galangin | galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 17090139 |
| C037032 | galangin | galangin results in decreased activity of CYP1A2 protein | 20806393|2105393 |
| C037556 | gamma-valerolactone | gamma-valerolactone results in decreased activity of CYP1A2 protein | 15916432 |
| D015248 | Gemfibrozil | Gemfibrozil results in decreased activity of CYP1A2 protein | 26599973 |
| D015248 | Gemfibrozil | [Gemfibrozil results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Amodiaquine | 26599973 |
| D019833 | Genistein | CYP1A2 protein results in increased chemical synthesis of Genistein | 12814970 |
| D019833 | Genistein | CYP1A2 protein results in increased metabolism of Genistein | 12814970 |
| D019833 | Genistein | Genistein results in decreased activity of CYP1A2 protein | 20806393|2105393 |
| D019833 | Genistein | Genistein results in decreased expression of CYP1A2 mRNA | 24967385 |
| D019833 | Genistein | CYP1A2 protein results in increased hydroxylation of Genistein | 15587933 |
| C014568 | genkwanin | CYP1A2 protein results in increased metabolism of genkwanin | 19666078 |
| C048393 | germacrone | germacrone results in decreased activity of CYP1A2 protein | 23850985 |
| C033273 | Gestodene | [Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein | 16198659 |
| C033273 | Gestodene | [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in decreased metabolism of tizanidine | 16198659 |
| C033273 | Gestodene | Gestodene inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | 9305587 |
| C063170 | Ginkgo biloba extract | Ginkgo biloba extract results in decreased activity of CYP1A2 protein | 15147983 |
| C063170 | Ginkgo biloba extract | Ginkgo biloba extract results in increased expression of CYP1A2 mRNA | 19034627 |
| C063170 | Ginkgo biloba extract | Ginkgo biloba extract results in increased expression of and results in increased activity of CYP1A2 protein | 18421621 |
| C063170 | Ginkgo biloba extract | Ginkgo biloba extract results in increased expression of CYP1A2 mRNA | 18421621 |
| C477042 | ginkgolide A | ginkgolide A results in increased activity of CYP1A2 protein | 18421621 |
| C477042 | ginkgolide A | ginkgolide A results in increased expression of CYP1A2 mRNA | 18421621 |
| C045856 | ginkgolide B | ginkgolide B results in increased expression of and results in increased activity of CYP1A2 protein | 18421621 |
| C045856 | ginkgolide B | ginkgolide B results in increased expression of CYP1A2 mRNA | 18421621 |
| C119493 | glucoerucin | glucoerucin results in increased expression of CYP1A2 protein | 20833222 |
| C119494 | glucoraphanin | glucoraphanin results in increased expression of CYP1A2 protein | 20833222 |
| C023847 | Glu-P-2 | CYP1A2 protein affects the metabolism of Glu-P-2 | 2655891 |
| C023847 | Glu-P-2 | CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Glu-P-2 | 28160022 |
| C023847 | Glu-P-2 | Glu-P-2 results in increased expression of CYP1A2 mRNA | 27644595 |
| D005978 | Glutathione | [CYP1A2 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac | 24246759 |
| D005978 | Glutathione | "[CYP1A2 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results in increased activity of 7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methyl)-1,5-naphthyridin-4-amine" | 20825217 |
| D005978 | Glutathione | Glutathione inhibits the reaction [myristicin results in decreased activity of CYP1A2 protein] | 26091900 |
| D006034 | Glycyrrhetinic Acid | [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP1A2 protein | 21800547 |
| C465546 | green tea extract AR25 | green tea extract AR25 promotes the reaction [FOS protein binds to CYP1A2 enhancer] | 10620351 |
| C465546 | green tea extract AR25 | green tea extract AR25 promotes the reaction [JUND protein binds to CYP1A2 enhancer] | 10620351 |
| C465546 | green tea extract AR25 | green tea extract AR25 promotes the reaction [JUN protein binds to CYP1A2 enhancer] | 10620351 |
| D006118 | Griseofulvin | Griseofulvin promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline] | 9029748 |
| D006118 | Griseofulvin | Griseofulvin affects the expression of CYP1A2 mRNA | 12735108 |
| D006145 | Guanethidine | Guanethidine inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | 16510159 |
| C473027 | GW 3965 | GW 3965 results in increased expression of CYP1A2 mRNA | 23041609 |
| D006202 | Hair Dyes | CYP1A2 protein polymorphism affects the susceptibility to Hair Dyes | 12663508 |
| D055768 | Halogenated Diphenyl Ethers | Halogenated Diphenyl Ethers results in increased expression of CYP1A2 | 18774282 |
| D006427 | Hemin | Hemin inhibits the reaction [arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]] | 22159698 |
| D006427 | Hemin | Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP1A2 protein] | 26747958 |
| D006427 | Hemin | Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP1A2 protein] | 26747958 |
| D006427 | Hemin | [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP1A2 protein | 26747958 |
| C481602 | heptylparaben | heptylparaben results in decreased activity of CYP1A2 protein | 27432241 |
| D006571 | Heterocyclic Compounds | CYP1A2 protein affects the metabolism of and results in increased activity of Heterocyclic Compounds | 12505289 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased expression of CYP1A2 mRNA | 2856071 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased expression of CYP1A2 protein | 10696772|2539049 |
| C012348 | higenamine | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CYP1A2 mRNA | 28843594 |
| D017313 | Fenretinide | Fenretinide results in increased expression of CYP1A2 mRNA | 28973697 |
| C042686 | humulene | humulene results in decreased activity of CYP1A2 protein | 29074051 |
| C050426 | huperzine A | CYP1A2 protein results in increased metabolism of huperzine A | 12586202 |
| D006830 | Hydralazine | Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D006830 | Hydralazine | Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D006861 | Hydrogen Peroxide | CYP1A2 protein results in increased abundance of Hydrogen Peroxide | 25061110 |
| D047348 | Hydrolyzable Tannins | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CYP1A2 mRNA | 28843594 |
| D047348 | Hydrolyzable Tannins | Hydrolyzable Tannins results in decreased activity of CYP1A2 protein | 12749824 |
| C058309 | hypaconitine | CYP1A2 protein results in increased metabolism of hypaconitine | 21550385 |
| C082585 | iberin | iberin results in decreased activity of [CYP1A2 protein co-treated with CYP1A1 protein] | 22664424 |
| D007052 | Ibuprofen | Ibuprofen results in decreased expression of CYP1A2 mRNA | 25596134 |
| D007069 | Ifosfamide | Ifosfamide results in increased expression of CYP1A2 mRNA | 25596134 |
| D007099 | Imipramine | CYP1A2 protein affects the metabolism of Imipramine | 15286053 |
| D007099 | Imipramine | CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine | 15922009 |
| D007099 | Imipramine | CYP1A2 protein results in increased metabolism of Imipramine | 11714871 |
| D007099 | Imipramine | Imipramine inhibits the reaction [resveratrol results in decreased activity of CYP1A2 protein] | 11714871 |
| D007099 | Imipramine | Organophosphorus Compounds inhibits the reaction [CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine] | 15922009 |
| C002921 | imipramine N-oxide | CYP1A2 protein results in increased abundance of imipramine N-oxide | 27320963 |
| C031534 | imperatorin | imperatorin results in increased expression of CYP1A2 protein | 18692084 |
| C013352 | indacrinone | indacrinone analog results in decreased activity of CYP1A2 protein | 15916432 |
| C093582 | indan | indan results in decreased activity of CYP1A2 protein | 15916432 |
| C041508 | indeno(1,2,3-cd)pyrene | "indeno(1,2,3-cd)pyrene results in increased expression of CYP1A2 mRNA" | 17253728 |
| D007200 | Indican | Indican results in increased expression of CYP1A2 mRNA | 20000589 |
| C027185 | indirubin | indirubin results in increased expression of CYP1A2 mRNA | 15056799 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased expression of CYP1A2 mRNA | 28357125 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased expression of CYP1A2 | 22328411 |
| C016517 | indole-3-carbinol | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] | 22129741 |
| C016517 | indole-3-carbinol | indole-3-carbinol affects the expression of CYP1A2 mRNA | 21396975 |
| C016517 | indole-3-carbinol | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | 22129741 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased activity of CYP1A2 | 12147290 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased activity of CYP1A2 protein | 12147290 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased expression of CYP1A2 | 22328411|9806166 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased expression of CYP1A2 protein | 8384853 |
| D007211 | Indoles | CYP1A2 protein results in increased glutathionylation of Indoles | 22429462 |
| C075954 | indolo(3,2-b)carbazole | "indolo(3,2-b)carbazole results in increased expression of CYP1A2 mRNA" | 12419834 |
| D007213 | Indomethacin | TLR4 protein affects the reaction [Indomethacin results in decreased activity of CYP1A2 protein] | 12927920 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of CYP1A2 mRNA | 16771604 |
| C015293 | indopan | indopan analog results in decreased activity of CYP1A2 protein | 26599973 |
| C015293 | indopan | [indopan analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| C015293 | indopan | indopan results in decreased activity of CYP1A2 protein | 26599973 |
| C015293 | indopan | [indopan results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D007505 | Iron-Dextran Complex | Iron-Dextran Complex inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 9443932 |
| D007505 | Iron-Dextran Complex | Iron-Dextran Complex results in decreased activity of CYP1A2 protein | 9443932 |
| D015056 | 1-Methyl-3-isobutylxanthine | 1-Methyl-3-isobutylxanthine results in decreased activity of CYP1A2 protein | 11465391 |
| C549713 | isocarbophos | CYP1A2 protein results in increased metabolism of and results in decreased sulfation of and affects the activity of isocarbophos | 24752505 |
| C055542 | isoimperatorin | CYP1A2 protein results in increased oxidation of isoimperatorin | 25500267 |
| C040920 | isoliquiritigenin | "isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]" | 25110319 |
| C040920 | isoliquiritigenin | isoliquiritigenin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 25110319 |
| C018326 | isomalathion | isomalathion results in decreased expression of CYP1A2 mRNA | 24333466 |
| C015304 | isopimpinellin | isopimpinellin results in increased expression of CYP1A2 protein | 18692084 |
| C518329 | isopropyl-9H-thioxanthen-9-one | isopropyl-9H-thioxanthen-9-one results in increased expression of CYP1A2 mRNA | 20558275 |
| D007545 | Isoproterenol | Isoproterenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D007545 | Isoproterenol | Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | 15710352 |
| D007545 | Isoproterenol | Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] | 15710352 |
| C028904 | isoproturon | isoproturon results in increased activity of CYP1A2 protein | 22310298 |
| C028904 | isoproturon | isoproturon results in increased expression of CYP1A2 mRNA | 22310298 |
| C028904 | isoproturon | isoproturon results in decreased activity of CYP1A2 protein | 18420780 |
| C016527 | isoquercitrin | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA | 20033131 |
| C015959 | isosafrole | isosafrole results in increased expression of CYP1A2 mRNA | 8722114 |
| C015959 | isosafrole | isosafrole inhibits the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] | 12062927 |
| C015959 | isosafrole | isosafrole results in decreased activity of CYP1A2 protein | 12062927 |
| C015959 | isosafrole | isosafrole results in increased expression of CYP1A2 mRNA | 11285323 |
| C015959 | isosafrole | isosafrole results in increased expression of CYP1A2 | 3377821 |
| C512910 | isoxanthohumol | isoxanthohumol results in increased expression of CYP1A2 mRNA | 15672752 |
| D017275 | Isradipine | Isradipine results in increased expression of CYP1A2 mRNA | 27732883 |
| D007559 | Ivermectin | Ivermectin results in increased expression of CYP1A2 mRNA | 24998875 |
| C006552 | kaempferol | kaempferol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 21256954 |
| C006552 | kaempferol | kaempferol results in decreased activity of CYP1A2 protein | 20806393|2105393 |
| C006552 | kaempferol | kaempferol results in increased expression of CYP1A2 mRNA | 19034627 |
| C006552 | kaempferol | kaempferol results in increased expression of and results in increased activity of CYP1A2 protein | 18421621 |
| C006552 | kaempferol | kaempferol results in increased expression of CYP1A2 mRNA | 18421621 |
| C477388 | KC 500 | KC 500 results in increased expression of CYP1A2 mRNA | 12117779 |
| D007654 | Ketoconazole | Ketoconazole results in increased expression of CYP1A2 protein | 7986207 |
| D007654 | Ketoconazole | Ketoconazole affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D007654 | Ketoconazole | Ketoconazole inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | 9305587 |
| D007654 | Ketoconazole | Ketoconazole results in decreased activity of CYP1A2 protein | 15618748|1591643 |
| D007654 | Ketoconazole | Ketoconazole results in increased expression of CYP1A2 mRNA | 25000292 |
| D007654 | Ketoconazole | Ketoconazole results in increased expression of CYP1A2 protein | 25000292 |
| D007654 | Ketoconazole | Ketoconazole inhibits the reaction [CYP1A2 protein results in increased oxidation of Uroporphyrinogens] | 1567206 |
| D007654 | Ketoconazole | Ketoconazole results in decreased activity of CYP1A2 protein | 18420780 |
| D007654 | Ketoconazole | Ketoconazole inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] | 19858067 |
| D007654 | Ketoconazole | Ketoconazole results in decreased activity of CYP1A2 protein | 12814958|1587949 |
| C099406 | L 742694 | L 742694 affects the expression of CYP1A2 mRNA | 15102944 |
| D064747 | Lansoprazole | Lansoprazole results in increased expression of CYP1A2 mRNA | 12623754 |
| D064747 | Lansoprazole | Lansoprazole results in increased expression of CYP1A2 protein | 8169844|9744552 |
| D064747 | Lansoprazole | Lansoprazole results in increased expression of CYP1A2 mRNA | 25626140 |
| D064747 | Lansoprazole | Lansoprazole results in increased expression of CYP1A2 protein | 14550749|9152597 |
| D064747 | Lansoprazole | Lansoprazole results in increased expression of CYP1A2 | 8930576 |
| C476223 | laquinimod | laquinimod analog results in increased expression of CYP1A2 mRNA | 28433708 |
| D007854 | Lead | Lead affects the expression of CYP1A2 mRNA | 23631153 |
| C017461 | lead nitrate | lead nitrate results in decreased activity of CYP1A2 protein | 11162773 |
| C017461 | lead nitrate | "lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]" | 8902619 |
| C017461 | lead nitrate | "lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 protein]" | 8902619 |
| C017461 | lead nitrate | "lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA]" | 8902619 |
| C017461 | lead nitrate | "lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 protein]" | 8902619 |
| C017461 | lead nitrate | lead nitrate inhibits the reaction [2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 mRNA] | 8902619 |
| C017461 | lead nitrate | lead nitrate inhibits the reaction [2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 protein] | 8902619 |
| C017461 | lead nitrate | lead nitrate inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 8902619 |
| C017461 | lead nitrate | lead nitrate inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 protein] | 8902619 |
| C017461 | lead nitrate | lead nitrate inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A2 protein] | 8902619 |
| C017461 | lead nitrate | lead nitrate results in decreased expression of and results in decreased activity of CYP1A2 protein | 8902619 |
| C045463 | leflunomide | leflunomide results in increased expression of CYP1A2 mRNA | 28988120 |
| C045463 | leflunomide | leflunomide results in increased expression of CYP1A2 mRNA | 24136188 |
| C052901 | lemongrass oil | lemongrass oil affects the expression of CYP1A2 mRNA | 25976427 |
| C052901 | lemongrass oil | lemongrass oil results in increased expression of CYP1A2 mRNA | 25660481 |
| D007912 | Lentinan | Lentinan results in decreased expression of CYP1A2 | 15630237 |
| C011896 | lephetamine | CYP1A2 protein results in decreased alkylation of lephetamine | 26276083 |
| C070840 | licochalcone A | licochalcone A results in decreased activity of CYP1A2 protein | 26100226 |
| D008012 | Lidocaine | CYP1A2 protein affects the metabolism of Lidocaine | 15447735 |
| D001556 | Lindane | Lindane results in increased activity of CYP1A2 protein | 12842176|1664153 |
| D001556 | Lindane | Lindane results in increased expression of and results in increased activity of CYP1A2 protein | 18486174 |
| D001556 | Lindane | Lindane results in increased expression of CYP1A2 mRNA | 17919674|1798429 |
| D001556 | Lindane | Lindane results in increased expression of CYP1A2 protein | 12842176|1791967 |
| D001556 | Lindane | Methylcholanthrene promotes the reaction [Lindane results in increased expression of and results in increased activity of CYP1A2 protein] | 18486174 |
| D001556 | Lindane | Phenobarbital promotes the reaction [Lindane results in increased expression of and results in increased activity of CYP1A2 protein] | 18486174 |
| C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of CYP1A2 mRNA" | 26220752 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 22466549 |
| D008070 | Lipopolysaccharides | Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | 15710352 |
| D008070 | Lipopolysaccharides | Colforsin inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | 15710352 |
| D008070 | Lipopolysaccharides | Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | 15710352 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased activity of CYP1A2 protein | 15542068|1571035 |
| D008070 | Lipopolysaccharides | N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | 15542068 |
| D008070 | Lipopolysaccharides | Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] | 15710352 |
| D008070 | Lipopolysaccharides | Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] | 15710352 |
| D008095 | Lithocholic Acid | Lithocholic Acid results in decreased activity of CYP1A2 protein | 18420780 |
| D008095 | Lithocholic Acid | CYP1A2 protein results in increased metabolism of Lithocholic Acid | 18039809 |
| D008095 | Lithocholic Acid | [CYP1A2 protein results in increased metabolism of Lithocholic Acid] which results in increased chemical synthesis of Lithocholic Acid analog | 18039809 |
| D008152 | Loxapine | CYP1A2 results in increased metabolism of Loxapine | 21826677 |
| C015329 | lycopene | lycopene inhibits the reaction [Atrazine results in increased expression of CYP1A2 mRNA] | 26775023 |
| C005498 | magnolol | magnolol results in decreased activity of CYP1A2 protein | 19140158 |
| D008294 | Malathion | CYP1A2 protein affects the metabolism of Malathion | 15557345 |
| D008294 | Malathion | Malathion results in increased expression of CYP1A2 mRNA | 22310298 |
| D008344 | Maneb | Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of CYP1A2 protein] | 23159886 |
| D008344 | Maneb | Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP1A2 mRNA] | 23159886 |
| D008344 | Maneb | [Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of CYP1A2 protein | 23159886 |
| D008344 | Maneb | [Paraquat co-treated with Maneb] results in increased expression of CYP1A2 mRNA | 23159886 |
| D008344 | Maneb | Silymarin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of CYP1A2 protein] | 23159886 |
| D008344 | Maneb | Silymarin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP1A2 mRNA] | 23159886 |
| C501277 | Mangifera indica extract | Mangifera indica extract results in decreased activity of CYP1A2 protein | 22815239 |
| C501277 | Mangifera indica extract | Mangifera indica extract results in increased expression of CYP1A2 mRNA | 22815239 |
| C501277 | Mangifera indica extract | Mangifera indica extract results in decreased activity of CYP1A2 protein | 18053976 |
| C013592 | mangiferin | mangiferin results in decreased activity of CYP1A2 protein | 22815239 |
| C013592 | mangiferin | mangiferin results in increased expression of CYP1A2 mRNA | 22815239 |
| C013592 | mangiferin | mangiferin results in decreased activity of CYP1A2 protein | 18053976 |
| D008463 | Mebendazole | Mebendazole results in increased expression of CYP1A2 protein | 12841937 |
| D008463 | Mebendazole | Mebendazole results in increased expression of CYP1A2 protein | 12841937 |
| D008468 | Meclizine | Meclizine inhibits the reaction [[Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 mRNA] | 15272053 |
| D008468 | Meclizine | [Meclizine binds to and results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 mRNA | 15272053 |
| D008528 | Mefenamic Acid | CYP1A2 protein results in increased glutathionylation of Mefenamic Acid analog | 25372302 |
| D008528 | Mefenamic Acid | CYP1A2 protein results in increased hydroxylation of Mefenamic Acid | 25372302 |
| D008528 | Mefenamic Acid | Mefenamic Acid results in decreased activity of CYP1A2 protein | 18816299 |
| D008550 | Melatonin | CYP1A2 protein affects the metabolism of Melatonin | 15626586|1582491 |
| D008550 | Melatonin | CYP1A2 protein results in decreased methylation of Melatonin | 15616152 |
| D008550 | Melatonin | CYP1A2 protein results in increased hydroxylation of Melatonin | 15616152|2263405 |
| D008550 | Melatonin | CYP1A2 protein results in increased metabolism of Melatonin | 17565714 |
| D008550 | Melatonin | Melatonin inhibits the reaction [CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene] | 19919601 |
| D008550 | Melatonin | Melatonin results in decreased activity of CYP1A2 protein | 19919601 |
| D008550 | Melatonin | [ABCB6 gene mutant form results in decreased expression of CYP1A2 mRNA] inhibits the reaction [CYP1A2 protein results in increased metabolism of Melatonin] | 25623066|2562306 |
| D008550 | Melatonin | [ABCB6 gene mutant form results in decreased expression of CYP1A2 protein] inhibits the reaction [CYP1A2 protein results in increased metabolism of Melatonin] | 25623066 |
| D008550 | Melatonin | CYP1A2 protein results in increased metabolism of Melatonin | 25623066 |
| D008550 | Melatonin | [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of CYP1A2 mRNA | 20033131 |
| D008558 | Melphalan | Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D008558 | Melphalan | Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D008627 | Mercuric Chloride | Mercuric Chloride results in decreased activity of CYP1A2 protein | 11162773 |
| D008628 | Mercury | Mercury affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 23231920 |
| D008628 | Mercury | Mercury inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 22579925 |
| D008628 | Mercury | Mercury promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 22579925 |
| D008628 | Mercury | Mercury results in increased activity of CYP1A2 protein | 22579925 |
| D008687 | Metformin | Metformin results in increased expression of CYP1A2 mRNA | 19022234 |
| D008687 | Metformin | Metformin results in decreased expression of CYP1A2 mRNA | 25596134 |
| D008691 | Methadone | CYP1A2 protein affects the metabolism of Methadone | 11145498 |
| D008694 | Methamphetamine | CYP1A2 protein affects the metabolism of Methamphetamine metabolite | 16038959 |
| D008715 | Methionine | "[3,4,5,3',4'-pentachlorobiphenyl co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of CYP1A2 mRNA" | 28973532 |
| D008715 | Methionine | [LEP gene mutant form results in increased susceptibility to [Methionine co-treated with Choline]] which results in decreased expression of CYP1A2 mRNA | 27712037 |
| D008715 | Methionine | [LEP gene mutant form results in increased susceptibility to [Methionine co-treated with Choline]] which results in decreased expression of CYP1A2 protein | 27712037 |
| D008715 | Methionine | "[Methionine deficiency co-treated with Choline deficiency co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased expression of CYP1A2 mRNA" | 28163111 |
| D003915 | Dextromethorphan | CYP1A2 protein affects the metabolism of Dextromethorphan | 15199075 |
| D008727 | Methotrexate | Methotrexate inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D008727 | Methotrexate | Methotrexate results in decreased expression of CYP1A2 mRNA | 15120968 |
| D008731 | Methoxychlor | CYP1A2 protein results in decreased methylation of Methoxychlor | 12167570|1243379 |
| D008731 | Methoxychlor | CYP1A2 protein results in increased hydroxylation of Methoxychlor | 9047321 |
| D008731 | Methoxychlor | Methoxychlor results in increased expression of CYP1A2 mRNA | 21924250 |
| D008731 | Methoxychlor | ESR1 protein promotes the reaction [Methoxychlor results in increased expression of CYP1A2 mRNA] | 21252393 |
| D008731 | Methoxychlor | Methoxychlor results in increased expression of CYP1A2 mRNA | 21252393 |
| D008731 | Methoxychlor | Methoxychlor results in increased expression of and results in increased activity of CYP1A2 protein | 12919727 |
| D008732 | Methoxydimethyltryptamines | Methoxydimethyltryptamines analog results in decreased activity of CYP1A2 protein | 26599973 |
| D008732 | Methoxydimethyltryptamines | [Methoxydimethyltryptamines analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D008730 | Methoxsalen | Methoxsalen results in decreased activity of CYP1A2 protein | 8819299 |
| D008730 | Methoxsalen | Methoxsalen results in decreased activity of CYP1A2 protein | 18420780 |
| D008730 | Methoxsalen | Methoxsalen results in decreased activity of CYP1A2 protein | 12814958|1587949 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 mRNA | 9364010 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased activity of CYP1A2 protein | 16639589 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 protein | 16639589 |
| D008748 | Methylcholanthrene | AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | 15155550 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 mRNA | 15155550 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 protein | 15155550 |
| D008748 | Methylcholanthrene | AHR protein affects the susceptibility to [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | 20171196 |
| D008748 | Methylcholanthrene | [Celsior co-treated with Methylcholanthrene] results in increased expression of CYP1A2 mRNA | 15448115 |
| D008748 | Methylcholanthrene | Dehydroepiandrosterone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | 23603339 |
| D008748 | Methylcholanthrene | [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | 19022236 |
| D008748 | Methylcholanthrene | Dexamethasone inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | 19022236 |
| D008748 | Methylcholanthrene | Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | 19022236 |
| D008748 | Methylcholanthrene | Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D008748 | Methylcholanthrene | Methylcholanthrene promotes the reaction [Nicardipine results in increased expression of CYP1A2 mRNA] | 20067464 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased activity of CYP1A2 protein | 19022236|1911856 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 mRNA | 12107646|1576988 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 protein | 15769886|1616784 |
| D008748 | Methylcholanthrene | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]] | 19022236 |
| D008748 | Methylcholanthrene | Nicardipine promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | 20067464 |
| D008748 | Methylcholanthrene | AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | 6749129 |
| D008748 | Methylcholanthrene | AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 protein] | 6749129 |
| D008748 | Methylcholanthrene | CTNNB1 gene mutant form affects the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | 25174530 |
| D008748 | Methylcholanthrene | CYP1A2 affects the susceptibility to Methylcholanthrene | 19772856 |
| D008748 | Methylcholanthrene | [Methylcholanthrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A2 mRNA | 21498875 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased activity of CYP1A2 protein | 16639589|4054433 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 mRNA | 11356909|1154929 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 protein | 16167840|1663958 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 protein | 7701848 |
| D008748 | Methylcholanthrene | lead nitrate inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A2 protein] | 8902619 |
| D008748 | Methylcholanthrene | Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D008748 | Methylcholanthrene | Methylcholanthrene promotes the reaction [CYP1A2 protein results in increased oxidation of Toluene] | 1994898 |
| D008748 | Methylcholanthrene | Methylcholanthrene promotes the reaction [Lindane results in increased expression of and results in increased activity of CYP1A2 protein] | 18486174 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased activity of CYP1A2 protein | 15302093|1559011 |
| D008748 | Methylcholanthrene | [Methylcholanthrene results in increased activity of CYP1A2 protein] which results in increased oxidation of Uroporphyrinogens | 1617633 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of and results in increased activity of CYP1A2 protein | 15946133 |
| D008748 | Methylcholanthrene | "[[Methylcholanthrene results in increased expression of CYP1A1 protein] co-treated with [Methylcholanthrene results in increased expression of CYP1A2 protein]] results in decreased susceptibility to 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole" | 11999409 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 mRNA | 10476907|1077264 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 protein | 11285323|1199940 |
| D008748 | Methylcholanthrene | protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | 15302093 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CYP1A2 | 15890479 |
| D008752 | Methylene Chloride | Methylene Chloride affects the expression of CYP1A2 mRNA | 28392392 |
| D012862 | Skatole | Skatole results in increased expression of CYP1A2 mRNA | 28571685 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in decreased activity of CYP1A2 protein" | 24211539 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "CYP1A2 affects the metabolism of N-Methyl-3,4-methylenedioxyamphetamine" | 21871945 |
| C051786 | metolachlor | metolachlor results in increased activity of CYP1A2 protein | 10813365 |
| D008825 | Miconazole | Miconazole results in increased expression of CYP1A2 mRNA | 22262564 |
| D015735 | Mifepristone | [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | 19022236 |
| D015735 | Mifepristone | [Dexamethasone co-treated with Mifepristone] results in increased activity of CYP1A2 protein | 19022236 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]] | 19022236 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] | 19022236 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] | 17690134 |
| D016685 | Mitomycin | Mitomycin results in decreased activity of CYP1A2 protein | 15696929 |
| C001801 | mitragynine | mitragynine results in increased activity of CYP1A2 protein | 23274770 |
| C001801 | mitragynine | mitragynine results in increased expression of CYP1A2 mRNA | 23274770 |
| C001801 | mitragynine | mitragynine results in increased expression of CYP1A2 protein | 23274770 |
| C028577 | monobutyl phthalate | monobutyl phthalate results in decreased activity of CYP1A2 protein | 27432241 |
| D008999 | Monocrotophos | Monocrotophos results in increased expression of CYP1A2 protein | 21445290 |
| C020300 | monomethylarsonic acid | monomethylarsonic acid results in increased expression of CYP1A2 mRNA | 17481689 |
| C031448 | musk ketone | musk ketone results in increased expression of CYP1A2 mRNA | 9441723 |
| C031448 | musk ketone | musk ketone results in increased activity of CYP1A2 protein | 10630706 |
| C031448 | musk ketone | musk ketone results in increased expression of CYP1A2 protein | 10630706 |
| C031447 | musk xylene | musk xylene metabolite results in increased expression of CYP1A2 mRNA | 9397191 |
| C031447 | musk xylene | musk xylene results in increased expression of CYP1A2 mRNA | 9397191 |
| C031447 | musk xylene | musk xylene results in increased activity of CYP1A2 protein | 10630706 |
| C031447 | musk xylene | musk xylene results in increased expression of CYP1A2 protein | 10630706 |
| D009173 | Mycophenolic Acid | Mycophenolic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 25929522 |
| C005246 | myristicin | CYP1A2 protein affects the oxidation of myristicin | 12523956 |
| C005246 | myristicin | Glutathione inhibits the reaction [myristicin results in decreased activity of CYP1A2 protein] | 26091900 |
| C005246 | myristicin | myristicin results in decreased activity of CYP1A2 protein | 26091900 |
| C583365 | N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide | "N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide results in increased expression of CYP1A2 mRNA" | 29244179 |
| C560625 | N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine | N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 21493753 |
| C534983 | N-(2-amino-3-methyl-n-butyl)-3-((bis-4-fluorophenyl)methoxy)tropane | CYP1A2 protein results in increased metabolism of N-(2-amino-3-methyl-n-butyl)-3-((bis-4-fluorophenyl)methoxy)tropane | 18425847 |
| C104820 | N-(3-(aminomethyl)benzyl)acetamidine | N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] | 15542068 |
| C554954 | N-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-1H-indazole-3-carboxamide hydrochloride | N-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-1H-indazole-3-carboxamide hydrochloride results in increased expression of CYP1A2 mRNA | 28174063 |
| C507425 | N-(4-cyano-benzo(b)thiophene-2-carbonyl)guanidine | CYP1A2 protein results in increased hydroxylation of N-(4-cyano-benzo(b)thiophene-2-carbonyl)guanidine | 16857327 |
| C028473 | N-acetyl-4-benzoquinoneimine | CYP1A2 protein results in increased abundance of N-acetyl-4-benzoquinoneimine | 24661219 |
| C028473 | N-acetyl-4-benzoquinoneimine | CYP1A2 protein results in increased chemical synthesis of and results in increased abundance of N-acetyl-4-benzoquinoneimine | 19679878 |
| C028473 | N-acetyl-4-benzoquinoneimine | CYP1A2 protein results in increased abundance of N-acetyl-4-benzoquinoneimine | 24552538 |
| C028473 | N-acetyl-4-benzoquinoneimine | [CYP1A2 results in increased oxidation of Acetaminophen] which results in increased chemical synthesis of N-acetyl-4-benzoquinoneimine | 8861779 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of CYP1A2 mRNA" | 25620056 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of CYP1A2 mRNA" | 25620056 |
| C031721 | naphthalene | naphthalene analog results in decreased activity of CYP1A2 protein | 15916432 |
| C031721 | naphthalene | naphthalene inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] | 16790556 |
| C031721 | naphthalene | naphthalene inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] | 16790556 |
| C031721 | naphthalene | naphthalene results in decreased activity of CYP1A2 protein | 15916432|1679055 |
| C031721 | naphthalene | naphthalene results in decreased activity of CYP1A2 protein | 19563207 |
| C501268 | naphtho(2,3-a)pyrene | "naphtho(2,3-a)pyrene results in increased expression of CYP1A2 mRNA" | 17253728 |
| D015058 | 1-Naphthylisothiocyanate | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CYP1A2 mRNA | 27344345 |
| D015058 | 1-Naphthylisothiocyanate | "[1-Naphthylisothiocyanate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in decreased expression of CYP1A2 protein" | 15598703 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in decreased expression of CYP1A2 protein | 15598703 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of CYP1A2 mRNA | 20551477 |
| D015058 | 1-Naphthylisothiocyanate | "[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with 1-Naphthylisothiocyanate] results in decreased expression of CYP1A2 protein" | 15598703 |
| C005273 | naringenin | naringenin results in decreased activity of CYP1A2 protein | 21053930 |
| C005274 | naringin | naringin results in decreased activity of CYP1A2 protein | 21053930 |
| C498045 | NCX 4040 | NCX 4040 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 19542225 |
| C498045 | NCX 4040 | NCX 4040 results in decreased activity of CYP1A2 protein | 19542225 |
| C028787 | N-desmethyltamoxifen | CYP1A2 protein results in increased metabolism of N-desmethyltamoxifen | 29285606 |
| C028787 | N-desmethyltamoxifen | "[CYP1A2 protein results in increased metabolism of N-desmethyltamoxifen] which results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene" | 29285606 |
| C051752 | nefazodone | nefazodone results in increased expression of CYP1A2 mRNA | 24136188 |
| C000598690 | N-ethyl-1,2-diphenylethylamine | "CYP1A2 protein results in decreased alkylation of N-ethyl-1,2-diphenylethylamine" | 26276083 |
| C026385 | n-hexane | CYP1A2 protein results in increased hydroxylation of n-hexane | 16484137 |
| C026385 | n-hexane | diallyl trisulfide inhibits the reaction [n-hexane results in increased expression of CYP1A2 protein] | 28115069 |
| C026385 | n-hexane | n-hexane results in increased expression of and results in increased activity of CYP1A2 protein | 28115069 |
| D009529 | Nicardipine | Methylcholanthrene promotes the reaction [Nicardipine results in increased expression of CYP1A2 mRNA] | 20067464 |
| D009529 | Nicardipine | Nicardipine promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | 20067464 |
| D009529 | Nicardipine | Nicardipine results in decreased activity of CYP1A2 protein | 15863898 |
| D009529 | Nicardipine | Nicardipine results in increased expression of CYP1A2 mRNA | 20067464 |
| D009532 | Nickel | Nickel results in decreased expression of CYP1A2 mRNA | 24768652 |
| C022838 | nickel chloride | nickel chloride results in decreased expression of CYP1A2 protein | 21784029 |
| C028007 | nickel monoxide | nickel monoxide results in decreased expression of CYP1A2 mRNA | 19167457 |
| D009534 | Niclosamide | Niclosamide results in decreased activity of CYP1A2 protein | 11124226 |
| D009538 | Nicotine | Nicotine results in decreased activity of CYP1A2 protein | 15916432 |
| D009538 | Nicotine | Nicotine results in increased expression of CYP1A2 protein | 11849738 |
| D009538 | Nicotine | Nicotine results in decreased expression of CYP1A2 mRNA | 26463278 |
| D009543 | Nifedipine | Nifedipine results in decreased activity of CYP1A2 protein | 10805063 |
| D009543 | Nifedipine | Nifedipine results in decreased activity of CYP1A2 protein | 18420780 |
| D009543 | Nifedipine | Nifedipine inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] | 19858067 |
| C012655 | nimesulide | CYP1A2 protein results in increased glutathionylation of nimesulide | 26524229 |
| C012655 | nimesulide | nimesulide results in decreased expression of CYP1A2 mRNA | 24136188 |
| D015737 | Nisoldipine | Nisoldipine results in decreased activity of CYP1A2 protein | 10805063 |
| C000598691 | N-isopropyl-1,2-diphenylethylamine | "CYP1A2 protein results in decreased alkylation of N-isopropyl-1,2-diphenylethylamine" | 26276083 |
| C008625 | nitroaniline | nitroaniline analog results in increased activity of CYP1A2 protein | 9545601 |
| C008625 | nitroaniline | nitroaniline analog results in increased expression of CYP1A2 mRNA | 9545601 |
| C008625 | nitroaniline | nitroaniline analog results in increased expression of CYP1A2 protein | 9545601 |
| D009582 | Nitrofurantoin | Nitrofurantoin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| C041150 | N-methyl-7H-dibenzo(c,g)carbazole | "CYP1A2 protein affects the metabolism of and results in increased activity of N-methyl-7H-dibenzo(c,g)carbazole" | 15534862 |
| C062567 | N-methyl-N-2-(methylsulfinyl)ethylpropionic acid amide | CYP1A2 protein results in increased activity of N-methyl-N-2-(methylsulfinyl)ethylpropionic acid amide | 15725615 |
| C468271 | N-methyl-N-benzylnitrosamine | N-methyl-N-benzylnitrosamine results in decreased activity of CYP1A2 protein | 12222751 |
| C578955 | N,N-diallyl-5-methoxytryptamine | "N,N-diallyl-5-methoxytryptamine results in decreased activity of CYP1A2 protein" | 26599973 |
| C578955 | N,N-diallyl-5-methoxytryptamine | "[N,N-diallyl-5-methoxytryptamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin" | 26599973 |
| C578955 | N,N-diallyl-5-methoxytryptamine | "N,N-diallyl-5-methoxytryptamine results in decreased activity of CYP1A2 protein" | 26599973 |
| C578955 | N,N-diallyl-5-methoxytryptamine | "[N,N-diallyl-5-methoxytryptamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Caffeine" | 26599973 |
| C574385 | N,N-didesmethyl-4-hydroxytamoxifen | "CYP1A2 protein results in increased metabolism of N,N-didesmethyl-4-hydroxytamoxifen" | 29285606 |
| C574385 | N,N-didesmethyl-4-hydroxytamoxifen | "[CYP1A2 protein results in increased metabolism of N,N-didesmethyl-4-hydroxytamoxifen] which results in increased abundance of N,N-didesmethyl-4-hydroxytamoxifen" | 29285606 |
| C454677 | N,N-diethyl-3-hydroxymethylbenzamide | "CYP1A2 protein results in increased chemical synthesis of N,N-diethyl-3-hydroxymethylbenzamide" | 11854147 |
| C033695 | N,N-diisopropyltryptamine | "N,N-diisopropyltryptamine analog results in decreased activity of CYP1A2 protein" | 26599973 |
| C033695 | N,N-diisopropyltryptamine | "[N,N-diisopropyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin" | 26599973 |
| C008661 | nobiletin | CYP1A2 protein results in increased metabolism of nobiletin | 22743247 |
| C058272 | norclozapine | [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of norclozapine | 11151749 |
| C058272 | norclozapine | CYP1A2 protein results in increased chemical synthesis of norclozapine | 18809730 |
| C058272 | norclozapine | Fluvoxamine inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of norclozapine] | 18809730 |
| C058272 | norclozapine | CYP1A2 protein results in increased metabolism of norclozapine | 12969762 |
| D009643 | Norfloxacin | Norfloxacin binds to CYP1A2 protein | 8905919 |
| D009643 | Norfloxacin | Norfloxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 8905919 |
| C017576 | norgestimate | [Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP1A2 protein | 16291717 |
| C010262 | norharman | CYP1A2 protein affects the metabolism of [norharman co-treated with aniline] | 15279827 |
| D009661 | Nortriptyline | Nortriptyline results in increased metabolism of CYP1A2 protein | 18359012 |
| C072936 | notoginsenoside R1 | notoginsenoside R1 results in decreased activity of CYP1A2 protein | 25834921 |
| C064976 | O(6)-benzylguanine | O(6)-benzylguanine inhibits the reaction [CYP1A2 protein affects the metabolism of Phenacetin] | 11751525 |
| C064976 | O(6)-benzylguanine | O(6)-benzylguanine inhibits the reaction [CYP1A2 protein results in increased metabolism of Dacarbazine metabolite] | 11751525 |
| C064976 | O(6)-benzylguanine | O(6)-benzylguanine results in decreased activity of CYP1A2 protein | 11751525 |
| C064976 | O(6)-benzylguanine | CYP1A2 protein affects the oxidation of O(6)-benzylguanine | 11751525 |
| C464660 | obeticholic acid | obeticholic acid inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of Acetaminophen] | 27939613 |
| C464660 | obeticholic acid | obeticholic acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 27939613 |
| C464660 | obeticholic acid | obeticholic acid results in decreased activity of CYP1A2 protein | 27939613 |
| C464660 | obeticholic acid | obeticholic acid results in decreased expression of CYP1A2 mRNA | 27939613 |
| C025589 | ochratoxin A | CYP1A2 protein results in increased susceptibility to ochratoxin A | 11189750|2178165 |
| C025589 | ochratoxin A | ochratoxin A results in increased expression of CYP1A2 mRNA | 21834667 |
| C014138 | octachlorostyrene | octachlorostyrene results in increased activity of CYP1A2 protein | 19525444 |
| C014138 | octachlorostyrene | octachlorostyrene results in increased expression of CYP1A2 mRNA | 19525444 |
| D019787 | Linoleic Acid | Linoleic Acid results in decreased activity of CYP1A2 protein | 16978661 |
| D015242 | Ofloxacin | [Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | 11408986 |
| D019319 | Okadaic Acid | CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Okadaic Acid | 26374342 |
| D019319 | Okadaic Acid | CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Okadaic Acid | 26374342 |
| C076029 | olanzapine | CYP1A2 protein affects the metabolism of olanzapine | 15545309|1588314 |
| C076029 | olanzapine | Fluvoxamine inhibits the reaction [CYP1A2 protein affects the metabolism of olanzapine] | 15545309 |
| D009828 | Oleanolic Acid | Oleanolic Acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 15043991 |
| D009828 | Oleanolic Acid | Oleanolic Acid results in decreased activity of CYP1A2 protein | 15043991 |
| D009828 | Oleanolic Acid | Oleanolic Acid results in decreased expression of CYP1A2 mRNA | 23948738 |
| D009828 | Oleanolic Acid | Oleanolic Acid results in decreased expression of CYP1A2 mRNA | 18706400 |
| C011521 | olivacine | CYP1A2 protein affects the metabolism of olivacine analog | 14709624 |
| C011521 | olivacine | olivacine analog results in increased expression of and results in increased activity of CYP1A2 protein | 14709624 |
| C026209 | oltipraz | "oltipraz inhibits the reaction [CYP1A2 results in increased activity of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline]" | 10775323 |
| C026209 | oltipraz | oltipraz metabolite results in decreased activity of CYP1A2 protein | 10775323 |
| C026209 | oltipraz | oltipraz results in decreased activity of CYP1A2 protein | 10775323 |
| C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of CYP1A2 mRNA] | 22496397 |
| C026209 | oltipraz | oltipraz results in increased expression of CYP1A2 mRNA | 22496397 |
| C026209 | oltipraz | CYP1A2 protein affects the metabolism of oltipraz | 15831204|1592076 |
| C026209 | oltipraz | oltipraz results in increased activity of CYP1A2 protein | 8625305 |
| C026209 | oltipraz | oltipraz results in increased expression of CYP1A2 mRNA | 8625305 |
| D009853 | Omeprazole | AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A2 mRNA] | 20171196 |
| D009853 | Omeprazole | Omeprazole results in decreased activity of CYP1A2 protein | 16035375 |
| D009853 | Omeprazole | Omeprazole results in increased activity of CYP1A2 promoter | 18502397 |
| D009853 | Omeprazole | Omeprazole results in increased activity of CYP1A2 protein | 19118567|1923059 |
| D009853 | Omeprazole | Omeprazole results in increased expression of and results in increased activity of CYP1A2 protein | 15802389 |
| D009853 | Omeprazole | Omeprazole results in increased expression of CYP1A2 mRNA | 12040753|1262375 |
| D009853 | Omeprazole | Omeprazole results in increased expression of CYP1A2 protein | 12841937|2178402 |
| D009853 | Omeprazole | [Omeprazole results in increased expression of CYP1A2 protein] which results in decreased alkylation of Phenacetin | 22524704 |
| D009853 | Omeprazole | Omeprazole results in decreased activity of CYP1A2 protein | 18420780 |
| D009853 | Omeprazole | [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | 22687989 |
| D009853 | Omeprazole | Omeprazole results in increased expression of CYP1A2 mRNA | 19118567|2562614 |
| D009853 | Omeprazole | Omeprazole results in increased expression of CYP1A2 protein | 9152597 |
| D009853 | Omeprazole | Omeprazole results in increased expression of CYP1A2 | 8930576 |
| D017294 | Ondansetron | CYP1A2 protein affects the metabolism of Ondansetron | 15286053 |
| C016340 | o,p'-DDT | "o,p'-DDT results in increased expression of CYP1A2 mRNA" | 21924250 |
| C016340 | o,p'-DDT | "o,p'-DDT affects the expression of CYP1A2 mRNA" | 18925944 |
| D009943 | Organophosphorus Compounds | Organophosphorus Compounds inhibits the reaction [CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine] | 15922009 |
| D009943 | Organophosphorus Compounds | Organophosphorus Compounds results in decreased activity of CYP1A2 protein | 17936932 |
| D016566 | Organoselenium Compounds | Organoselenium Compounds binds to and results in decreased activity of CYP1A2 protein | 21732699 |
| D009966 | Orphenadrine | Orphenadrine inhibits the reaction [CYP1A2 protein results in decreased ethylation of 7-ethoxy-4-trifluoromethylcoumarin] | 9241656 |
| D009966 | Orphenadrine | Orphenadrine inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 7-hydroxy-4-trifluoromethylcoumarin] | 9241656 |
| D009966 | Orphenadrine | Orphenadrine results in decreased activity of CYP1A2 protein | 9241656 |
| D009966 | Orphenadrine | Orphenadrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D008939 | Mitotane | Mitotane results in increased expression of CYP1A2 mRNA | 25542188 |
| C012466 | oxadiazon | oxadiazon results in increased expression of CYP1A2 mRNA | 26710982 |
| D010078 | Oxazines | CYP1A2 protein results in increased metabolism of Oxazines | 12569440|2263405 |
| D010078 | Oxazines | [CYP1A2 protein results in increased metabolism of Oxazines] which results in increased chemical synthesis of Oxazines | 23669205|2385098 |
| D010078 | Oxazines | CYP1A2 protein results in increased oxidation of Oxazines | 21964418 |
| D010078 | Oxazines | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of Oxazines] | 12569440 |
| D010078 | Oxazines | furafylline inhibits the reaction [[CYP1A2 protein results in increased metabolism of Oxazines] which results in increased chemical synthesis of Oxazines] | 23850985 |
| D010078 | Oxazines | perfluorooctane sulfonic acid inhibits the reaction [CYP1A2 protein results in increased oxidation of Oxazines] | 21964418 |
| C011030 | oxfendazole | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA | 20033131 |
| C011030 | oxfendazole | [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of CYP1A2 mRNA | 20033131 |
| C011030 | oxfendazole | [Diethylnitrosamine co-treated with oxfendazole] results in increased expression of CYP1A2 mRNA | 20033131 |
| C011030 | oxfendazole | [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | 18754104 |
| D010100 | Oxygen | CYP1A2 gene mutant form inhibits the reaction [beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A1 mRNA]] | 29180065 |
| D010100 | Oxygen | CYP1A2 gene mutant form inhibits the reaction [Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]] | 29180065 |
| D010100 | Oxygen | CYP1A2 gene mutant form inhibits the reaction [Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of NQO1 protein]] | 29180065 |
| D010100 | Oxygen | CYP1A2 gene mutant form results in increased susceptibility to Oxygen | 29180065 |
| D010100 | Oxygen | [CYP1A2 gene mutant form results in increased susceptibility to Oxygen] which results in increased expression of NQO1 mRNA | 29180065 |
| D010100 | Oxygen | Oxygen deficiency affects the reaction [CYP1A2 protein results in increased metabolism of aristolochic acid I] | 26845733 |
| D010100 | Oxygen | Oxygen deficiency results in decreased expression of CYP1A2 mRNA | 19695866 |
| D010100 | Oxygen | beta-Naphthoflavone promotes the reaction [Oxygen results in increased activity of CYP1A2 protein] | 21745492 |
| D010100 | Oxygen | beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A2 mRNA] | 21745492 |
| D010100 | Oxygen | [beta-Naphthoflavone results in increased expression of CYP1A2 protein] inhibits the reaction [CYP1A1 gene mutant form results in increased susceptibility to Oxygen] | 28201809 |
| D010100 | Oxygen | [beta-Naphthoflavone results in increased expression of CYP1A2 protein] which results in decreased susceptibility to Oxygen | 28201809 |
| D010100 | Oxygen | Oxygen inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 protein] | 29180065 |
| D010100 | Oxygen | Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] | 21745492 |
| D010100 | Oxygen | Oxygen results in increased activity of CYP1A2 protein | 21745492 |
| D010100 | Oxygen | Oxygen results in increased expression of CYP1A2 mRNA | 25703676 |
| D010100 | Oxygen | Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP1A2 protein] | 26747958 |
| D010100 | Oxygen | Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP1A2 protein] | 26747958 |
| D010100 | Oxygen | Oxygen deficiency affects the reaction [CYP1A2 protein results in increased metabolism of aristolochic acid I] | 26845733 |
| D010100 | Oxygen | [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP1A2 protein | 26747958 |
| D010100 | Oxygen | [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP1A2 protein | 26747958 |
| D010100 | Oxygen | [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP1A2 protein | 26747958 |
| D010100 | Oxygen | [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP1A2 protein | 26747958 |
| D010100 | Oxygen | Oxygen inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 24657529 |
| D010126 | Ozone | AHR protein affects the reaction [Ozone results in increased expression of CYP1A2 mRNA] | 19536146 |
| D010126 | Ozone | AHR protein affects the reaction [Ozone results in increased expression of CYP1A2 protein] | 19536146 |
| D010126 | Ozone | Ozone results in increased expression of CYP1A2 mRNA | 19536146 |
| D010126 | Ozone | Ozone results in increased expression of CYP1A2 protein | 19536146 |
| D010126 | Ozone | Ozone results in decreased expression of CYP1A2 mRNA | 16183385 |
| D017239 | Paclitaxel | Paclitaxel results in decreased activity of CYP1A2 protein | 19909766 |
| D017239 | Paclitaxel | Paclitaxel results in increased expression of CYP1A2 mRNA | 15585946 |
| C064276 | pantoprazole | pantoprazole results in increased expression of CYP1A2 mRNA | 25626140 |
| C064276 | pantoprazole | pantoprazole results in increased expression of CYP1A2 protein | 9152597 |
| D010208 | Papaverine | Papaverine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D010269 | Paraquat | Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of CYP1A2 protein] | 23159886 |
| D010269 | Paraquat | Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP1A2 mRNA] | 23159886 |
| D010269 | Paraquat | Acetylcysteine inhibits the reaction [Paraquat results in increased expression of and results in increased activity of CYP1A2 protein] | 23159886 |
| D010269 | Paraquat | Acetylcysteine inhibits the reaction [Paraquat results in increased expression of CYP1A2 mRNA] | 23159886 |
| D010269 | Paraquat | [Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of CYP1A2 protein | 23159886 |
| D010269 | Paraquat | [Paraquat co-treated with Maneb] results in increased expression of CYP1A2 mRNA | 23159886 |
| D010269 | Paraquat | Paraquat results in increased activity of CYP1A2 protein | 20888808 |
| D010269 | Paraquat | Paraquat results in increased expression of and results in increased activity of CYP1A2 protein | 23159886 |
| D010269 | Paraquat | Paraquat results in increased expression of CYP1A2 mRNA | 20888808|2315988 |
| D010269 | Paraquat | Paraquat results in increased expression of CYP1A2 protein | 20888808 |
| D010269 | Paraquat | Silymarin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of CYP1A2 protein] | 23159886 |
| D010269 | Paraquat | Silymarin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP1A2 mRNA] | 23159886 |
| D010269 | Paraquat | Silymarin inhibits the reaction [Paraquat results in increased expression of and results in increased activity of CYP1A2 protein] | 23159886 |
| D010269 | Paraquat | Silymarin inhibits the reaction [Paraquat results in increased expression of CYP1A2 mRNA] | 23159886 |
| D010278 | Parathion | CYP1A2 protein affects the metabolism of Parathion | 12669189|1555734 |
| D010278 | Parathion | Parathion results in increased expression of CYP1A2 mRNA | 26196221 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of CYP1A2 mRNA | 22352393|2421647 |
| C410127 | PCB 180 | PCB 180 results in increased activity of CYP1A2 protein | 15743714 |
| C410127 | PCB 180 | "[3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] promotes the reaction [AHR protein results in increased expression of CYP1A2 mRNA]" | 20961953 |
| C410127 | PCB 180 | "[AHR protein co-treated with CYP1A2 protein] affects the susceptibility to [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180]" | 20961953 |
| C410127 | PCB 180 | CYP1A2 results in decreased susceptibility to PCB 180 | 21571617 |
| C410127 | PCB 180 | PCB 180 promotes the reaction [AHR protein results in increased expression of CYP1A2] | 20961953 |
| C066957 | pelargonidin | pelargonidin results in increased expression of CYP1A2 mRNA | 23419638 |
| C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased expression of CYP1A2 mRNA | 19270788 |
| C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased expression of CYP1A2 mRNA | 18243468 |
| C003060 | pentachlorobenzene | pentachlorobenzene results in increased expression of CYP1A2 protein | 10696772 |
| D010416 | Pentachlorophenol | Pentachlorophenol results in increased expression of CYP1A2 mRNA | 23892564 |
| D010424 | Pentobarbital | Pentobarbital results in increased expression of CYP1A2 mRNA | 10064569 |
| D010431 | Pentoxifylline | Pentoxifylline results in decreased activity of CYP1A2 protein | 11465391 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid inhibits the reaction [CYP1A2 protein results in increased oxidation of Oxazines] | 21964418 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of CYP1A2 mRNA | 20936131 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid affects the expression of CYP1A2 mRNA | 18281256 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of CYP1A2 mRNA | 20118188 |
| C023036 | perfluorooctanoic acid | PPARA promotes the reaction [perfluorooctanoic acid results in increased expression of CYP1A2 mRNA] | 20118188 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of CYP1A2 mRNA | 16221955|1916217 |
| D010480 | Perhexiline | Perhexiline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D026023 | Permethrin | Permethrin results in increased expression of CYP1A2 mRNA | 21784029 |
| D026023 | Permethrin | Permethrin results in increased expression of CYP1A2 protein | 21784029 |
| D010575 | Pesticides | Pesticides results in decreased activity of CYP1A2 protein | 17936932 |
| D010615 | Phenacetin | CYP1A2 protein affects the metabolism of Phenacetin | 15801540 |
| D010615 | Phenacetin | CYP1A2 protein results in increased oxidation of Phenacetin | 17097115 |
| D010615 | Phenacetin | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [CYP1A2 protein results in decreased ethylation of Phenacetin]" | 8020169 |
| D010615 | Phenacetin | 2-aminofluorene inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 28119166 |
| D010615 | Phenacetin | 4-amino-2-phenoxymethanesulfonanilide promotes the reaction [CYP1A2 protein results in increased oxidation of Phenacetin] | 19053182 |
| D010615 | Phenacetin | [5-bromotryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | [5-chlorotryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | [5-fluoro-alpha-methyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | [5-fluoro-alpha-methyltryptamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | [5-fluorotryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | [5-methyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | [7-methyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | 8-phenyltheophylline inhibits the reaction [CYP1A2 protein results in decreased ethylation of Phenacetin] | 11465391 |
| D010615 | Phenacetin | [alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | [Amiodarone results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | CYP1A2 protein affects the metabolism of Phenacetin | 11751525|1580154 |
| D010615 | Phenacetin | CYP1A2 protein results in decreased ethylation of Phenacetin | 11303964|1243379 |
| D010615 | Phenacetin | CYP1A2 protein results in increased metabolism of Phenacetin | 12401345|1246791 |
| D010615 | Phenacetin | [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen | 19135037 |
| D010615 | Phenacetin | CYP1A2 protein results in increased oxidation of Phenacetin | 10985777|1128470 |
| D010615 | Phenacetin | CYP1A2 protein results in increased oxidation of Phenacetin analog | 11284709 |
| D010615 | Phenacetin | [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 16049126|2385098 |
| D010615 | Phenacetin | [indopan analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | [indopan results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | [Methoxydimethyltryptamines analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | "[N,N-diallyl-5-methoxytryptamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin" | 26599973 |
| D010615 | Phenacetin | "[N,N-diisopropyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin" | 26599973 |
| D010615 | Phenacetin | O(6)-benzylguanine inhibits the reaction [CYP1A2 protein affects the metabolism of Phenacetin] | 11751525 |
| D010615 | Phenacetin | obeticholic acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 27939613 |
| D010615 | Phenacetin | Oleanolic Acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 15043991 |
| D010615 | Phenacetin | [Omeprazole results in increased expression of CYP1A2 protein] which results in decreased alkylation of Phenacetin | 22524704 |
| D010615 | Phenacetin | Phenacetin results in increased activity of CYP1A2 protein | 15802386 |
| D010615 | Phenacetin | [Tryptamines analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| D010615 | Phenacetin | zileuton inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 14570767 |
| D010615 | Phenacetin | CYP1A2 protein results in increased oxidation of Phenacetin | 9195021 |
| D010615 | Phenacetin | CYP1A2 protein affects the metabolism of Phenacetin | 15766918 |
| D010615 | Phenacetin | CYP1A2 protein affects the metabolism of Phenacetin | 15766918 |
| D010615 | Phenacetin | CYP1A2 protein affects the metabolism of Phenacetin | 15742976 |
| D010615 | Phenacetin | CYP1A2 protein results in increased metabolism of Phenacetin | 10445756 |
| D010615 | Phenacetin | Phenacetin inhibits the reaction [CYP1A2 protein results in increased oxidation of Uroporphyrinogens] | 1567206 |
| D010615 | Phenacetin | Phenacetin results in increased expression of CYP1A2 protein | 15742976 |
| D010615 | Phenacetin | CYP1A2 protein affects the metabolism of Phenacetin | 15231049|1580154 |
| D010615 | Phenacetin | CYP1A2 protein results in decreased ethylation of Phenacetin | 11911841|1206436 |
| D010615 | Phenacetin | CYP1A2 protein results in increased metabolism of Phenacetin | 12222751|1765172 |
| D010615 | Phenacetin | [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen | 28438436 |
| D010615 | Phenacetin | Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 8905919 |
| D010615 | Phenacetin | Norfloxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 8905919 |
| C031181 | phenanthrene | CYP1A2 protein results in increased metabolism of and results in increased activity of phenanthrene | 19766613 |
| C031181 | phenanthrene | CYP1A2 protein results in increased oxidation of phenanthrene | 27137136 |
| C031181 | phenanthrene | [CYP1A2 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol | 27137136 |
| C031181 | phenanthrene | [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA | 7750161 |
| C031181 | phenanthrene | CYP1A2 protein results in increased metabolism of and results in increased activity of phenanthrene | 19766613 |
| C031181 | phenanthrene | phenanthrene results in increased activity of CYP1A2 protein | 8001243 |
| C031181 | phenanthrene | phenanthrene results in decreased activity of CYP1A2 protein | 19563207 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in decreased activity of CYP1A2 mRNA | 20442190 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in decreased expression of CYP1A2 protein | 20025923 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in increased expression of CYP1A2 mRNA | 15672752|2044219 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in decreased expression of CYP1A2 protein | 20025923 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in increased activity of [CYP1A1 protein co-treated with CYP1A2 protein] | 22664424 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in increased expression of CYP1A2 mRNA | 22664424 |
| D010634 | Phenobarbital | Phenobarbital results in decreased expression of CYP1A2 mRNA | 19952500 |
| D010634 | Phenobarbital | Meclizine inhibits the reaction [[Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 mRNA] | 15272053 |
| D010634 | Phenobarbital | Phenobarbital results in decreased activity of CYP1A2 protein | 19909766 |
| D010634 | Phenobarbital | Phenobarbital results in increased activity of CYP1A2 protein | 19118567 |
| D010634 | Phenobarbital | [Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 mRNA | 15272053 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of CYP1A2 mRNA | 19118567|2225856 |
| D010634 | Phenobarbital | ciprofibrate inhibits the reaction [Phenobarbital results in increased expression of CYP1A2 mRNA] | 17962186 |
| D010634 | Phenobarbital | MED1 protein promotes the reaction [Phenobarbital results in increased expression of CYP1A2 mRNA] | 16109766 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of CYP1A2 mRNA | 23091169 |
| D010634 | Phenobarbital | "[Phenobarbital co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of CYP1A2 mRNA" | 23681119 |
| D010634 | Phenobarbital | Phenobarbital results in increased activity of CYP1A2 protein | 10064569 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of CYP1A2 mRNA | 10064569|1610976 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of CYP1A2 protein | 10064569|1869208 |
| D010634 | Phenobarbital | pirinixic acid inhibits the reaction [Phenobarbital results in increased expression of CYP1A2 mRNA] | 17962186 |
| D010634 | Phenobarbital | Choline deficiency promotes the reaction [Phenobarbital results in increased expression of CYP1A2 protein] | 18798224 |
| D010634 | Phenobarbital | Phenobarbital promotes the reaction [Lindane results in increased expression of and results in increased activity of CYP1A2 protein] | 18486174 |
| D010634 | Phenobarbital | Phenobarbital results in decreased expression of CYP1A2 mRNA | 11328961|1559606 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of CYP1A2 mRNA | 20226384|2327357 |
| D019800 | Phenol | CYP1A2 protein affects the susceptibility to Phenol | 8242868 |
| C008838 | phenthoate | phenthoate results in increased expression of CYP1A2 mRNA | 22310298 |
| D010656 | Phenylephrine | Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 16510159 |
| D010656 | Phenylephrine | Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 16510159 |
| D010656 | Phenylephrine | Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | 16510159 |
| D010672 | Phenytoin | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Phenytoin | 23397584 |
| D010695 | Phlorhizin | Phlorhizin results in decreased expression of CYP1A2 mRNA | 22538082 |
| C018637 | phorone | phorone results in increased expression of CYP1A2 mRNA | 24494203 |
| D010713 | Phosphatidylcholines | Phosphatidylcholines affects the activity of CYP1A2 protein | 15966743 |
| C483858 | phosphatidylethanolamine | phosphatidylethanolamine results in increased stability of and results in increased activity of CYP1A2 protein | 15966743 |
| C008905 | physcione | physcione results in decreased activity of CYP1A2 protein | 27633141 |
| C121565 | pifithrin | pifithrin results in decreased activity of CYP1A2 protein | 16258175 |
| C121565 | pifithrin | pifithrin results in increased expression of CYP1A2 mRNA | 16258175 |
| C121565 | pifithrin | pifithrin results in increased expression of CYP1A2 protein | 16258175 |
| C041648 | pimobendan | CYP1A2 protein results in decreased methylation of pimobendan | 10611143 |
| C448623 | pipermethystine | pipermethystine results in increased expression of CYP1A2 protein | 17329236 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of CYP1A2 mRNA | 21784029 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of CYP1A2 protein | 21784029 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of CYP1A2 mRNA | 8722114|9233375 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of CYP1A2 protein | 9233375 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of CYP1A2 mRNA | 18544911|2073543 |
| D010882 | Piperonyl Butoxide | Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of CYP1A2 mRNA] | 18544911 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYP1A2 mRNA | 19710929 |
| C006253 | pirinixic acid | [pirinixic acid co-treated with PPARA] results in decreased expression of CYP1A2 mRNA | 20813756 |
| C006253 | pirinixic acid | pirinixic acid inhibits the reaction [Phenobarbital results in increased expression of CYP1A2 mRNA] | 17962186 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of CYP1A2 mRNA | 17962186|1846767 |
| C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CYP1A2 mRNA] | 18467677|2005976 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of CYP1A2 mRNA | 19162173 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 11064004 |
| D010936 | Plant Extracts | Plant Extracts results in decreased activity of CYP1A2 protein | 23850985 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of CYP1A2 mRNA | 19041297|2355793 |
| D010936 | Plant Extracts | Plant Extracts results in increased activity of CYP1A2 protein | 15025748 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of CYP1A2 mRNA | 15629189|2444630 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of CYP1A2 mRNA | 18158835 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of CYP1A2 mRNA | 23262642 |
| D010936 | Plant Extracts | Plant Extracts affects the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | 20096675 |
| D010936 | Plant Extracts | Plant Extracts results in decreased activity of CYP1A2 protein | 15831081 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of and results in increased activity of CYP1A2 protein | 15598702 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of CYP1A2 mRNA | 19041297|2052177 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of CYP1A2 protein | 20521779 |
| D028321 | Plant Preparations | Plant Preparations results in decreased expression of CYP1A2 mRNA | 26530625 |
| D028321 | Plant Preparations | Plant Preparations results in decreased activity of CYP1A2 protein | 27697540 |
| D028321 | Plant Preparations | Plant Preparations results in decreased expression of CYP1A2 mRNA | 27697540 |
| D028321 | Plant Preparations | Plant Preparations results in decreased expression of CYP1A2 protein | 24973489 |
| D028321 | Plant Preparations | Plant Preparations results in increased expression of and results in increased activity of CYP1A2 protein | 15807986 |
| D028321 | Plant Preparations | Plant Preparations results in increased expression of CYP1A2 mRNA | 21056093 |
| D028321 | Plant Preparations | Plant Preparations results in increased expression of CYP1A2 protein | 21056093 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls results in increased expression of CYP1A2 mRNA | 9364010 |
| D011078 | Polychlorinated Biphenyls | "[Polychlorinated Biphenyls co-treated with Dibenzofurans, Polychlorinated] results in increased activity of CYP1A2 protein" | 17051818 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls results in increased activity of CYP1A2 protein | 15743714 |
| D011078 | Polychlorinated Biphenyls | CYP1A2 affects the susceptibility to Polychlorinated Biphenyls | 22935098 |
| D000072317 | Polychlorinated Dibenzodioxins | "[Polychlorinated Dibenzodioxins co-treated with Dibenzofurans, Polychlorinated] results in increased expression of CYP1A2 mRNA" | 17850846 |
| D000072317 | Polychlorinated Dibenzodioxins | Polychlorinated Dibenzodioxins results in decreased activity of CYP1A2 protein | 15659567 |
| D000072317 | Polychlorinated Dibenzodioxins | Polychlorinated Dibenzodioxins results in decreased activity of CYP1A2 protein | 15659567 |
| D011084 | Polycyclic Aromatic Hydrocarbons | Polycyclic Aromatic Hydrocarbons results in increased expression of CYP1A2 protein | 15824912 |
| D011084 | Polycyclic Aromatic Hydrocarbons | Polycyclic Aromatic Hydrocarbons results in increased activity of CYP1A2 protein | 7750161 |
| D011084 | Polycyclic Aromatic Hydrocarbons | Polycyclic Aromatic Hydrocarbons results in increased expression of CYP1A2 mRNA | 7750161 |
| D011084 | Polycyclic Aromatic Hydrocarbons | Polycyclic Aromatic Hydrocarbons results in increased expression of CYP1A2 mRNA | 3379039 |
| D011092 | Polyethylene Glycols | Polyethylene Glycols results in increased activity of CYP1A2 protein | 22558349 |
| D011092 | Polyethylene Glycols | Polyethylene Glycols results in increased activity of CYP1A2 protein | 22558349 |
| D059808 | Polyphenols | Polyphenols results in decreased expression of CYP1A2 mRNA | 19370779 |
| D059808 | Polyphenols | Polyphenols results in decreased expression of CYP1A2 protein | 19370779 |
| D059808 | Polyphenols | Polyphenols results in decreased activity of CYP1A2 protein | 15831081 |
| D011134 | Polysaccharides | Polysaccharides results in decreased activity of CYP1A2 protein | 17827724 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of CYP1A2 mRNA | 23608068 |
| D017035 | Pravastatin | Pravastatin results in decreased expression of CYP1A2 mRNA | 27225895 |
| D017035 | Pravastatin | Pravastatin results in decreased expression of CYP1A2 mRNA | 27225895 |
| D011223 | Praziquantel | CYP1A2 protein affects the metabolism of Praziquantel | 12920490 |
| D011224 | Prazosin | Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | 16510159 |
| D011224 | Prazosin | Prazosin promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 16510159 |
| D011224 | Prazosin | Prazosin promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 16510159 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] | 28428138 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in increased expression of CYP1A2 mRNA | 27413110 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of CYP1A2 mRNA | 15596064|1916217 |
| D011319 | Primaquine | CYP1A2 protein affects the metabolism of Primaquine | 12920490 |
| D011319 | Primaquine | [CYP1A2 protein results in increased expression of HBG2 protein] which affects the susceptibility to Primaquine | 19616568 |
| D011319 | Primaquine | CYP1A2 protein results in increased metabolism of Primaquine | 19616568 |
| D011319 | Primaquine | Primaquine results in increased activity of CYP1A2 promoter | 18502397 |
| D011319 | Primaquine | Primaquine results in increased expression of CYP1A2 mRNA | 12451431|1262375 |
| D011335 | Proadifen | Proadifen results in decreased activity of CYP1A2 protein | 15618748 |
| C045362 | prochloraz | prochloraz results in increased expression of CYP1A2 mRNA | 21784029 |
| C045362 | prochloraz | prochloraz results in increased expression of CYP1A2 protein | 21784029 |
| C045362 | prochloraz | prochloraz results in increased expression of CYP1A2 mRNA | 25182419 |
| C024273 | profenofos | profenofos results in decreased activity of CYP1A2 protein | 20183062 |
| C024273 | profenofos | profenofos results in increased expression of CYP1A2 mRNA | 22310298 |
| C011088 | propachlor | propachlor results in increased activity of CYP1A2 protein | 10813365 |
| C045950 | propiconazole | propiconazole results in increased expression of CYP1A2 protein | 7986207 |
| C045950 | propiconazole | propiconazole results in increased expression of CYP1A2 mRNA | 19409404 |
| C045950 | propiconazole | propiconazole results in increased expression of CYP1A2 mRNA | 16730040|1901034 |
| C045950 | propiconazole | propiconazole results in increased activity of CYP1A2 protein | 3190755 |
| C045950 | propiconazole | propiconazole results in increased expression of CYP1A2 mRNA | 15603923|1664397 |
| C045950 | propiconazole | propiconazole results in increased expression of CYP1A2 protein | 7986207 |
| D011433 | Propranolol | CYP1A2 protein affects the metabolism of Propranolol | 15286053 |
| D011433 | Propranolol | Propranolol results in increased expression of CYP1A2 protein | 15618653 |
| D011433 | Propranolol | Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] | 15710352 |
| D011433 | Propranolol | Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] | 15710352 |
| C006068 | propylparaben | propylparaben results in decreased activity of CYP1A2 protein | 27432241 |
| C009091 | protocatechuic acid | protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | 15302093 |
| D054328 | Proton Pump Inhibitors | Proton Pump Inhibitors results in increased expression of CYP1A2 mRNA | 25626140 |
| C009093 | protopine | protopine results in increased expression of CYP1A2 mRNA | 21419197 |
| C107773 | pterostilbene | pterostilbene results in decreased activity of CYP1A2 protein | 16684708 |
| C511975 | purpurin | purpurin results in decreased activity of CYP1A2 protein | 12379470 |
| C511975 | purpurin | purpurin results in increased activity of CYP1A2 protein | 12744663 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 17959153 |
| C432165 | pyrazolanthrone | pyrazolanthrone results in increased expression of CYP1A2 mRNA | 17959153 |
| C432165 | pyrazolanthrone | resveratrol inhibits the reaction [pyrazolanthrone results in increased expression of CYP1A2 mRNA] | 17959153 |
| C030984 | pyrene | CYP1A2 protein results in increased hydroxylation of pyrene | 15016593 |
| C030984 | pyrene | [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA | 7750161 |
| C030984 | pyrene | pyrene results in increased expression of and results in increased activity of CYP1A2 protein | 17618724 |
| C030984 | pyrene | pyrene results in increased expression of CYP1A2 mRNA | 17618724|2616011 |
| C030984 | pyrene | pyrene results in increased expression of CYP1A2 protein | 26160115 |
| C030984 | pyrene | pyrene results in decreased activity of CYP1A2 protein | 19563207 |
| C023666 | pyridine | pyridine results in increased activity of CYP1A2 protein | 10413312|1046338 |
| C023666 | pyridine | pyridine results in increased expression of CYP1A2 mRNA | 10463385|1857340 |
| C023666 | pyridine | pyridine results in increased expression of CYP1A2 protein | 10413312|1046338 |
| C021079 | pyridoxal isonicotinoyl hydrazone | [pyridoxal isonicotinoyl hydrazone co-treated with Daunorubicin] results in increased activity of CYP1A2 protein | 15588138 |
| C021079 | pyridoxal isonicotinoyl hydrazone | [pyridoxal isonicotinoyl hydrazone co-treated with Doxorubicin] results in increased activity of CYP1A2 protein | 15588138 |
| C021079 | pyridoxal isonicotinoyl hydrazone | pyridoxal isonicotinoyl hydrazone results in decreased activity of CYP1A2 protein | 15588138 |
| D011748 | Pyrogallol | Pyrogallol results in increased activity of CYP1A2 protein | 18789925 |
| D011748 | Pyrogallol | Pyrogallol results in increased expression of CYP1A2 mRNA | 18789925 |
| D011748 | Pyrogallol | resveratrol inhibits the reaction [Pyrogallol results in increased activity of CYP1A2 protein] | 18789925 |
| D011748 | Pyrogallol | resveratrol inhibits the reaction [Pyrogallol results in increased expression of CYP1A2 mRNA] | 18789925 |
| D011759 | Pyrrolidines | CYP1A2 protein affects the metabolism of Pyrrolidines | 21053377 |
| D011763 | Pyrrolizidine Alkaloids | Pyrrolizidine Alkaloids results in increased expression of CYP1A2 mRNA | 26100227 |
| D011794 | Quercetin | Quercetin affects the activity of CYP1A2 protein | 21053930 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 21256954 |
| D011794 | Quercetin | Quercetin inhibits the reaction [beta-apo-8'-carotenal promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]] | 16970932 |
| D011794 | Quercetin | Quercetin inhibits the reaction [beta-apo-8'-carotenal results in increased expression of CYP1A2 protein] | 16970932 |
| D011794 | Quercetin | Quercetin inhibits the reaction [beta Carotene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]] | 16970932 |
| D011794 | Quercetin | "Quercetin inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane]" | 16544949 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D011794 | Quercetin | Quercetin promotes the reaction [JUND protein binds to CYP1A2 enhancer] | 10620351 |
| D011794 | Quercetin | Quercetin promotes the reaction [JUN protein binds to CYP1A2 enhancer] | 10620351 |
| D011794 | Quercetin | Quercetin results in decreased activity of CYP1A2 protein | 12949046|1591643 |
| D011794 | Quercetin | Quercetin results in increased expression of CYP1A2 mRNA | 19034627|2125695 |
| D011794 | Quercetin | "Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein]" | 22044346 |
| D011794 | Quercetin | Quercetin results in decreased activity of CYP1A2 protein | 18420780 |
| D011794 | Quercetin | "Quercetin inhibits the reaction [CYP1A2 results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline]" | 11752233 |
| D011794 | Quercetin | Quercetin results in increased expression of and results in increased activity of CYP1A2 protein | 18421621 |
| D011794 | Quercetin | Quercetin results in increased expression of CYP1A2 mRNA | 18421621 |
| D011802 | Quinidine | Quinidine affects the reaction [CYP1A2 protein results in increased oxidation of 4-amino-2-phenoxymethanesulfonanilide] | 19053182 |
| D011802 | Quinidine | Quinidine results in decreased activity of CYP1A2 protein | 15916432 |
| D011803 | Quinine | Quinine results in increased expression of CYP1A2 mRNA | 12451431 |
| C037219 | quinoline | quinoline analog results in decreased activity of CYP1A2 protein | 15916432 |
| D011806 | Quinolinium Compounds | Quinolinium Compounds results in increased expression of CYP1A2 mRNA | 23000282 |
| D064750 | Rabeprazole | Rabeprazole results in increased expression of CYP1A2 mRNA | 12623754 |
| D064750 | Rabeprazole | Rabeprazole results in increased expression of CYP1A2 mRNA | 25626140 |
| C495910 | ramelteon | CYP1A2 protein results in increased metabolism of ramelteon | 17069551 |
| D017382 | Reactive Oxygen Species | [[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] which results in increased abundance of Reactive Oxygen Species | 20118626 |
| D012110 | Reserpine | Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | 16510159 |
| D012110 | Reserpine | Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 16510159 |
| D012110 | Reserpine | [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] | 16510159 |
| D012110 | Reserpine | [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 16510159 |
| C059514 | resveratrol | CYP1A2 protein affects the metabolism of resveratrol | 15276085 |
| C059514 | resveratrol | Imipramine inhibits the reaction [resveratrol results in decreased activity of CYP1A2 protein] | 11714871 |
| C059514 | resveratrol | NADP promotes the reaction [resveratrol results in decreased activity of CYP1A2 protein] | 11714871 |
| C059514 | resveratrol | "resveratrol inhibits the reaction [15,16-dihydrotanshinone I results in increased expression of CYP1A2 mRNA]" | 21262253 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 10496959 |
| C059514 | resveratrol | resveratrol inhibits the reaction [cryptotanshinone results in increased expression of CYP1A2 mRNA] | 21262253 |
| C059514 | resveratrol | "resveratrol inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane]" | 16544949 |
| C059514 | resveratrol | resveratrol inhibits the reaction [pyrazolanthrone results in increased expression of CYP1A2 mRNA] | 17959153 |
| C059514 | resveratrol | resveratrol inhibits the reaction [tanshinone results in increased expression of CYP1A2 mRNA] | 21262253 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 19376845|2920974 |
| C059514 | resveratrol | resveratrol promotes the reaction [CYP1A2 protein results in increased metabolism of Caffeine] | 20716633 |
| C059514 | resveratrol | resveratrol results in decreased activity of CYP1A2 protein | 11714871 |
| C059514 | resveratrol | resveratrol analog results in decreased activity of CYP1A2 protein | 16684708 |
| C059514 | resveratrol | resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA] | 26204831 |
| C059514 | resveratrol | resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 protein] | 26204831 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Pyrogallol results in increased activity of CYP1A2 protein] | 18789925 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Pyrogallol results in increased expression of CYP1A2 mRNA] | 18789925 |
| C059514 | resveratrol | resveratrol results in decreased activity of CYP1A2 protein | 18420780|2595647 |
| C059514 | resveratrol | [resveratrol co-treated with Streptozocin] results in decreased expression of CYP1A2 mRNA | 25905778 |
| C059514 | resveratrol | resveratrol results in decreased expression of CYP1A2 mRNA | 25905778 |
| C003300 | retrorsine | retrorsine results in increased expression of CYP1A2 | 24799337 |
| C020491 | rhein | rhein results in decreased activity of CYP1A2 protein | 27633141 |
| D012293 | Rifampin | Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D012293 | Rifampin | Rifampin results in increased expression of CYP1A2 mRNA | 15977188 |
| D012293 | Rifampin | Rifampin results in increased expression of CYP1A2 protein | 15977188|1759030 |
| D012293 | Rifampin | [Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of CYP1A2 mRNA | 29162470 |
| D012293 | Rifampin | [[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in decreased expression of CYP1A2 protein | 25835148 |
| D012293 | Rifampin | Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D019438 | Ritonavir | Ritonavir results in increased expression of CYP1A2 mRNA | 11918509 |
| D019438 | Ritonavir | Ritonavir results in decreased expression of CYP1A2 mRNA | 17719200 |
| C116926 | rofecoxib | rofecoxib inhibits the reaction [CYP1A2 protein results in increased metabolism of Caffeine] | 16934051 |
| C116926 | rofecoxib | rofecoxib inhibits the reaction [CYP1A2 protein results in increased metabolism of tizanidine] | 15834531|1693405 |
| C116926 | rofecoxib | rofecoxib results in decreased activity of CYP1A2 protein | 18816299 |
| C116926 | rofecoxib | rofecoxib results in decreased activity of CYP1A2 protein | 15834531 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of CYP1A2 mRNA | 25572481|2559613 |
| C089730 | rosiglitazone | rosiglitazone results in decreased expression of CYP1A2 mRNA | 25596134 |
| C028632 | rutecarpine | rutecarpine analog binds to and results in decreased activity of CYP1A2 protein | 12852960 |
| C028632 | rutecarpine | rutecarpine binds to and results in decreased activity of CYP1A2 protein | 12852960 |
| C028632 | rutecarpine | rutecarpine promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline] | 15720787 |
| C028632 | rutecarpine | rutecarpine results in increased activity of CYP1A2 protein | 15720787 |
| D012451 | Safrole | Safrole results in decreased activity of CYP1A2 protein | 15778010 |
| D012451 | Safrole | Safrole results in increased expression of CYP1A2 mRNA | 8722114 |
| C413684 | salicylaldehyde isonicotinoyl hydrazone | [salicylaldehyde isonicotinoyl hydrazone co-treated with Daunorubicin] results in increased activity of CYP1A2 protein | 15588138 |
| C413684 | salicylaldehyde isonicotinoyl hydrazone | [salicylaldehyde isonicotinoyl hydrazone co-treated with Doxorubicin] results in increased activity of CYP1A2 protein | 15588138 |
| C413684 | salicylaldehyde isonicotinoyl hydrazone | salicylaldehyde isonicotinoyl hydrazone results in decreased activity of CYP1A2 protein | 15588138 |
| C031060 | salicylamide | salicylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 14729655 |
| D012503 | Saponins | Saponins results in decreased expression of CYP1A2 mRNA | 26590097 |
| C515233 | saracatinib | CYP1A2 protein results in increased oxidation of saracatinib | 27769111 |
| C034557 | schizandrer A | schizandrer A results in decreased activity of CYP1A2 protein | 25753323 |
| C034734 | schizandrin A | schizandrin A results in decreased activity of CYP1A2 protein | 25753323 |
| C031409 | schizandrin C | schizandrin C results in decreased activity of CYP1A2 protein | 25753323 |
| C033585 | schizandrol B | schizandrol B results in decreased activity of CYP1A2 protein | 25753323 |
| C458179 | scutellarein | CYP1A2 protein affects the metabolism of scutellarein | 19666078 |
| D012631 | Secobarbital | Secobarbital results in increased expression of CYP1A2 mRNA | 10064569 |
| D012642 | Selegiline | CYP1A2 protein affects the metabolism of Selegiline | 16198659 |
| D012643 | Selenium | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] | 21424224 |
| C009237 | senecionine | senecionine results in increased expression of CYP1A2 mRNA | 26100227 |
| C100180 | sesamex | sesamex results in increased expression of CYP1A2 mRNA | 8722114 |
| C016101 | shikonin | shikonin results in decreased activity of CYP1A2 protein | 28941798 |
| C016101 | shikonin | shikonin results in decreased activity of CYP1A2 protein | 28941798 |
| C120148 | SIB 1893 | SIB 1893 results in decreased activity of CYP1A2 protein | 15193955 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of CYP1A2 mRNA | 23806026 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CYP1A2 mRNA | 25351596 |
| D012834 | Silver | Silver results in increased expression of CYP1A2 mRNA | 20219766 |
| D012838 | Silymarin | Silymarin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of CYP1A2 protein] | 23159886 |
| D012838 | Silymarin | Silymarin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP1A2 mRNA] | 23159886 |
| D012838 | Silymarin | Silymarin inhibits the reaction [Paraquat results in increased expression of and results in increased activity of CYP1A2 protein] | 23159886 |
| D012838 | Silymarin | Silymarin inhibits the reaction [Paraquat results in increased expression of CYP1A2 mRNA] | 23159886 |
| D012839 | Simazine | CYP1A2 protein results in decreased susceptibility to Simazine | 26771455 |
| D012839 | Simazine | Simazine results in increased activity of CYP1A2 protein | 9711812 |
| D012839 | Simazine | Simazine results in increased expression of CYP1A2 protein | 9711812 |
| C059295 | sinensetin | CYP1A2 protein results in increased metabolism of sinensetin | 19666078 |
| D012906 | Smoke | Smoke affects the reaction [CYP1A2 gene polymorphism affects the metabolism of Clozapine] | 16044115 |
| D012906 | Smoke | Smoke promotes the reaction [CYP1A2 protein results in increased metabolism of Clozapine] | 16044115 |
| D012906 | Smoke | Smoke results in increased activity of CYP1A2 protein | 16044115 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [benzo(k)fluoranthene results in increased expression of CYP1A2 mRNA] | 11162773 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [benzo(k)fluoranthene results in increased expression of CYP1A2 protein] | 11162773 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 20188822 |
| C017947 | sodium arsenite | sodium arsenite results in decreased activity of CYP1A2 protein | 11162773 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of CYP1A2 | 23052196 |
| C017947 | sodium arsenite | tin mesoporphyrin inhibits the reaction [sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]] | 20188822 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 22535251 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of CYP1A2 mRNA | 17451858|2506574 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of CYP1A2 mRNA | 22535251 |
| C016104 | sodium bichromate | [Benzo(a)pyrene co-treated with sodium bichromate] results in decreased expression of CYP1A2 mRNA | 22613061 |
| C028982 | sodium chromate(VI) | CYP1A2 protein results in increased reduction of sodium chromate(VI) | 1903091 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in decreased expression of CYP1A2 mRNA | 21340527 |
| C001873 | sporidesmin | sporidesmin affects the expression of CYP1A2 mRNA | 28193462 |
| C075117 | squalestatin 1 | squalestatin 1 results in increased expression of CYP1A2 mRNA | 27225895 |
| C075117 | squalestatin 1 | squalestatin 1 results in increased expression of CYP1A2 mRNA | 27225895 |
| C523402 | SR 13668 | SR 13668 results in increased expression of CYP1A2 mRNA | 19135037 |
| C539817 | S-sulindac | "S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]" | 19276279 |
| C539817 | S-sulindac | S-sulindac inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 19276279 |
| C539817 | S-sulindac | S-sulindac results in decreased activity of CYP1A2 protein | 19276279 |
| D013241 | Sterigmatocystin | CYP1A2 protein results in increased glutathionylation of and results in increased hydroxylation of Sterigmatocystin | 20929267 |
| D013241 | Sterigmatocystin | [CYP1A2 protein results in increased glutathionylation of and results in increased hydroxylation of Sterigmatocystin] which results in increased chemical synthesis of Sterigmatocystin metabolite | 20929267 |
| C012042 | steviol | steviol results in increased expression of CYP1A2 mRNA | 28887089 |
| C012042 | steviol | steviol results in increased expression of CYP1A2 protein | 28887089 |
| C012043 | stevioside | stevioside results in increased expression of CYP1A2 mRNA | 28887089 |
| C012043 | stevioside | stevioside results in increased expression of CYP1A2 protein | 28887089 |
| C021092 | stiripentol | stiripentol results in decreased activity of CYP1A2 protein | 16022579 |
| D013311 | Streptozocin | Streptozocin results in decreased expression of CYP1A2 protein | 12700423 |
| D013311 | Streptozocin | [resveratrol co-treated with Streptozocin] results in decreased expression of CYP1A2 mRNA | 25905778 |
| D013311 | Streptozocin | Streptozocin results in decreased expression of CYP1A2 mRNA | 25905778 |
| D013311 | Streptozocin | Streptozocin results in increased expression of CYP1A2 protein | 17442507 |
| D013311 | Streptozocin | [Streptozocin results in increased expression of CYP1A2 protein] which results in increased metabolism of Diazinon | 17442507 |
| D020058 | Styrene | gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP1A2 protein] | 18202523 |
| D020058 | Styrene | Styrene results in increased expression of CYP1A2 mRNA | 16418063|1820252 |
| D020058 | Styrene | Styrene results in increased expression of CYP1A2 protein | 16418063|1820252 |
| C024075 | styrofoam | styrofoam analog affects the activity of CYP1A2 protein | 19909766 |
| C024075 | styrofoam | styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP1A2 protein] | 19909766 |
| C033006 | sudan III | sudan III results in increased expression of CYP1A2 protein | 20308224 |
| D013426 | Sulfaphenazole | Sulfaphenazole results in decreased activity of CYP1A2 protein | 15916432 |
| C016766 | sulforafan | "sulforafan inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]" | 19362136 |
| C016766 | sulforafan | sulforafan inhibits the reaction [anthracene results in increased activity of CYP1A2 protein] | 19362136 |
| C016766 | sulforafan | sulforafan inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | 19202560 |
| C016766 | sulforafan | sulforafan results in decreased expression of CYP1A2 mRNA | 20442190 |
| C016766 | sulforafan | sulforafan results in decreased activity of [CYP1A2 protein co-treated with CYP1A1 protein] | 22664424 |
| C016766 | sulforafan | sulforafan results in increased expression of CYP1A2 protein | 15906351 |
| D013458 | Sulfur Dioxide | Sulfur Dioxide results in decreased activity of CYP1A2 protein | 16023800 |
| D013458 | Sulfur Dioxide | Sulfur Dioxide results in decreased expression of CYP1A2 mRNA | 16023800 |
| D013467 | Sulindac | Sulindac results in increased expression of CYP1A2 mRNA | 17985343 |
| D013467 | Sulindac | Sulindac results in decreased expression of CYP1A2 mRNA | 24136188 |
| D013467 | Sulindac | Sulindac results in increased expression of CYP1A2 mRNA | 16531450 |
| C025462 | sulindac sulfide | sulindac sulfide results in increased expression of CYP1A2 mRNA | 17985343 |
| D013469 | Sulpiride | Sulpiride inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 26466350 |
| D013469 | Sulpiride | Sulpiride results in decreased expression of CYP1A2 mRNA | 26466350 |
| C473478 | sunitinib | sunitinib results in increased expression of CYP1A2 mRNA | 26797788 |
| D013491 | Suppressor Factors, Immunologic | "Suppressor Factors, Immunologic results in increased expression of CYP1A2 mRNA" | 23000282 |
| D013498 | Suramin | Suramin results in decreased activity of CYP1A2 protein | 11124226 |
| C446685 | systhane | systhane results in increased expression of CYP1A2 mRNA | 19409404 |
| D014284 | Triiodothyronine | Triiodothyronine affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 28478156 |
| D014284 | Triiodothyronine | Triiodothyronine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein] | 28478156 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased expression of CYP1A2 mRNA | 28478156 |
| D013619 | Tacrine | Tacrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013619 | Tacrine | CYP1A2 protein affects the metabolism of Tacrine | 15258105 |
| D013619 | Tacrine | Tacrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013619 | Tacrine | Tacrine results in decreased activity of CYP1A2 protein | 15258105 |
| C508967 | tamarixetin | tamarixetin results in increased expression of CYP1A2 mRNA | 19034627 |
| D013629 | Tamoxifen | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Tamoxifen | 23397584 |
| D013629 | Tamoxifen | CYP1A2 protein results in increased metabolism of Tamoxifen | 29285606 |
| D013629 | Tamoxifen | "[CYP1A2 protein results in increased metabolism of Tamoxifen] which results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene" | 29285606 |
| D013629 | Tamoxifen | Tamoxifen metabolite results in increased activity of CYP1A2 protein | 29285606 |
| D013629 | Tamoxifen | Tamoxifen results in decreased activity of CYP1A2 protein | 18420780 |
| D013629 | Tamoxifen | CYP1A2 protein results in increased hydroxylation of Tamoxifen | 15587933 |
| C059006 | tangeretin | tangeretin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 17090139 |
| C021751 | tanshinone | Dactinomycin inhibits the reaction [tanshinone results in increased expression of CYP1A2 mRNA] | 21262253 |
| C021751 | tanshinone | resveratrol inhibits the reaction [tanshinone results in increased expression of CYP1A2 mRNA] | 21262253 |
| C021751 | tanshinone | tanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | 21262253 |
| C021751 | tanshinone | tanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | 21262253 |
| C021751 | tanshinone | tanshinone results in increased expression of CYP1A2 mRNA | 21262253 |
| C021751 | tanshinone | tanshinone results in increased expression of CYP1A2 protein | 21262253 |
| C516109 | tasquinimod | tasquinimod analog results in increased expression of CYP1A2 mRNA | 28433708 |
| C031655 | tauroursodeoxycholic acid | tauroursodeoxycholic acid results in decreased expression of CYP1A2 mRNA | 15885361 |
| D013662 | Tea | Tea results in decreased expression of CYP1A2 mRNA | 19370779 |
| D013662 | Tea | Tea results in decreased expression of CYP1A2 protein | 19370779 |
| D013662 | Tea | Tea results in increased expression of and results in increased activity of CYP1A2 protein | 24815822 |
| C087114 | tebuconazole | NR1I3 promotes the reaction [tebuconazole results in increased expression of CYP1A2 mRNA] | 25656644 |
| C087114 | tebuconazole | tebuconazole results in increased expression of CYP1A2 mRNA | 25656644 |
| C105050 | tegaserod | tegaserod results in decreased activity of CYP1A2 protein | 11560869 |
| C010347 | terbutryne | CYP1A2 protein results in increased metabolism of terbutryne | 8971136 |
| C010347 | terbutryne | POR protein promotes the reaction [CYP1A2 protein results in increased metabolism of terbutryne] | 8971136 |
| C501413 | tesaglitazar | tesaglitazar results in decreased expression of CYP1A2 mRNA | 21515302 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 15155550 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | 15155550 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | 15155550 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | 26854739|8955152 |
| D013749 | Tetrachlorodibenzodioxin | 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | "2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]" | 19276279 |
| D013749 | Tetrachlorodibenzodioxin | "2,3,3',4,4',5-hexachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | "2,3,3',4,4'-pentachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | "2,3',4,4',5-pentachlorobiphenyl inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | "2,4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | "2,7-dinitrofluorene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | "3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 17183067 |
| D013749 | Tetrachlorodibenzodioxin | "3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]" | 17183067 |
| D013749 | Tetrachlorodibenzodioxin | "3',4'-dimethoxyflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]" | 28357125 |
| D013749 | Tetrachlorodibenzodioxin | 4-nitroquinolone-1-oxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein polymorphism affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 27535091 |
| D013749 | Tetrachlorodibenzodioxin | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Aminoquinolines inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Azacitidine promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 12927368 |
| D013749 | Tetrachlorodibenzodioxin | Benzo(a)pyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Chlorpromazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | CYP1A2 protein affects the susceptibility to Tetrachlorodibenzodioxin | 16636061 |
| D013749 | Tetrachlorodibenzodioxin | Dantrolene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 19022236 |
| D013749 | Tetrachlorodibenzodioxin | Ditiocarb inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | ellipticine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP1A2 mRNA | 19619570 |
| D013749 | Tetrachlorodibenzodioxin | flavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 17090139 |
| D013749 | Tetrachlorodibenzodioxin | furafylline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 17090139 |
| D013749 | Tetrachlorodibenzodioxin | Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | isoliquiritigenin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 25110319 |
| D013749 | Tetrachlorodibenzodioxin | Isoproterenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Methotrexate inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] | 19022236 |
| D013749 | Tetrachlorodibenzodioxin | Mycophenolic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 25929522 |
| D013749 | Tetrachlorodibenzodioxin | N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 21493753 |
| D013749 | Tetrachlorodibenzodioxin | NCX 4040 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 19542225 |
| D013749 | Tetrachlorodibenzodioxin | Nitrofurantoin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Papaverine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Perhexiline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Plant Extracts inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 11064004 |
| D013749 | Tetrachlorodibenzodioxin | pyrazolanthrone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 17959153 |
| D013749 | Tetrachlorodibenzodioxin | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 19376845|2920974 |
| D013749 | Tetrachlorodibenzodioxin | Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | salicylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 14729655 |
| D013749 | Tetrachlorodibenzodioxin | sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 20188822 |
| D013749 | Tetrachlorodibenzodioxin | S-sulindac inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 19276279 |
| D013749 | Tetrachlorodibenzodioxin | Tacrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | tangeretin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 17090139 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CYP1A2 mRNA | 22298810 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A2 mRNA | 14729655 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with AHR mRNA] affects the expression of CYP1A2 mRNA | 20619336 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of CYP1A2 mRNA | 29162470 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A2 enhancer] | 17785579 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased activity of CYP1A2 protein | 15659567 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | 16426572|1718306 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein | 14709624|1642657 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | 11064004|1136831 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | 11370663|1625817 |
| D013749 | Tetrachlorodibenzodioxin | tin mesoporphyrin inhibits the reaction [sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]] | 20188822 |
| D013749 | Tetrachlorodibenzodioxin | tolcapone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | trichostatin A promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 12927368 |
| D013749 | Tetrachlorodibenzodioxin | Triiodothyronine affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 28478156 |
| D013749 | Tetrachlorodibenzodioxin | Triiodothyronine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein] | 28478156 |
| D013749 | Tetrachlorodibenzodioxin | Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 16214954|2249639 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP1A2 mRNA] | 15034205 |
| D013749 | Tetrachlorodibenzodioxin | ARNT affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 11043581|2093516 |
| D013749 | Tetrachlorodibenzodioxin | CYP1A2 affects the susceptibility to Tetrachlorodibenzodioxin | 21095216 |
| D013749 | Tetrachlorodibenzodioxin | CYP1A2 protein affects the abundance of and affects the susceptibility to Tetrachlorodibenzodioxin | 15003330 |
| D013749 | Tetrachlorodibenzodioxin | CYP1A2 protein affects the abundance of Tetrachlorodibenzodioxin | 10448125|1969527 |
| D013749 | Tetrachlorodibenzodioxin | [CYP1A2 protein affects the abundance of Tetrachlorodibenzodioxin] inhibits the reaction [CYP1A1 protein results in increased metabolism of Tetrachlorodibenzodioxin] | 19695277 |
| D013749 | Tetrachlorodibenzodioxin | CYP1A2 protein affects the susceptibility to Tetrachlorodibenzodioxin | 16636061 |
| D013749 | Tetrachlorodibenzodioxin | Iron-Dextran Complex inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 9443932 |
| D013749 | Tetrachlorodibenzodioxin | Mercury affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 23231920 |
| D013749 | Tetrachlorodibenzodioxin | Mercury inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 22579925 |
| D013749 | Tetrachlorodibenzodioxin | Mercury promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 22579925 |
| D013749 | Tetrachlorodibenzodioxin | sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 22535251 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CYP1A2 mRNA | 20819909|2637764 |
| D013749 | Tetrachlorodibenzodioxin | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of CYP1A2 mRNA" | 28433925 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with AHR protein] results in increased expression of CYP1A2 mRNA | 21534955 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in increased expression of CYP1A2 mRNA | 25975270 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [Butyrates results in increased expression of CYP1A2 mRNA] | 15252868 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [trichostatin A results in increased expression of CYP1A2 mRNA] | 15252868 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A2 gene] | 28213091 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A2 promoter] | 21889950 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CYP1A2 mRNA | 15034205 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A2 mRNA | 22496397 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | 10986007|1663606 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein | 23423713|2512931 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 | 15722456|2421300 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | 11043581|1313028 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | 17997381|2109521 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin results in increased localization of AHR protein] which results in increased expression of CYP1A2 mRNA | 8215422 |
| D013749 | Tetrachlorodibenzodioxin | Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 1313028 |
| D013749 | Tetrachlorodibenzodioxin | Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] | 23423713 |
| D013749 | Tetrachlorodibenzodioxin | Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 23423713 |
| D013749 | Tetrachlorodibenzodioxin | Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] | 23423713 |
| D013749 | Tetrachlorodibenzodioxin | Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 23423713 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | 20153503 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | 20153503 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 | 15993909 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | 15664428 |
| D013749 | Tetrachlorodibenzodioxin | 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | "2,4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | "2,7-dinitrofluorene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]" | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Acetaminophen inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | AHR gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 23859880 |
| D013749 | Tetrachlorodibenzodioxin | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Aminoquinolines inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] | 22159698 |
| D013749 | Tetrachlorodibenzodioxin | arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 22159698 |
| D013749 | Tetrachlorodibenzodioxin | Benzo(a)pyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | CYP1A2 protein binds to and affects the abundance of Tetrachlorodibenzodioxin | 16966094 |
| D013749 | Tetrachlorodibenzodioxin | Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 17690134 |
| D013749 | Tetrachlorodibenzodioxin | Ditiocarb inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | "Drugs, Chinese Herbal promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]" | 16901605 |
| D013749 | Tetrachlorodibenzodioxin | ellipticine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | furafylline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Hemin inhibits the reaction [arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]] | 22159698 |
| D013749 | Tetrachlorodibenzodioxin | Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Levodopa inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] | 17690134 |
| D013749 | Tetrachlorodibenzodioxin | Orphenadrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Tacrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CYP1A2 mRNA | 22298810 |
| D013749 | Tetrachlorodibenzodioxin | "[Tetrachlorodibenzodioxin co-treated with 2,3,4,7,8-pentachlorodibenzofuran co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein" | 17342195 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [CYP1A2 protein results in decreased methylation of 7-methoxyresorufin] | 12635099 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] | 12062927 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased activity of CYP1A2 protein | 15659567 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | 12062927|1678109 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein | 11585058|2215969 |
| D013749 | Tetrachlorodibenzodioxin | "[Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] which results in increased activity of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline" | 11585058 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | 10568693|1091096 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | 12361703|1260615 |
| D013749 | Tetrachlorodibenzodioxin | tin mesoporphyrin inhibits the reaction [arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]] | 22159698 |
| D013749 | Tetrachlorodibenzodioxin | tolcapone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin binds to AHR protein] which binds to CYP1A2 enhancer | 9169078 |
| D013750 | Tetrachloroethylene | CYP1A2 protein results in increased metabolism of Tetrachloroethylene | 11684365 |
| D013750 | Tetrachloroethylene | Tetrachloroethylene results in decreased expression of CYP1A2 mRNA | 28973375 |
| C582340 | tetradecabromodiphenoxybenzene | tetradecabromodiphenoxybenzene analog results in increased expression of CYP1A2 mRNA | 26854739 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [FOS protein binds to CYP1A2 enhancer] | 10620351 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [JUND protein binds to CYP1A2 enhancer] | 10620351 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [JUN protein binds to CYP1A2 enhancer] | 10620351 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 1313028 |
| C096277 | tetrahydrocurcumin | tetrahydrocurcumin inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA] | 26102010 |
| C018674 | tetrahydrofuran | NR1I2 protein affects the reaction [tetrahydrofuran results in increased expression of CYP1A2 mRNA] | 28495613 |
| C018674 | tetrahydrofuran | NR1I3 protein affects the reaction [tetrahydrofuran results in increased expression of CYP1A2 mRNA] | 28495613 |
| C018674 | tetrahydrofuran | tetrahydrofuran results in increased expression of CYP1A2 mRNA | 28495613 |
| C014215 | tetrahydropalmatine | tetrahydropalmatine results in decreased expression of CYP1A2 mRNA | 28257954 |
| C014215 | tetrahydropalmatine | tetrahydropalmatine results in decreased expression of CYP1A2 protein | 28257954 |
| D013792 | Thalidomide | Thalidomide results in decreased expression of CYP1A2 mRNA | 28892372 |
| D013805 | Theobromine | CYP1A2 protein results in increased chemical synthesis of Theobromine | 1302044 |
| D013805 | Theobromine | CYP1A2 protein results in increased metabolism of Theobromine | 10215755 |
| D013805 | Theobromine | furafylline affects the reaction [CYP1A2 protein results in increased metabolism of Theobromine] | 10215755 |
| D013806 | Theophylline | CYP1A2 gene SNP affects the metabolism of Theophylline | 20797314 |
| D013806 | Theophylline | CYP1A2 gene SNP affects the susceptibility to Theophylline | 12732846 |
| D013806 | Theophylline | CYP1A2 promoter SNP affects the hydroxylation of Theophylline | 16841220 |
| D013806 | Theophylline | CYP1A2 protein affects the metabolism of Theophylline | 12732846|1569282 |
| D013806 | Theophylline | CYP1A2 protein results in increased chemical synthesis of Theophylline | 1302044 |
| D013806 | Theophylline | CYP1A2 protein results in increased metabolism of Theophylline | 11483122|9701106 |
| D013806 | Theophylline | Fluvoxamine inhibits the reaction [CYP1A2 protein affects the metabolism of Theophylline] | 9029748 |
| D013806 | Theophylline | Griseofulvin promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline] | 9029748 |
| D013806 | Theophylline | [Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | 11408986 |
| D013806 | Theophylline | Theophylline results in decreased activity of CYP1A2 protein | 11465391 |
| D013806 | Theophylline | zafirlukast inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | 9701106 |
| D013806 | Theophylline | CYP1A2 protein affects the metabolism of Theophylline | 15970798 |
| D013806 | Theophylline | andrographolide affects the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | 20096675 |
| D013806 | Theophylline | CYP1A2 protein affects the metabolism of Theophylline | 15720787|1598536 |
| D013806 | Theophylline | CYP1A2 protein results in increased metabolism of Theophylline | 20096675 |
| D013806 | Theophylline | Plant Extracts affects the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | 20096675 |
| D013806 | Theophylline | rutecarpine promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline] | 15720787 |
| D013806 | Theophylline | [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Theophylline | 16556082 |
| D013827 | Thiabendazole | beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole] | 10936227 |
| D013827 | Thiabendazole | CYP1A2 protein affects the metabolism of Thiabendazole | 10936227|1292049 |
| D013827 | Thiabendazole | Thiabendazole results in decreased activity of CYP1A2 protein | 11124226|1626136 |
| D013827 | Thiabendazole | Thiabendazole results in increased expression of CYP1A2 mRNA | 18570159 |
| D013827 | Thiabendazole | beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole] | 10936227 |
| D013827 | Thiabendazole | CYP1A2 protein affects the metabolism of Thiabendazole | 10936227 |
| D013827 | Thiabendazole | Thiabendazole results in increased expression of CYP1A2 mRNA | 15110098|1853937 |
| D013827 | Thiabendazole | Thiabendazole results in increased expression of CYP1A2 protein | 15110098 |
| C417209 | thiacloprid | thiacloprid results in increased expression of CYP1A2 mRNA | 21784029 |
| C417209 | thiacloprid | thiacloprid results in increased expression of CYP1A2 protein | 21784029 |
| D013853 | Thioacetamide | [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP1A2 mRNA | 28943392 |
| D013853 | Thioacetamide | Thioacetamide results in decreased expression of CYP1A2 mRNA | 23411599 |
| D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D008063 | Thioctic Acid | [CYP1A1 protein co-treated with CYP1A2 protein] affects the reaction [[Thioctic Acid results in decreased activity of POR protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]] | 21932800 |
| D013875 | Thiophanate | Thiophanate results in increased expression of CYP1A2 protein | 10096430 |
| D013881 | Thioridazine | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine | 23397584 |
| D013881 | Thioridazine | CYP1A2 protein results in increased metabolism of and results in increased activity of Thioridazine | 19482014 |
| D013988 | Ticlopidine | CYP1A2 protein results in increased oxidation of and results in increased cleavage of Ticlopidine metabolite | 19170597 |
| D013988 | Ticlopidine | Ticlopidine inhibits the reaction [CYP1A2 protein results in increased oxidation of 4-amino-2-phenoxymethanesulfonanilide] | 19053182 |
| D013988 | Ticlopidine | Ticlopidine results in decreased activity of CYP1A2 protein | 10759690 |
| C055421 | tin mesoporphyrin | tin mesoporphyrin inhibits the reaction [sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]] | 20188822 |
| C055421 | tin mesoporphyrin | tin mesoporphyrin inhibits the reaction [arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]] | 22159698 |
| C023754 | tizanidine | Ciprofloxacin inhibits the reaction [CYP1A2 protein affects the metabolism of tizanidine] | 15592331 |
| C023754 | tizanidine | CYP1A2 protein affects the metabolism of tizanidine | 15592331|1619865 |
| C023754 | tizanidine | CYP1A2 protein results in increased metabolism of tizanidine | 17618427 |
| C023754 | tizanidine | [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in decreased metabolism of tizanidine | 16198659 |
| C023754 | tizanidine | rofecoxib inhibits the reaction [CYP1A2 protein results in increased metabolism of tizanidine] | 15834531|1693405 |
| C023754 | tizanidine | CYP1A2 protein results in increased metabolism of tizanidine | 15834531 |
| D014028 | Tobacco Smoke Pollution | "3',4'-dimethoxyflavone affects the reaction [Tobacco Smoke Pollution analog results in increased expression of CYP1A2 mRNA]" | 28357125 |
| D014028 | Tobacco Smoke Pollution | CYP1A2 protein affects the susceptibility to Tobacco Smoke Pollution | 18499698 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution analog results in increased activity of CYP1A2 protein | 28357125 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution analog results in increased expression of CYP1A2 mRNA | 28357125 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased activity of CYP1A2 protein | 1913651 |
| C024746 | tobacco tar | tobacco tar results in increased activity of CYP1A2 protein | 17089110 |
| C066340 | tolcapone | tolcapone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| C066340 | tolcapone | tolcapone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| C066340 | tolcapone | tolcapone results in increased expression of CYP1A2 mRNA | 24136188 |
| C009500 | tolfenamic acid | ALB protein inhibits the reaction [tolfenamic acid results in decreased activity of CYP1A2 protein] | 17618427 |
| C009500 | tolfenamic acid | tolfenamic acid results in decreased activity of CYP1A2 protein | 17618427|1881629 |
| D014050 | Toluene | Acetone promotes the reaction [Toluene results in increased expression of CYP1A2 protein] | 8996725 |
| D014050 | Toluene | CYP1A2 protein results in increased oxidation of Toluene | 1994898 |
| D014050 | Toluene | Methylcholanthrene promotes the reaction [CYP1A2 protein results in increased oxidation of Toluene] | 1994898 |
| D014050 | Toluene | Toluene results in increased expression of CYP1A2 protein | 8996725 |
| D014112 | Toxaphene | Toxaphene results in increased expression of CYP1A2 mRNA | 26187448 |
| C099150 | trabectedin | trabectedin results in decreased expression of CYP1A2 mRNA | 12154027 |
| C507866 | trans-1,2-dihydro-1,2-naphthalenediol | "CYP1A2 protein results in increased abundance of trans-1,2-dihydro-1,2-naphthalenediol" | 16243959 |
| C495469 | trans-3-(4'-hydroxyphenyl)-2-propenoic acid | trans-3-(4'-hydroxyphenyl)-2-propenoic acid results in decreased activity of CYP1A2 protein | 15841493 |
| C542064 | trantinterol | trantinterol affects the activity of CYP1A2 protein | 21466844 |
| D014191 | Tranylcypromine | Tranylcypromine affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D014191 | Tranylcypromine | Tranylcypromine results in decreased activity of CYP1A2 protein | 15916432 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of CYP1A2 mRNA | 16882163|7697808 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CYP1A2 mRNA | 16985168 |
| D014212 | Tretinoin | Tretinoin results in decreased activity of CYP1A2 protein | 18420780 |
| C032910 | triadimefon | triadimefon results in increased expression of CYP1A2 mRNA | 20659493 |
| D014223 | Triamterene | CYP1A2 protein results in increased hydroxylation of Triamterene | 16035375 |
| D014227 | Triazines | alpha-naphthoflavone inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | 9305587 |
| D014227 | Triazines | CYP1A2 protein results in increased metabolism of Triazines | 9305587 |
| D014227 | Triazines | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | 9305587 |
| D014227 | Triazines | Gestodene inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | 9305587 |
| D014227 | Triazines | Ketoconazole inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | 9305587 |
| D014239 | Trichloroepoxypropane | "[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene" | 8961944 |
| D014239 | Trichloroepoxypropane | "[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene" | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of Benzo(a)pyrene | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene | 8961944 |
| D014239 | Trichloroepoxypropane | "[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene" | 8961944 |
| D014239 | Trichloroepoxypropane | "[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene" | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of Benzo(a)pyrene | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene | 8961944 |
| D014239 | Trichloroepoxypropane | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene | 8961944 |
| D014241 | Trichloroethylene | Trichloroethylene results in increased expression of CYP1A2 mRNA | 19254012 |
| C012589 | trichostatin A | trichostatin A promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 12927368 |
| C012589 | trichostatin A | trichostatin A results in increased expression of CYP1A2 mRNA | 12927368|2835712 |
| C012589 | trichostatin A | Tetrachlorodibenzodioxin inhibits the reaction [trichostatin A results in increased expression of CYP1A2 mRNA] | 15252868 |
| C012589 | trichostatin A | trichostatin A results in increased expression of CYP1A2 mRNA | 15252868 |
| D014295 | Trimethoprim | Trimethoprim results in decreased activity of CYP1A2 protein | 26599973 |
| D014295 | Trimethoprim | [Trimethoprim results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Amodiaquine | 26599973 |
| C052920 | trimethylarsine oxide | trimethylarsine oxide results in increased expression of CYP1A2 mRNA | 26144063 |
| C052920 | trimethylarsine oxide | trimethylarsine oxide results in increased expression of CYP1A2 protein | 26144063 |
| C052920 | trimethylarsine oxide | trimethylarsine oxide results in increased expression of CYP1A2 mRNA | 17481689 |
| D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP1A2 protein | 18079364 |
| D014315 | Triterpenes | Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of CYP1A2 mRNA] | 18544911 |
| C057693 | troglitazone | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to troglitazone | 23397584 |
| D014363 | Tryptamines | Tryptamines analog results in decreased activity of CYP1A2 protein | 26599973 |
| D014363 | Tryptamines | [Tryptamines analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin | 26599973 |
| C112106 | UAB 30 | UAB 30 results in increased expression of CYP1A2 mRNA | 19135037 |
| C112106 | UAB 30 | UAB 30 analog results in decreased expression of CYP1A2 mRNA | 23292798 |
| C112106 | UAB 30 | UAB 30 results in increased expression of CYP1A2 mRNA | 23292798 |
| D014577 | Uroporphyrinogens | CYP1A2 protein affects the metabolism of Uroporphyrinogens | 9224771 |
| D014577 | Uroporphyrinogens | "2-amino-3,4-dimethylimidazo(4,5-f)quinoline inhibits the reaction [CYP1A2 protein results in increased oxidation of Uroporphyrinogens]" | 1567206 |
| D014577 | Uroporphyrinogens | CYP1A2 protein results in increased oxidation of Uroporphyrinogens | 1567206 |
| D014577 | Uroporphyrinogens | Ketoconazole inhibits the reaction [CYP1A2 protein results in increased oxidation of Uroporphyrinogens] | 1567206 |
| D014577 | Uroporphyrinogens | Phenacetin inhibits the reaction [CYP1A2 protein results in increased oxidation of Uroporphyrinogens] | 1567206 |
| D014577 | Uroporphyrinogens | CYP1A2 protein results in increased oxidation of Uroporphyrinogens | 1617633 |
| D014577 | Uroporphyrinogens | [Methylcholanthrene results in increased activity of CYP1A2 protein] which results in increased oxidation of Uroporphyrinogens | 1617633 |
| D014577 | Uroporphyrinogens | CYP1A2 protein affects the metabolism of Uroporphyrinogens | 9972481 |
| C066668 | vadimezan | Acridines analog inhibits the reaction [CYP1A2 protein results in increased oxidation of vadimezan] | 16120190 |
| C066668 | vadimezan | CYP1A2 protein results in increased oxidation of vadimezan | 16120190 |
| C406224 | valdecoxib | valdecoxib results in increased expression of CYP1A2 mRNA | 24136188 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of CYP1A2 mRNA | 17292431 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of CYP1A2 mRNA | 17381134 |
| D014639 | Vanadium | Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] | 23423713 |
| D014639 | Vanadium | Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 23423713 |
| D014639 | Vanadium | Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] | 23423713 |
| D014639 | Vanadium | Vanadium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | 23423713 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CYP1A2 protein | 20435083 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CYP1A2 mRNA | 22352393|2421647 |
| C521013 | veliparib | CYP1A2 protein results in increased metabolism of veliparib | 21436403 |
| D014700 | Verapamil | Verapamil results in decreased activity of CYP1A2 protein | 18420780 |
| C025643 | vinclozolin | vinclozolin results in increased expression of CYP1A2 protein | 7986207 |
| C025643 | vinclozolin | [fenarimol co-treated with vinclozolin] affects the expression of CYP1A2 protein | 17686559 |
| C025643 | vinclozolin | [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP1A2 protein | 17686559 |
| C025643 | vinclozolin | vinclozolin results in increased expression of CYP1A2 protein | 7986207 |
| C029297 | vinylidene chloride | vinylidene chloride results in decreased expression of CYP1A2 protein | 10547960 |
| D024483 | Vitamin K 3 | Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D024483 | Vitamin K 3 | Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | 18493746 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in increased activity of CYP1A2 protein | 15603920 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in increased expression of CYP1A2 mRNA | 15603920 |
| C574123 | walrycin A | walrycin A results in increased expression of CYP1A2 mRNA | 22314385 |
| D014859 | Warfarin | CYP1A2 protein affects the metabolism of Warfarin | 14676821|1528051 |
| D014859 | Warfarin | CYP1A2 SNP affects the susceptibility to Warfarin | 28079798 |
| C009687 | wortmannin | wortmannin inhibits the reaction [INS1 protein inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] | 26466350 |
| C009687 | wortmannin | wortmannin inhibits the reaction [INS1 protein results in decreased expression of CYP1A2 mRNA] | 26466350 |
| C104536 | xanthohumol | "xanthohumol inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA]" | 22138251 |
| C104536 | xanthohumol | xanthohumol results in increased expression of CYP1A2 mRNA | 22138251 |
| D015016 | Yohimbine | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CYP1A2 mRNA | 28843594 |
| C062735 | zafirlukast | zafirlukast inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | 9701106 |
| C029659 | zearalenol | CYP1A2 protein results in increased hydroxylation of zearalenol | 19931366 |
| C029659 | zearalenol | [CYP1A2 protein results in increased hydroxylation of zearalenol] which results in increased chemical synthesis of Catechols | 19931366 |
| C063449 | zileuton | zileuton inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | 14570767 |
| C063449 | zileuton | zileuton results in decreased activity of CYP1A2 protein | 14570767 |
| D015032 | Zinc | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] | 21424224 |
| C017803 | zinc protoporphyrin | [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP1A2 protein | 26747958 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of CYP1A2 mRNA | 24714768|2559613 |
| C089750 | zolmitriptan | zolmitriptan results in decreased activity of CYP1A2 protein | 18816299 |
| C049109 | zolpidem | CYP1A2 protein results in increased metabolism of zolpidem | 16449812 |
| D015049 | Zoxazolamine | CYP1A2 protein results in increased metabolism of and results in decreased activity of Zoxazolamine | 16109766 |